UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 20172023
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to ____
Commission File Number: 001-36537
TRUPANION, INC.
(Exact name of registrant as specified in its charter)
Delaware
Delaware83-0480694
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
6100 4th Avenue S, Suite 200
Seattle,Washington98108
Seattle, Washington 98108
(855)727 - 9079
(855) 727 - 9079
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Exchange on Which Registered
Common Stock,stock, $0.00001 par value per shareTRUPThe NASDAQ Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. o Yes x No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. o Yes x No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. xYes o No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). xYes o No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of large"large accelerated filer, accelerated" "accelerated filer, and smaller" "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated fileroAccelerated filerx
Non-accelerated filero(Do not check if smaller reporting company)Smaller reporting companyo
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  x
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes x No
The aggregate market value of the registrants common stock held by non-affiliates as of June 30, 2017,2023, the last business day of the registrants most recently completed second fiscal quarter, was approximately $521,061,388$622,812,960 using the closing price on that day of $22.38.$19.68.
As of February 7, 2018,19, 2024, there were approximately 30,128,27741,814,768 shares of the registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference from the definitive proxy statement to be filed by the registrant in connection with the 20182024 Annual Meeting of Stockholders (Proxy Statement). The Proxy Statement will be filed by the registrant with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the registrant’s fiscal year ended December 31, 2017.2023.







TRUPANION, INC.
Annual Report on Form 10-K
For the Fiscal Year Ended December 31, 20172023
TABLE OF CONTENTS

Page
Item 1.
Item 1A.
Item 1B.
Item 2.1C.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
Item 15.
Item 16.








Note About Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act), and sectionSection 27A of the Securities Act of 1933, as amended (Securities Act).All statements contained in this Annual Report on Form 10-K other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “potentially,” “estimate,” “target,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan” and “expect,” and similar expressions that convey uncertainty of future events or outcomes, are intended to identify forward-looking statements.
These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I. Item 1A. “Risk Factors” and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Annual Report on Form 10-K may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
You should not rely on forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law.


Unless otherwise stated or the context otherwise indicates, references to “we,” “us,” “our” and similar references refer to Trupanion, Inc. and its subsidiaries taken as a whole.





2






PART I
Item 1. Business
Our Mission
Our mission is to help the pets we all love receive the best veterinary care.loving, responsible pet owners budget and care for their pets.
Our Company and ApproachOverview
We provide medical insurance for cats and dogs throughoutin the United States, Canada, Continental Europe, and Puerto Rico. OurAustralia. Through our data-driven, vertically-integrated approach, enables us to provide pet owners with what we believe is the highestdevelop and offer high value medical insurance for their pets,products, priced specifically for each pet’s unique characteristics.characteristics and coverage level. Our growing and loyal membermembership base provides us with highly predictable and recurring revenue.
We operate in two business segments: subscription business and other business. We generate revenue in our subscription business segment primarily by subscription fees from direct-to-consumer products. We operate our subscription business segment similar to other subscription-based businesses, with a focus on maximizingachieving a target margin prior to our pet acquisition expense and acquiring as many pets as possible at our targeted average estimated internal rate of return. Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties and, in Canada, low and medium average revenue per unit (ARPU) products marketed under the lifetime valuebrand names Furkin and PHI Direct. We provide a full suite of each pet while sustaining a favorable ratioservices and support for these products and they are designed to align with the target margin profile of lifetime value relative to acquisition cost, based on our desired return on investment.subscription business segment. Within our subscription business segment we also offer products in Continental Europe, which are currently underwritten using third-party underwriters.
Our target marketother business segment is largecomprised of revenue from other product offerings with third parties with whom we generally have a business-to-business relationship. This business segment has a different margin profile than our subscription segment and under-penetrated. We have pioneered a unique solution that sits at the centerincludes revenue from writing policies on behalf of the pet medical ecosystem, meeting the needs of pets, pet ownersthird parties and veterinarians,revenue from other products and we believe we are uniquely positioned to continue to drive market penetration. insurance software solutions.
Our aggregate total pets enrolled grew from 31,207 pets on January 1, 2010 to 423,194 pets on December 31, 2017, which represents a compound annual growth rate of 39%.Business
Total Revenue by New and Existing Pets Enrolled
(in millions)
It is very difficult for pet owners to budget for veterinary expenses when their pet becomingpets become sick or injured when petinjured. Pet owners don'tdo not know whether their pet'spet’s health will be average,“average,” “lucky,” or “unlucky.” Over the life of a pet, veterinary expense for a lucky orversus unlucky and the cost of medical care varies dramatically by geography and pet breed. Acan vary from $500 to more than $50,000. Even if a pet owner budgeting for average medical care costs is not an effective solution for an unlucky pet. Additionally,ends up being “average” over its life, the timing of accidents or illnesses may not align with the owner's budgeting approach. pet owner’s budget. Further, many pet owners do not know how to budget for the “average” cost of medical care for their pets. Average veterinary expenses often greatly exceed the expectations of pet owners and vary dramatically based on a multitude of factors, including the availability of care by region and the types of treatments advisable for specific pet breeds. Consequently, self-insuring is not an effective solution for many pet owners as the cost of pet medical care has been outpacing inflation for over 20 years due to advancements in medical procedures and technology and due to increased availability of high-quality care.
Our monthly subscription products, priced specifically for each pet’s unique characteristics and coverage level, help pet owners budget for unforeseen medical expenses. Through our high quality medical insurance products, pet owners are able to ensure coverage for the best care for their pet and avoid decisions being made due to financial constraints. Our monthly subscription business model also provides us with high quality predictable and recurring revenue.
Our subscription business’s cost-plus model is designed to spread the risk evenly within each categorycategories of pets. Our goalpets so our members can better budget for unexpected veterinary costs. We have been collecting comprehensive pet health data for over 20 years. We believe our data and approach to pricing is unmatched by other pet insurers and provides us with a greater understanding of anticipated veterinary costs. We leverage this to chargeprice our subscription plan for each pet the appropriate amount forbased on their specific circumstances (e.g.,such as breed, age at enrollment,(at enrollment), geography, etc.)desired deductible or co-payment and coverage level, so that, each pet receives the same value proposition, and, in aggregate, the extra amountamounts paid by owners of lucky pets covershelps to cover the veterinary costs incurred by unlucky pets. To an informed, responsible, and lovingWe believe our actuarial team, working with our granular data, is able to price our subscription plan much more accurately than any other players in the pet owner, Trupanion is a hedgehealth insurance industry, enabling us to help them budget for the unexpected cost and variable timing of necessary veterinary care.

3




We provide our members with a high-quality medical planthe most accurate cost and highest value proposition relative to coverage level.
Our core “Trupanion” product was designed by veterinarians to enable them to practice the best medicine – thus recommending the optimal treatment for the life of their cat or dog. Our product is simple, fair, and covers all unexpected illnesses and injuries, including those that are most likely to occur with particular breeds of pet, which other insurance providers may label as congenital or hereditary conditions. We pay 90% of actual veterinary costs if a pet becomes sick or injured, including all diagnostic tests, surgeries, and medications. In general, only certain taxes, examination fees, and medical issues existing prior to enrollment are not included. Once enrolled in our subscription, we pay for the veterinary costs for the pet's entire life, and pet owners are free to use any licensed veterinarian in the United States and Canada, including any referral or specialty hospital. We aim to pay veterinarians directly, within five minutes of the veterinary invoice being created and prior to the pet owner checking out, eliminating the traditional reimbursement model and providing our members the convenience of not having to pay out of pocket or confirm treatment.
Veterinarians are able to recommend treatment to Trupanion members without having their decisions dictated by costs or the financial burden of the pet owner. Veterinarians, aspet. As a result, are ablewe believe our Trupanion-branded products enable veterinarians to establish stronger relationshipsties and better alignment with pet owners who are protected by Trupanion. Our members tend totheir clients. Members with a Trupanion-branded product visit veterinarianstheir veterinarian more frequently and selectspend more money on the best course of treatment for their pet regardlesspet.This results in better health outcomes for pets, which we believe creates a flywheel effect that has been the key driver of cost.growth for our subscription business.
We generate revenue primarily from our members' subscription fees. Fees are paid at
3



Through the beginning of each subscription period, which automatically renews on a monthly basis. Since 2010, at least 88%use of our proprietary, patented software designed to communicate directly with a veterinary hospital’s practice management system, we are able to offer a differentiated experience to pet owners. Using our software, veterinary hospitals can receive payment from us directly for approved invoices in seconds, with their clients (our members) only paying their deductible or co-payment for covered treatments. We believe this unique and patented solution, which is offered free to veterinarians and pet owners, transforms the insurance experience.
Through our "Powered by Trupanion" suite of products, which are marketed by third parties, we are broadening our distribution in the retail and corporate worksite channels. Our "Powered by Trupanion" products offer the same differentiated experience Trupanion pet owners receive but with options for varying levels of coverage to meet budgetary requirements. Our Furkin and PHI Direct products are currently distributed direct-to-consumer in Canada.
Our other business segment is comprised of other product offerings with third parties with whom we generally have a business-to-business relationship, and this business segment has a different margin profile than our subscription business revenue every quarter has come from existing members who had active subscriptions at the beginningsegment. Products in this segment include providing pet medical insurance policies on behalf of the quarter. DueU.S. Department of Veterans Affairs program, employer sponsored programs, and underwriting policies on behalf of third parties that do not carry reference to the Trupanion brand. Additionally, our focusother business segment includes the sale of insurance software solutions.
Our target markets are large and under-penetrated, as measured by insured pets:
North America1
Continental Europe2
Australia3
Household dogs and cats (in thousands)210,000 160,750 8,900 
Pet insurance market penetration3.0 %8.4 %9.0 %
1According to IBIS World and Canadian Animal Health Institute, there are approximately 210 million household dogs and cats in the United States and Canada. North American Pet Health Insurance Association estimates that the penetration rate for medical insurance for cats and dogs in North America is approximately three percent. We believe that over the long-term, the North American penetration rate can reach levels comparable to the U.K., where, according to Global Market Insights, approximately one in four cats and dogs has medical insurance.
2According to FEDIAF European Facts & Figures, GfK Czech consumer panel, and KVL Czech Republic, there are approximately 161 million household dogs and cats in Continental Europe. The estimated penetration rate for medical insurance for cats and dogs is approximately eight and a half percent.
3According to PetKeen, there are approximately 8.9 million household dogs and cats in the Australia. The estimated penetration rate for medical insurance for cats and dogs is approximately nine percent.
Our total enrolled pets grew from 31,207 pets on providing a superior value proposition and member experience, our members are very loyal, as evidenced by our 98.5% average monthly retention rate since 2010. For more information regarding average monthly retention, including an explanation of how we calculate this metric, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Operating Metrics.”
We enrolled our first pet in Canada in 2000 and our first pet in the United States in 2008. Our revenue for the year endedJanuary 1, 2010 to 1,714,473 pets on December 31, 2017 was $242.7 million, representing2023, which represents a compound annual growth rate of 44% from33%. As a result, our revenue ofhas grown from $19.1 million for the year ended December 31, 2010. We have made and expectin 2010 to continue to make substantial investments$1,108.6 million in member acquisition and in expanding our operations to support our expected growth. For the year ended December 31, 2017, we had2023 which represents a net losscompound annual growth rate of $1.5 million and our accumulated deficit was $82.8 million at December 31, 2017.34%.
Total Rev by Quarter 12-31-23.jpg
4



Our Strategy
We are focused on attracting and retaining members by providing a best-in-class value and member experience by focusingexperience. In particular, we concentrate on the following strategies:following:
Increase the number of referringIncreasing leads from veterinary practices.hospitals. We intend to increase the number of veterinary practiceshospitals that are actively introducing Trupanionhelp their clients learn about high quality medical insurance, and to their clients.
Increase the number of referrals from active veterinary practices. We intend to continue increasing the number and quality of interactions that we have with veterinarians to accelerateincrease the rate at which active veterinary practiceshospitals refer leads to us leads.by leveraging our outside sales team of Territory Partners who interface directly with veterinarians.
IncreaseIncreasing referrals from members. We seek to grow the number of third-party referrals from members. We believe that it is critical to our long-term success that existing members that add a pet or refer their friends and family to Trupanion,Trupanion. We do so we focusby focusing on improving the member experience. For example, Trupanion Express® is designed to directly payexperience, including increasing the percentage of veterinary invoices eliminatingthat are paid directly to veterinarians through our patented, proprietary software.
Improving conversion. We are investing to increase the reimbursement model and transforming the payment process to simplify the administrative hasslerate at which we convert pet owners receiving quotes for our subscription plan into enrolled members.
Improve online lead generation and conversion. Targeting a 71% value proposition. We aim to return to our members 71% of premiums we collect in the aggregate, which we believe is the highest targeted value proposition in our industry. Our ability to target the highest sustainable value proposition stems from our low cost operating model. Achieving our targeted value proposition requires we grow our ARPU in-line with the cost of veterinary care.
Improving retention. Member retention is a key part of our strategy. Historically, members in their first year of membership have the lowest retention rate. We are investing in the education process for our online marketing capabilities,members and intend to continue to do soimproving initial member communication and experiences in order to fully captureincrease our retention rates.
Automating payment of veterinary invoices. We use artificial intelligence and machine learning to leverage data to automate the online opportunity. Our online marketing initiatives have played an integral rolepayment of a portion of our veterinary invoices. We intend to increase the percentage of veterinary invoices paid without human intervention with the goal of ensuring that we can process veterinary invoices in converting leads to enrolled petsseconds, at a lower cost and also in generating new leads.without reducing the quality of service.
Explore otherExpanding additional member acquisition channels. We regularly evaluateare growing new member acquisition channels.channels including employee benefits, point-of-sale, retail and direct-to-consumer, for the sale of our pet medical insurance products. We intendalso continue to aggressively pursue thosenew channels that we believe could, over time, generate an attractive ratio of lifetime value relative to acquisition cost, based ondeliver our desired return on investment.
ExpandAligning with strategic partners. We maintain relationships with players who are leaders in their field, have long-term alignment, and recognize the value of our brand and expertise. These companies generally have well-developed distribution channels but do not have our expertise in pet medical insurance.
Expanding internationally. While we are currently focused on capturing the large opportunitymajority of our revenue is derived from the sale of insurance products in the U.S. and Canadian markets,Canada, we may choosehave operations in Europe and operate in Australia through a joint-venture. We continue to explore other international expansion opportunities.
Expanding our product offering. We have introduced additional monthly subscription products, maintaining what we believe to be the highest value pet medical insurance, but with reduced coverage that is less expensive.
Pursuing non-insurance revenue offerings. We intend to continue pursuing opportunities to provide pet owners with complementary products and services. For example, we have invested in a pet food initiative to explore whether pets on a calorie-controlled, high-quality diet have improved health outcomes that can justify a decrease in the future.
Pursue other revenue opportunities.cost of their medical insurance. We may opportunistically engage in other revenue opportunities. For example, our wholly-owned insurance subsidiary, American Pet Insurance Company, has partnered with unaffiliated general agents offering pet insurance products since 2012.

4




also sell software solutions to third parties.
Sales and Marketing (New Pet Acquisition)
Marketing to Veterinarians
Veterinary practices representWe generate leads through a diverse set of member acquisition channels, which we then convert into members primarily through our largest referral source,contact center, website and combined withother direct-to-consumer activities. These channels primarily include leads from third-parties such as veterinarians, strategic partners and referrals from members, accounted for approximately 76%existing members.
We build awareness of our leads in 2017. Our Territory Partner model was designed to facilitate frequent, in-person, face-to-face communications with veterinarians and their staff aboutcore Trupanion product predominately through the benefitsveterinary community, engaging our team of Trupanion and high-quality medical insurance for the life of a pet. The most important job of a Territory Partner is to build strong relationships with each veterinarian hospital, so the staff can trust and recommend Trupanion. Alignment with veterinarians is critical for a positive member experience, long term retention, and pet owner referrals. We strongly believe that earning the trust of veterinarians and their staff is the first step to successfully capturing more of the North American market.
The current market for veterinary services is highly fragmented and includes many sole-owner veterinary practices and small veterinary practices that are difficult to reach. We believe that no pet insurance company has a referral group that compares in scale to our Territory Partners and that it would be extremely difficult, costly and time consuming to replicate.“Territory Partners." Our Territory Partners are independent contractors who market our product and are paid fees based on activity in their regions. Their role is to create meaningful, long-term relationships with veterinarians and to educate those veterinarians about the benefits of high quality medical insurance for pets. We believe this structure aligns our interests and provides a platform that we can leverage over time.
Sales Our Territory Partner approach is unique and Marketing to Pet Owners
We generate leads through a diverse set of third-party referrals and online member acquisition channels, which we then convert into members throughunmatched in our website and contact center.
Referrals from third-parties. We actively promote the value of Trupanion to veterinarians, veterinary affiliates (including purchasing groups and other veterinary membership organizations), corporate employee benefit providers, and shelters and breeders so they can inform their clients on the benefits of Trupanion. For the year ended December 31, 2017, 67% of our new pet enrollments were generated from these third-party referrals (excluding referral from existing members).
Referrals from existing members. For the year ended December 31, 2017, 26% of our new pet enrollments were generated from existing members adding a pet or referring their friends and family.
Online.industry. We believe many of our members spend somethat it would be extremely difficult, costly and time researching options before decidingconsuming for a competitor to purchase our subscription. A significant portion of the members we acquire from online leads come through our paid search marketing, email marketing, social media marketing and search engine optimization initiatives.replicate this model.
5



Competition
We compete primarily with consumers thatpet owners who choose to self-fund their veterinary costs, with cash ormainly via credit cards, as well as traditional "pet insurance" providersnew and new entrants to our market. The vast majority ofexisting pet owners in the United States and Canada do not currently have medical insurance for their pets. We are primarily focused on expanding the overall size of the market by improving the value proposition for consumers.brands. We view our primary competitive challenge as educating pet owners on why Trupanionhigh-quality medical insurance for pets is a better alternative to self-funding.self-insuring.
The vast majority of pet owners in the markets in which we operate do not currently have medical insurance for their pets and those that do have medical insurance for their pets do not typically move from one insurance company to another because pre-existing conditions would likely not be covered following a move. As a result, we are focused primarily on expanding the overall size of our markets by providing pet owners with high value, transparent medical coverage designed for each pet's unique characteristics and coverage level.
We have been competing against numerous brands at any given time in our operating history. In our experience, competing pet medical insurance companies generally fall into one of two segments: (a) traditional providers with low target price points and narrow coverage that is unlikely to cover things most likely to go wrong, like congenital and hereditary conditions, and (b) higher-value providers that offer some form of an annual plan designed to increase the cost of the plan as the pet ages.
In addition, new entrants backed by large insurance companies with substantial financial resources have attempted to enter the marketrecent years, there has been significant consolidation in the past and may do so again in the future. Further, traditional providers may consolidate,pet medical insurance industry resulting in the emergencemany brands being controlled by a small number of new providers that are vertically integrated or able to create other operational efficiencies, which could lead to increased competition. companies.
We believe that we have competitive strengthsadvantages that position usour product offering favorably relatedcompared to existing and potential competitors.other brands offered in the marketplace. These include:
broader coverage and a superior value proposition for pet owners due, in part, to our vertically integrated structure that reduces frictional costs,
a unique member acquisition strategy that weleverages the relationships our Territory Partners have developed using Territory Partners, in the veterinary community,
a proprietary database containing historicalover 20 years of comprehensive pet health data since the year 2000 that provides actionable data insights, a powerful technology infrastructure,enabling us to be more precise in our pricing and an experienced management team.pet acquisition expense, and

our patented, proprietary software which allows us to pay veterinary invoices directly at time of treatment.
5





Intellectual Property
We rely on federal, state, common law, and international rights, as well as contractual restrictions, to protect our intellectual property. We control access to our proprietary technology, software, and documentation by entering into confidentiality and invention assignment agreements with our employees and partners, and confidentiality and, in some cases, exclusive agreements with third parties, such as service providers, vendors, individuals and entities that may be exploring a business relationship with us. We also rely on a combination of intellectual property rights, including trade secrets, patents, copyrights, trademarks, and domain names to establish and protect our intellectual property. We seek to protect our proprietary position by filing patent applications in the United States and in jurisdictions outside of the United States related to our technology, inventions, and improvements that are important to our business. We hold six U.S. utility patents and one U.S. design patent related to our proprietary software, and we have multiple additional patent applications pending in the United States. We also have three issued utility patents and two issued design patents in other jurisdictions, as well as multiple additional patent applications pending. We additionally rely on data and market exclusivity, and patent term extensions when available. Our ability to protect and enforce our intellectual property rights is subject to risk and our failure to do so may adversely impact our business.
EmployeesHuman Capital Resources
We highly value our company culture. Our Team
We are a mission-driven company and attract employees that share ourmission driven organization with a diverse team united by a shared passion for pets. Our culture enablesteam members are our employees to channel that passion collectively toward our goalsgreatest asset, and is keywe focus on attracting great people to our success. team and offering high-quality experiences to all team members.
As of December 31, 2017,2023, we had 523 employees.employed 1,142 people across the U.S., Canada and Europe. Our team is further supported by 185 field sales Territory Partner business owners and their associates who represent Trupanion. We also contract with team members in the Philippines through a third-party service provider, and we operate in Australia through a joint venture.
Our team is increasingly global with team members working in our Seattle headquarters in the United States, in our offices in the U.K., Germany, and Czechia, and virtually across the U.S., Canada, and Europe. Our Seattle headquarters is pet friendly.
6



Benefits
We offer each team member substantially the same benefits, regardless of role or level in the organization (with appropriate variations due to the country in which they reside). We also recognize the importance of family and design our benefits plans to support the physical, financial, and emotional wellbeing of team members and their families.
The benefits available to all team members regardless of role include:
Childcare & Support for Parents – We understand the importance of family and offer benefits to support working parents.Most notably, we offer onsite childcare at our Seattle headquarters. Trupanion pays 100% of the tuition costs for one child per Trupanion team member, when space is available.
Resources for Wellbeing – We offer a variety of benefits to support wellness at and away from work, including free access to our onsite gym and an Employee Assistance Program for confidential support to navigate life's challenges. We also offer to our team members globally a virtual healthcare concierge service through a leading third-party provider specializing in the field of virtual medicine.
Sabbatical – For every five consecutive years of service at Trupanion, team members are eligible for a paid five-week sabbatical.
Paid Volunteer Time – The TruGiving Volunteer Program offers one paid work day per year to volunteer with an organization of each team member's choice.
Paid Time Off – At least four weeks of paid time off is granted to team members each year in January, and increases with tenure.
Medical Insurance for You – Trupanion pays 100% of the premiums for team members’ medical, dental, and vision coverage and offers options to enroll eligible family members.
Medical Insurance for Your Pet – Team members have the option to enroll one dog or cat in 100% company paid Trupanion medical insurance at the highest coverage level we offer.
Health Savings Account – Team members enrolled in our eligible medical plan have access to a Trupanion funded Health Spending Account.
Flexible Spending DollarsTeam members receive flexible spending dollars each year on benefits of their choice, including contributions to dependent premiums, fitness and nutrition, childcare, and personal development.
Leave of Absence & Salary Continuation – We provide all team members that are too ill or injured to work with access to time off through leave of absence at a reduced percentage of their salary through our disability pay programs.
Severance and Change in Control Policy – We have a Severance and Change in Control policy that applies equally to all team members, regardless of their role at Trupanion.
Diversity, Equity, and Inclusion
We believe that diversity, equity, and inclusion (DEI) is critical to supporting our fellow team members and enhancing our ability to fulfill our mission and achieve our goals. We strive to foster an environment where diversity of people with different perspectives and backgrounds can thrive. A core tenet of Trupanion is that we offer a work experience that applies equally to all team members, regardless of role, as noted for example with respect to our Benefits offerings. This approach extends throughout the way we work together; for example, team members that come into any of our offices work in an open environment where the size of working space is the same for everyone regardless of role or seniority.
We have multiple employee-led resource groups that celebrate aspects of our team’s diversity and help foster a welcoming and safe space for support, education, professional development, and networking. Our DEI Committee is also employee-led and focuses on cultivating a culture of inclusion and belonging by supporting DEI activities, fostering effective DEI communications with Trupanion employees and advising on ways to improve progress in Trupanion's commitment to DEI. We have also developed a DEI curriculum that is required for all team members, and we continue to develop accessibility enhancements to both our physical and digital spaces.
We have a large representation of women at Trupanion including 61% of leadership positions. Our culture of inclusion at Trupanion is in part reflected by, in 2023, 39% of our US new hires self-identifying that they are from an underrepresented group.
Trupanion is committed to paying equitably for equal work, regardless of gender or race/ethnicity, and conducts pay equity analyses as part of our efforts in furtherance of this commitment.
7



Career Development
At Trupanion we are committed to helping everyone grow and thrive along with the company. We are proud to continually see approximately 15% of our team members transitioning to new roles within Trupanion each year. Team members have access to ongoing development designed to help them succeed in their roles today, develop skills for the future, and build a career at Trupanion.
A sampling of our development opportunities include:
Trupanion Embark! – All team members participate in company orientation to learn about our history, culture, product, business model, and operations.
Mentorship – Our TruMentor program creates connection across departments, so team members can learn from and support each other in their development.
Professional skills – Our continuing education course catalogue includes a wide variety of topics related to our business, the animal health industry, and professional skills.
Leadership Development – Our Leadership Unleashed program offers development for aspiring, new and experienced managers to drive ownership and growth for the future of our business.
Regulation
Each For further information, refer to the Regulation section included in Part II Item 7 of this report.
United States Regulations
U.S. federal law and the laws and regulations of each United States state, the District of Columbiaterritory and U.S. territories and possessions, as well as all of the Canadian provinces, have insurance laws thatpossession apply to companies licensed to transact insurance business in the jurisdiction. Thethese jurisdictions. Our primary regulator of an insurance company, however, is located in its state of domicile. Our insurance subsidiary and underwriter, American Pet Insurance Company (APIC), is domiciled in New York State and its primary regulator is therefore the New York Department of Financial Services (NY DFS). serves as its primary regulator. APIC is currently licensed to do business in all 50 states, Puerto Rico and the District of Columbia in the United States.Columbia. As such, APIC is also subject to comprehensive regulation and supervision under laws and regulations of each U.S. state, territory, and federal laws.possession.
StateBecause APIC is domiciled in New York, APIC is subject to laws governing insurance regulators have broad authorityholding companies in New York. These laws, among other things, require that we file periodic information reports with respectthe NY DFS, including information concerning our capital structure, ownership, financial condition and general business operations; limit our ability to all aspectsenter into transactions between APIC and our other affiliated entities; restrict the ability of the insurance industry, including the following:any one person to acquire certain levels of our voting securities without prior regulatory approval; and restrict APIC’s ability to pay dividends to its holding company parent.
licensing to transact business, and approval and issuance of certificates of authority;
revoking or suspending previously issued certificates of authority;
assessing the officers and directors to ensure a minimum level of competency and trustworthiness;
licensing of individual producers and agents and business entities marketing and selling insurance products;
licensing of claims adjusters and third-party administrators;
penalizing for noncompliance with respect to licensing requirements and regulations;
admitting assets to statutory surplus and regulating the nature of investments;
regulating premium rate levels for the insurance products offered;
approving policy forms;
regulating claims practices; and
establishing reserve requirements and solvency standards.

RegulatorsOther state regulators also have broad authority to perform on-site market conduct examinations of our management and operations, marketing and sales, underwriting, customer service, claims handling and licensing. MarketRegulators may perform market conduct examinations can involve direct, on-site contact withby visiting our facilities for a companyperiod of time to identify potential regulatory violations, discussiondiscuss and correction of ancorrect identified problem,violations, or obtainingto obtain a better understanding of how the company is operatingwe operate in the marketplace.
State Further, U.S. state insurance laws and regulations in the United States require APIC to file financial statements with state insurance regulators everywherein each state where it is licensed and its operations and accounts are subject to examination at any time. APIC’s statutorily required financial statements are available to the public. APIC prepares statutory financial statements in accordance with accounting practices and procedures prescribed or permitted by these regulators. The National Association of Insurance Commissioners (NAIC) has approved a series of uniform statutory accounting principles (SAP) that have been adopted, in some cases with minor modifications, by all state insurance regulators. As a basis of accounting, SAP was developed to monitor and regulate the solvency of insurance companies. InWhen developing SAP, insurance regulators were primarily concerned with assuring an insurer’s ability to pay all its current and future obligations to policyholders. As a result, statutory accounting focuses on conservatively valuing the assets and liabilities of insurers, generally in accordance with standards specified by the insurer’s domiciliary state.state of domicile. The financial statements included in this document are prepared in accordance with U.S. generally accepted accounting principles. The values for assets, liabilities and equity reflected in these financial statements prepared in accordance with U.S. generally accepted accounting principles are usually different from those reflected in financial statements prepared under SAP.


6




In Canada, our medical2021, we established two new wholly-owned insurance is written by an unaffiliated Canadian-licensed insurer, Omega Generalsubsidiaries, ZPIC Insurance Company (Omega). Under the terms of our agreements with Omega, our subsidiary Trupanion Brokers Ontario acts as a general agent through a fronting(ZPIC) and reinsurance agreement with Omega pursuantQPIC Insurance Company (QPIC), domiciled in Missouri and Nebraska, respectively. ZPIC is currently licensed to which, we retain any financial risk associated with our Canadian business. Effective January 1, 2015, these agreements were restructured to include our segregated celldo business Wyndham Segregated Account AX (WICL), located in Bermuda. These restructured agreements automatically renew annually, but may be terminated by either party with one year’s written notice. Omega’s Canadian insurance operations are supervised and regulated by the Canadian federal, provincial and territorial governments. Omega is a fully licensed insurer in all of the Canadian provinces and territories in which we do business.
Though we are not directly regulated by the Bermuda Monetary Authority (BMA), WICL’s regulation and compliance impacts us as it could have an adverse impact on the ability of WICL to pay dividends. WICL is regulated by the BMA under the Insurance Act of 1978 (Insurance Act)41 states and the Segregated Accounts Company ActDistrict of 2000. The Insurance Act imposes on Bermuda insurance companies solvencyColombia. QPIC is currently licensed to do business in 30 states and liquidity standards, certain restrictions on the declaration and paymentDistrict of dividends and distributions, certain restrictions on the reduction ofColombia. We have funded required statutory capital and auditing and reporting requirements, and grants BMA the powers to supervise and, in certain circumstances, to investigate and intervene in the affairs ofthese new subsidiaries, however, neither subsidiary has begun underwriting insurance companies. Under the Insurance Act, WICLpolicies as a class 3 insurer is required to maintain available statutory capital and surplus at a level equal to or in excess of a prescribed minimum established by reference to net written premiums and loss reserves.
Under the Bermuda Companies Act of 1981, as amended, a Bermuda company may not declare or pay a dividend or make a distribution out of contributed surplus if there are reasonable grounds for believing that: (a) the company is, or would be after the payment, unable to pay its liabilities as they become due; or (b) the realizable value of the company’s assets would thereby be less than its liabilities. The Segregated Accounts Company Act of 2000 further requires that dividends out of a segregated account can only be paid to the extent that the cell remains solvent. The value of its assets must remain greater than the aggregate of its liabilities, issued share capital, and share premium accounts. Per our contractual agreements with WICL, the allowable dividend to be paid by WICL is equivalent to the positive undistributed profit attributable to the shares.
Insurance Holding Company Regulation
APIC is subject to laws governing insurance holding companies in New York, its state of domicile. These laws impact us in a number of ways, including the following:
We must file periodic information reports with the NY DFS, including information concerning our capital structure, ownership, financial condition and general business operations.
New York regulates certain transactions between APIC and our other affiliated entities, including the fee levels payable by APIC to affiliates that provide services to APIC.
New York law restricts the ability of any one person to acquire certain levels of our voting securities without prior regulatory approval. State insurance holding company regulations generally provide that no person, corporation or other entity may acquire control of an insurance company, or a controlling interest in any parent company of an insurance company, without the prior approval of such insurance company’s domiciliary state insurance regulator. Any person acquiring, directly or indirectly, 10% or more of the voting securities of an insurance company is presumed to have acquired “control” of the company. To obtain approval of any change in control, the proposed acquirer must file with the applicable insurance regulator an application disclosing, among other information, its background, financial condition, the financial condition of its affiliates, the source and amount of funds by which it will effect the acquisition, the criteria used in determining the nature and amount of consideration to be paid for the acquisition, proposed changes in the management and operations of the insurance company and other related matters. In considering an application to acquire control of an insurer, the insurance commissioner generally will consider such factors as the experience, competence and financial strength of the applicant, the integrity of the applicant’s board of directors and executive officers, the acquirer’s plans for the management and operation of the insurer and any anti-competitive results that may arise from the acquisition.
New York law restricts the ability of APIC to pay dividends to its holding company parent. These restrictions are based in part on the prior year’s statutory income and surplus. In general, dividends up to specified levels are considered ordinary and may be paid without prior approval, and dividends in larger amounts, or extraordinary dividends, are subject to approval by the NY DFS. An extraordinary dividend or distribution is defined as a dividend or distribution that, in the aggregate in any 12-month period, exceeds the lesser of (i) 10% of surplus as of the preceding December 31 or (ii) the insurer’s adjusted net investment income for such 12-month period, not including realized capital gains.

7




Financial Regulation of Insurers
Risk-Based Capital Requirements
The NAIC has adopted risk-based capital requirements for life, health and property and casualty insurance companies. Refer to Item 1A. “Risk Factors” for details of these requirements.
NAIC Insurance Regulatory Information System Ratios
The NAIC has developed a set of financial relationships or tests known as the Insurance Regulatory Information System, or IRIS, to assist state regulators in monitoring the financial condition of U.S. insurance companies and identifying companies requiring special attention or action. IRIS consists of a statistical phase and an analytical phase whereby financial examiners review insurers’ annual statements and financial ratios. The statistical phase consists of 12 key financial ratios based on year-end data that are generated from the NAIC database annually; each ratio has a “usual range” of results. For IRIS ratio purposes, APIC submits data annually to state insurance regulators who then analyze our data using prescribed financial data ratios. A ratio falling outside the prescribed “usual range” is not considered a failing result. Rather, unusual values are viewed as part of the regulatory early monitoring system. In many cases, it is not unusual for financially sound companies to have one or more ratios that fall outside the usual range. As of December 31, 2017, APIC had three such ratios outside the usual range, relating to net premiums written to surplus, change in net premiums written, and investment yield.2023.
Regulators may investigate or monitor an insurance company if its IRIS ratios fall outside the prescribed usual range. The inquiries made by state insurance regulators into an insurance company’s IRIS ratios can take various forms. In some instances, regulators may require the insurance company to provide a written explanation as to the causes of the particular ratios being outside the usual range, management’s actions to produce results that will be within the usual range in future years and what, if any, actions the insurance company’s domiciliary state insurance regulators have taken. Regulators are not required to take action if an IRIS ratio is outside the usual range, but, depending on the nature and scope of the particular insurance company’s exception, regulators may request additional information to monitor going forward and, as a consequence, may take additional regulatory action.
Insurance Guaranty Associations, Residual Markets, Wind Pools and State-specific Reinsurance Mechanisms
Most jurisdictions in which we operate have laws or regulations that require insurance companies doing business in the state to participate in various types of guaranty associations or other similar arrangements designed to protect policyholders from losses under insurance policies issued by insurance companies that become impaired or insolvent. Typically, these associations levy assessments, up to prescribed limits, on member insurers on the basis of the member insurer’s proportionate share of the business in the relevant jurisdiction in the lines of business in which the impaired or insolvent insurer is engaged. Some jurisdictions permit member insurers to recover assessments that they paid through full or partial premium tax offsets, usually over a period of years.
Some states in which APIC operates have residual markets, wind pools or state reinsurance mechanisms. The general intent behind these is to provide insurance to individuals and businesses that cannot find appropriate insurance in the private marketplace. The intent of state-specific reinsurance mechanisms generally is to stabilize the cost of, and ensure access to, reinsurance for admitted insurers writing business in the state. Historically, APIC has had minimal financial exposure to guaranty associations, residual markets, wind pools and state-specific reinsurance mechanisms; however there is no guarantee that these items will continue to be of low financial impact to APIC.
Federal Initiatives
The U.S. federal governmentlaw generally does not directly regulate the insurance business. Fromindustry. However, from time to time, various federal regulatory and legislative changes have been proposed in the insurance industry.proposed. Among the proposals that have in the past been, or are at present may be under consideration, are the possible introduction of federal regulation in addition to, or in lieu of, the current system of state regulation of insurers. There have also been proposals in various state legislatures (some of which have been enacted) to conform portions of their insurance laws and regulations to various model acts adopted by the NAIC. The NAIC has undertaken a Solvency Modernization Initiative focused on updating the U.S. insurance solvency regulation framework, including capital requirements, governance and risk management, group supervision, accounting and financial reporting and reinsurance. The NAIC Amendments are a result of these efforts. Additional requirements are also expected.

8






In August 2022, members of the National Association of Insurance Commissioners (NAIC) passed a pet insurance model act to establish appropriate regulatory standards for the pet insurance industry. It standardizes how insurers enforce waiting periods, certain policy conditions, and the sale of pet insurance in general. Since then, 7 states (DE, LA, ME, MS, NE, NH, and WA) have adopted the model act, some with slight variances, and 10 additional states (CA, DC, FL, MD, NY, NJ, OH, PA, RI, and VT) have draft legislation in progress for 2024. Trupanion is proactively engaged in the drafting and passage of the pet insurance law in these states through the North American Pet Health Insurance Association (NAPHIA).
In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) established a Federal Insurance Office within the U.S. Department of the Treasury. The Federal Insurance Office initially iswas charged with monitoring all aspects of the insurance industry (other than health insurance,(with exceptions for certain long-term care insurance and croptypes of insurance), gathering data and conducting a study on methods to modernize and improve the insurance regulatory system in the United States. It is not possible to predict whether, in what form or in what jurisdictions any of these proposals might be adopted, or the effect federal involvement in insurance will have, if any, on us.
PrivacyIndustry Regulations
The NAIC adopted risk-based capital requirements for life, health and Data Collection Regulationproperty and casualty insurance companies. APIC is subject to these risk-based capital requirements that require us to maintain certain levels of surplus, specifically $137.6 million as of December 31, 2023, to support our overall business operations in consideration of our size and risk profile. If we fail to maintain the amount of risk-based capital required, we will be subject to additional regulatory oversight. To comply with these regulations, we may be required to maintain capital that we would otherwise invest in our growth and operations. Refer to Item 1A. “Risk Factors” for additional details of these requirements.
There are numerous federal,Further, NAIC developed a set of financial relationships or tests known as the Insurance Regulatory Information System, or IRIS, to assist state regulators in monitoring the financial condition of U.S. insurance companies. As of December 31, 2023, APIC had one IRIS ratios outside the usual range relating to net premiums written to surplus. While a ratio outside the usual range is not considered a failing result, regulators may investigate or monitor an insurance company if its IRIS ratios fall outside the prescribed usual range. ZPIC and foreign laws regarding privacy and the protection of member data. The regulatory environment in this area for online businesses is very unsettled in the United States and internationally and new legislation is frequently being proposed and enacted.QPIC will be subject to similar regulations after they begin underwriting insurance policies.
Other Jurisdictions Regulations
In Canada, our insurance is written by an unaffiliated Canadian-licensed insurer, Omega General Insurance Company (Omega). Under the areaterms of information securityour agreements with Omega, we retain any financial risk associated with our Canadian business. In October 2023, Omega was acquired by Accelerant. Omega’s Canadian insurance operations are supervised and data protection, many states have passed laws requiring notification to users when thereregulated by Canadian federal, provincial and territorial governments and Omega is a security breach for personal data or requiringfully licensed insurer in all of the adoption of minimum information security standards. In addition, our operations subject us to certain payment card association operating rules, certification requirementsCanadian provinces and rules, including the Payment Card Industry Data Security Standard, a security standard for companies that collect, store or transmit certain data regarding credit and debit cards, credit and debit card holders and credit and debit card transactions.
Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or obtain and use our technology or data to develop products that may compete with our offerings. Policing unauthorized use of our technology or data is difficult. The laws of other countriesterritories in which we operate may offer little or no effective protectiondo business. In addition, we are required to fund a Canadian trust account in accordance with Canadian regulations. As of our proprietary technology. Our competitors could also independently develop technologies equivalentDecember 31, 2023, the account held CAD $15.7 million.
In 2022, we incorporated a new wholly-owned insurance subsidiary, GPIC Insurance Company (GPIC), domiciled in Canada. GPIC is currently licensed to ours,do business in all provinces and our intellectual property rights mayterritories in Canada except for Nunavut. We have funded required statutory capital to this new subsidiary; however, GPIC has not be broad enough for us to prevent competitors from selling products incorporating those technologies.
Companies in our industry and in other industries may own a large numberbegun underwriting insurance policies as of patents, copyrights and trademarks and may frequently request license agreements, threaten litigation or file suit against us based on allegations of infringement or other violations of intellectual property rights. From time to time, we face, and we expect to face in the future, allegations that we have infringed the trademarks, copyrights, patents and other intellectual property rights of third parties, including our competitors. As we face increasing competition and as our business grows, we will likely face more claims of infringement.
Information About Segments and Geographic RevenueDecember 31, 2023.
We have two reportablea segregated cell business segments. See Note 12called Wyndham Segregated Account AX (WICL), located in Bermuda. WICL is regulated by the Bermuda Monetary Authority (BMA). Insurance companies with a presence in Bermuda are subject to solvency and liquidity standards, certain restrictions on the declaration and payment of our audited consolidated financial statements includeddividends and distributions, certain restrictions on the reduction of statutory capital, and auditing and reporting requirements. In addition, BMA has the authority to supervise and, in this report for information about segmentscertain circumstances, investigate and geographic revenue. For financial information regarding our business, see Part II - Item 7 - "Management's Discussionintervene in the affairs of insurance companies. Most significantly, Bermudan law restricts WICL’s ability to declare or pay dividends and Analysisthe value of Financial ConditionWICL’s assets must remain greater than the aggregate of its liabilities, issued share capital, and Results of Operations" of this report and our audited consolidated financial statements and related notes included elsewhere in this report.share premium accounts.
Corporate Information
We were founded in Canada in 2000 as Vetinsurance Ltd. In 2006, we effected a business reorganization whereby Vetinsurance Ltd. became a consolidated subsidiary of Vetinsurance International, Inc., a Delaware corporation. In 2007, we began doing business as Trupanion. In 2013, we formally changed our name from Vetinsurance International, Inc. to Trupanion, Inc. Our principal executive offices are located at 6100 4th Avenue South, Seattle, Washington 98108, USA, and our telephone number is +1 (855) 727-9079. Our website address is www.trupanion.com. Information contained on, or that can be accessed through, our website is not incorporated by reference, and you should not consider information on our website to be part of this Annual Report on Form 10-K.

9






Available Information
We are required to file annual, quarterly and other reports, proxy statements and other information with the Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, as amended (Exchange Act).Act. We also make available, free of charge on the investor relations portion of our website at investors.trupanion.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after they are filed electronically with the SEC. You can inspect and copy our reports, proxy statements and other information filed with the SEC at the offices of the SEC’s Public Reference Room located at 100 F Street, NE, Washington D.C 20549 on official business days during the hours of 10 a.m. to 3 p.m. Eastern time. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the Public Reference Rooms. The SEC also maintains an Internet website at www.sec.gov where you can obtain our SEC filings. You can also obtain paper copies of these reports, without charge, by contacting Investor Relations at InvestorRelations@Trupanion.com.
Investors and others should note that we may announce material financial information to our investors using our investor relations website, SEC filings, our annual stockholder meeting, press releases, public conference calls, investor conferences, presentations and webcasts. We use these channels, as well as social media, to communicate with our members and the public about our company, our services and other issues. It is possible that the information we post on these channels, such as social media, could be deemed to be material information.

10






Item 1A. Risk Factors
Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this report, including our consolidated financial statements and related notes, as well as in our other filings with the SEC, in evaluating our business and before investing in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that are not expressly stated, that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, operating results, financial condition and prospects could be materially harmed. In that event, the price of our common stock could decline, and you could lose part or all of your investment.

Summary of Material Risk Factors
Our business is subject to numerous risks and uncertainties of which you should be aware. Among others, these risks relate to:
Our significant net losses since inception, ability to achieve and maintain profitability or our ability to maintain our rate of revenue growth in the future;
Our ability to grow and retain our member base, including uncertainties in the assumptions we use to determine our new pet acquisition spend, variable costs of attracting new members through online channels such as social media or search engines and from leads generated from Territory Partners, veterinarians and other third parties;
Our reliance on Territory Partners, whom we engage as independent contractors rather than employees, and other third parties;
The actual levels of our veterinary invoice expense (which may increase with use of our patented software for direct payment of invoices) and our ability to timely and accurately process valid invoices and to identify improper invoices;
Our ability to maintain certain levels of surplus capital under applicable insurance regulations;
Our ability to react to competitors and alternative financing methods for pet related medical costs;
Our ability to maintain and enhance our brand;
Our ability to maintain and scale our infrastructure, to invest in or acquire businesses, products or technologies, or otherwise manage our growth;
Changes in legal, judicial, social and other environmental conditions, which could result in unexpected claim and coverage liability;
Our reliance on key personnel and strategic relationships and our ability to maintain these relationships;
Fluctuations in foreign exchange rates, other issues relating to expanding our operations internationally, and general changes in the global economy that can cause our operating results to vary;
Ownership of multiple insurance subsidiaries in different jurisdictions;
Our ability to remediate the material weaknesses in internal control over financial reporting and maintain effective internal controls and security measures, including measures to mitigate cyber-attacks;
Our acceptance of automatic fund transfers, credit card and debit card payments;
Ownership of an office building;
Our ability to protect our intellectual property (IP), avoid violating IP rights of others, and maintain relationships with third parties providing necessary IP and technology to us;
The outcome of litigation or regulatory proceedings;
Our level of indebtedness, our ability to service our debt, and our ability to comply with covenants that may restrict our operations and limit our ability to expand our business;
Our ability to utilize net operating loss carryforwards and potential increases in our tax liabilities;
Our ability to comply with numerous laws and regulations applicable to our business, including state, federal and foreign laws relating to insurance, privacy, the internet, email and texting, and accounting matters; and
Our common stock, including missed earnings guidance, inadequate analyst coverage, trading volatility, lack of dividends, concentrated ownership, and anti-takeover provisions in our governing documents.

11



Risks Related to Our Business and Industry
We have incurred significant cumulative net losses since our inception and may not be able to achieve or maintain profitability in the future.
We have incurred significant cumulative net losses since our inception. We had aincurred net losslosses of $1.5$44.7 million forin the yearyears ended December 31, 2017. Additionally,2023 and 2022, and as of December 31, 2017, our2023, we had an accumulated deficit was $82.8of $216.3 million. We have funded our operations through equity financings and borrowings under a revolving linelines of credit and term loansloans. Our ability to achieve and more recently, positive cash flows from operations.maintain profitability will depend, in significant part, on obtaining new members, retaining our existing members, maintaining relationships with our strategic partners, and ensuring that our expenses, including new pet acquisition expense, do not exceed our revenue. We expect to make significant expenditures and investments in new pet acquisition and product initiatives and these expenditures may not be able to achieve or maintain profitabilityresult in the near future or at all.additional growth. Our recent growth, including our growth in revenue and membership may not be sustainable or may decrease, and we may not generate sufficient revenue to consistently achieve or maintain profitability. Additionally, we budget for our expense levels areexpenses based, in significant part, on our estimates of future revenue and many of these expenses are fixed in the short term. As a result, we may be unable to adjust our spending in a timely manner if our revenue falls short of our expectations.estimates. Accordingly, any significant shortfall of revenue in relation to our estimates could have an immediate negative effect on our financial results.
We have mademay not maintain our current rate of revenue growth.
Our revenue has increased quickly and plan to continue to make significant investments to growsubstantially in recent years. We believe that our member base. Our averagecontinued revenue growth will depend on, among other factors, our ability to:
improve our market penetration through cost-efficient and effective pet acquisition costprograms to attract new members;
convert leads into enrollments;
maintain high retention rates;
increase the lifetime value per pet;
maintain positive relationships with veterinarians and other lead sources;
maintain positive relationships with and increase the number of new pets we enroll depends on a number of factors, including the effectiveness of our sales execution and marketing initiatives, changes in costs of media, the mix of our sales and marketing expenditures and the competitive environment. Our average pet acquisition cost has in the past significantly varied and in the future may significantly vary period to period based upon specific marketing initiatives. We also regularly test new member acquisition channels and marketing initiatives, which often are more expensive than our traditional marketing channels and generally increase our average acquisition costs. We plan to expand the numberefficiency of Territory Partners in all of our target markets;
successfully integrate entities we use to reach veterinarians and other referral sources and to engage in other marketing activities, including direct to consumer advertising, which are likely to increaseacquire into our acquisition costs.business;
We expect to continue to make significant expenditures to maintain and expand our business internationally;
create and maintain positive relationships with strategic partners, particularly partners who present us with new sales channels and those who create software solutions for veterinary practices;
continue to offer products with a superior value with competitive features and rates;
price our subscriptions in relation to actual operating expenses and achieve required regulatory approval for pricing changes;
recruit, integrate and retain skilled, qualified and experienced sales professionals who can demonstrate our value proposition to new and existing members;
provide our members with superior service, including expenditures relatingtimely and efficient payment of veterinary invoices, and by recruiting, integrating and retaining skilled and experienced personnel who can efficiently review veterinary invoices and process payments;
generate new relationships and manage and maintain existing relationships and programs in our other business segment;
react to the acquisitionexisting and new competitors;
protect and defend our critical intellectual property;
increase awareness of new members, retentionand positive associations with medical insurance for pets and our brand;
react to unexpected developments and general macroeconomic conditions, including pandemics and unfavorable changes in economic conditions, such as inflation, rising interest rates, or a recession; and
successfully respond to and comply with regulations affecting our business and defend or prosecute any litigation.
You should not rely on our historical rate of revenue growth as an indication of our existing members and development and implementation of our technology platforms. These increased expenditures will make it more difficult for us to achieve and maintain future profitability. Our ability to achieve and maintain profitability depends on a number of factors, including our ability to attract and service members on a profitable basis. If we are unable to achieve or maintain profitability, we may not be able to execute our business plan, our prospects may be harmed and our stock price could be materially and adversely affected.performance.
12



We base our decisions regarding our membernew pet acquisition expenditures primarily on the projected lifetime value of the pets that we expect to acquire and the projected internal rate of return on marketing spend. Our estimates and assumptions may not accurately reflect our future results - we may overspend on membernew pet acquisition, and we may not be able to recover our memberpet acquisition costs or generate profits from these investments.
We invest significantly inhave made and plan to continue to make significant investments to grow our member acquisition.base. We spent $19.1$77.4 million on sales and marketingin new pet acquisition expense to acquire new members for the year ended December 31, 2017. We expect to2023. Our average pet acquisition cost and the number of new pets we enroll depends on a number of factors and assumptions, including the effectiveness of our sales execution and marketing initiatives, changes in costs of media, the mix of our pet acquisition expenditures and the competitive environment. Our average pet acquisition cost has increased over time and has significantly varied in the past. In the future, our average pet acquisition cost may continue to spend significant amountsrise or fall and vary significantly period to acquire additional members. We utilize Territory Partners, who are paid feesperiod based on activity in their regions, to communicate the benefits of our subscription to veterinarians through in-person visits. Veterinarians then educate pet owners, who visit our website or call our contact center to learn more about, and potentially enroll in, our subscription.upon specific marketing initiatives. We also invest in other third-party referrals and direct to consumerregularly test new member acquisition channels thoughand marketing initiatives, including direct-to-consumer initiatives, which often are more expensive than our traditional veterinarian-focused marketing channels and generally increase our average acquisition costs.
In addition, we have limited experience with some of them.
We base our decisions regarding our membernew pet acquisition expenditures primarily on the lifetime valueour internal rate of the pets that we project to acquire.return generated on an average pet. This analysis depends substantially on estimates and assumptions based on our historical experience with pets enrolled in earlier periods, including our key operating metrics described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Operating Metrics.”


metrics. If our estimates and assumptions regarding our internal rate of return and the lifetime value of the pets that we project to acquire and our related decisions regarding investments in membernew pet acquisition prove incorrect, or if the expectedour calculation of internal rate of return and lifetime value of the pets that we project to acquire differs significantly from that of pets acquired in prior periods, we may be unable to recover our membernew pet acquisition costsexpenses or generate profits from our investment in acquiring new members. Moreover, if our membernew pet acquisition costsexpenses increase or we invest in member acquisition channels that do not ultimately result in any or an adequatethe expected number of new member enrollments or enrollments cancel before we recoup our acquisition expenses, the return on our investment may be lower than we anticipate irrespective of the lifetime value of the pets that we project to acquire as a result of the new members. If we cannot generate profits from this investment, we may need to alter our growth strategy,strategies, and our growth rate and operating results may be adversely affected.
If In addition, even if we are unable to maintain high member retention rates, our growth prospects and revenue will be adversely affected.
We have historically experienced high average monthly retention rates. For example,decrease our average monthly retention rate between 2010 and 2017 was 98.5%. Ifpet acquisition cost, our effortsoperating margins may differ from our expectations due to satisfy ourincorrect assumptions relating to existing members areadding new pets or referring friends, expenses for member support, and other factors, some of which we do not successful or if new marketing initiatives result in enrolling more pets that inherently have a lower retention rate, we may not be able to maintain our retention rates. Members we obtain through aggressive promotions or other channels that involve relatively less meaningful contact between us and the member may be more likely to terminate their subscription. In the past, we have experienced reduced retention rates during periods of rapid member growth, as our retention rate generally has been lower during the first year of member enrollment. Members may choose to terminate their subscription for a variety of reasons, including perceived or actual lack of value, delays or other unsatisfactory experiences in how we review and process veterinary invoice payments, unsatisfactory member service, an economic downturn, increased subscription fees, loss of a pet, a more attractive offer from a competitor, changes in our subscription or other reasons, including reasons that are outside of our control. Our cost of acquiring a new member is substantially greater than the cost involved in maintaining our relationship with an existing member. If we are not able to successfully retain existing members and limit terminations, our revenue and operating margins will be adversely impacted and our business, operating results and financial condition would be harmed.
The prices of our subscriptions are based on assumptions and estimates and may be subject to regulatory approvals.estimates. If our actual experience differs from the assumptions and estimates used in pricing our subscriptions or if we are unable to obtain any necessary regulatory approval for our pricing, approvals we need, at all or in a timely manner, our revenue and financial condition could be adversely affected.
The pricing of our subscriptions reflectreflects amounts we expect to pay for a pet'spet’s medical care derivedand we derive these prices from assumptions that we make regardingbased on our analytics platform. Our analytics platform draws upon pet data we collect and we use this data to price our policy in response to a number of factors, including a pet’s species, breed, age, gender and location. Factors related to pet location include the current and assumed changes in the cost and availability of veterinary technology and treatments and local veterinary practicehospital preferences. The prices ofSome data that feeds into our subscriptions also include assumptionsanalytics platform is provided by third-party sources and estimates regarding our own operating costs and expenses. We monitor and manage our pricing and overall sales mix to achieve target returns. Profitability from new members emerges over a period of years depending on the nature and length of time a pet is enrolled, and is subject to variability as actual resultsthese sources may differ from pricing assumptions. If the subscription fees we collect are insufficient to cover actual costs, including veterinary invoice expense, operating costs and expenses within anticipated pricing allowances,limit or if our member retention rates are not high enough to ensure recovery of member acquisition costs, then our gross profit could be adversely affected, and our revenue may be insufficient to achieve profitability. Conversely, if our pricing assumptions differed from actual results such that we overpriced risks, our competitiveness and growth prospects could be adversely affected. Further, even if our pricing assumptions are accurate, we may not be able to obtain the necessary regulatory approvals for any pricing changes that we may determine are appropriate based on our pricing assumptions, which could prevent us from obtaining sufficient revenue from subscriptions to cover our costs, including veterinary invoice expense, processing costs, pet acquisition costs and other expenses in any such jurisdiction unless and until such regulatory approvals are obtained in appropriate amounts.
The anticipated benefits of our analytics platform may not be fully realized.
Our analytics platform draws upon our proprietary pet data to price our subscriptions. Theaccessing the data. Additionally, the assumptions we make about breeds and other factors in pricing may prove to be inaccurate and, accordingly, these pricing analytics may not accurately reflect the expense that we will ultimately incur. Furthermore, if any of our competitors develop similar or better data systems, adopt similar or better underwriting criteria and pricing models or receive our data, our competitive advantage could decline or be lost.


OurThe prices of our subscriptions also reflect assumptions and estimates regarding our own operating costs and expenses. We monitor and manage our pricing and overall sales mix to achieve our target returns. If the actual costs, including veterinary invoice expenseexpenses, operating costs and expenses within anticipated pricing allowances, are greater than our assumptions and estimates such that the premiums we collect are insufficient to cover these expenses, then our results could be adversely affected and our revenue may exceedbe insufficient to consistently maintain profitability. Conversely, if our current reserve established for veterinary invoicespricing assumptions differ from actual results such that we overprice risks, our competitiveness and growth prospects could be adversely affected.
In addition, most states require licensure and regulatory approval prior to marketing new insurance products. Our practice has been to regularly reevaluate and adjust the price of our subscriptions, with a goal of achieving our targeted payout ratio, subject to the review and approval of applicable state regulators, who may reduce or disallow our pricing changes. Such review has in the past resulted (for instance, during the COVID-19 pandemic), and may in the future result, in delayed implementation of pricing changes, which could adversely affect our operating results and financial condition. In addition, we may be prevented by regulators from implementing significant pricing changes, requiring us to raise rates more often than we otherwise may desire. This could damage our reputation with our members and reduce our retention rates, which could significantly damage our brand, result in the loss of expected revenue and otherwise harm our business, operating results and financial condition.
13



If we are unable to grow our member base and maintain high member retention rates, our growth prospects and revenue will be adversely affected.
Our recorded reserve for veterinary invoices is basedability to grow our business depends on retaining and expanding our best estimates of the amount of veterinary invoices we expect to pay, inclusive of an estimate for veterinary invoices we have not yet received, after considering known facts and interpretations of circumstances and the estimated cost to process and pay those veterinary invoices. We consider internal factors, including data from our proprietary data analytics platform, experience with similar cases, actual veterinary invoices paid, historical trends involving veterinary invoice payment patterns, patterns of receipt of veterinary invoices, seasonality, pending levels of unpaid veterinary invoices, veterinary invoice processing programs and contractual terms. We may also consider external factors, including changes in the law, court decisions, changes to regulatory requirements and economic conditions. Because reserves are estimates of veterinary invoices that have been incurred but are not yet submitted to us, the establishment of appropriate reserves is an inherently uncertain and complex process that involves significant subjective judgment. Further, we do not transfer or cede our risk as an insurer and, therefore, we maintain more risk than we would if we purchased reinsurance. The ultimate cost of paying veterinary invoices and the related administration may vary materially from recorded reserves, and such variance may result in adjustments to the reserve for veterinary invoices, which could have a material effect on our operating results.
We rely significantly on Territory Partners, veterinarians and other third parties to recommend us.
We rely significantly on Territory Partners and other third parties to cultivate direct veterinary relationships and build awareness of the benefits that we offer veterinarians and their clients. In turn, we rely on veterinarians to introduce and recommend Trupanion to their clients. We also rely significantly on other third parties, such as existing members, online and other businesses, animal shelters, breeders and veterinary affiliates, including veterinarian purchasing groups and associations, to help generate leads for our subscription. Veterinary referred leads represent our largest member acquisition channel. Inbase. For the year ended December 31, 2017, approximately 76%2023, we generated 64.0% of our enrollments camerevenue from referrals from veterinariansour subscription business segment. In order to increase our membership, we must continue to convince prospective members of the benefits of medical insurance for pets in general and our subscription in particular. To maintain our existing members, as well as people adding petsmember base, we need to their existingcontinue to reinforce the value of our subscription.
Many factors influence the success of our relationships with these referral sources, including:
the continued positive market presence, reputation and growth of our company and of the referral sources;
the effectiveness of referral sources;
the decision of any such referral source to support one or more of our competitors;
the interest of the referral sources’ customers or clients in our subscription;
the relationship and level of trust betweenWe utilize Territory Partners, who are paid fees based on enrollments and retention in their regions, to communicate the benefits of medical insurance to veterinarians through a combination of remote and between us and the referral source;
the percentage of the referral sources’ customers or clients that submit applications or use trial certificates to enroll throughin-person communications. Veterinarians then educate pet owners, who visit our website or call our contact center;
our abilitycenter to implement or maintain any marketing programs, including trial certificates,learn more about these benefits, and potentially become members. We also invest in any jurisdiction;other third-party and
our ability to work with the referral source to implement any changes in our marketing initiatives, including website changes, infrastructure and technology and other programs and initiatives necessary to generate positive consumer experiences.
In order for us to implement our business strategy and grow our revenue, we must effectively maintain and increase the number and quality of our relationships with Territory Partners, veterinarians and other referral sources, and continue to scale and improve our processes, programs and procedures that support them. Those processes, programs and procedures could become increasingly complex and difficult to manage. We expend significant time and resources attracting qualified Territory Partners and providing them with complete and current information about our business. Their relationship with us may be terminated at any time, and, if terminated, we may not recoup the costs associated with educating them about our subscription or be able to maintain any relationships they may have developed with veterinarians within their territories. Sometimes a single relationship may be used to cover multiple territories so that a terminated relationship could significantly impact our company. Further, if we experience an increase in the rate at which Territory Partner relationships are terminated, we may not develop or maintain relationships with veterinarians as quickly as direct-to-consumer member acquisition channels, though we have in the past. If the financial costlimited experience with some of them. We intend to maintain our relationships withTerritory Partner model and structure and we plan to introduce other distribution channels to increase lead generation and to engage in other sales and promotional activities, including direct-to-consumer advertising, all of which are likely to increase our acquisition costs. In addition, these go-to-market plans may face unexpected delays, costs or other challenges, such as decreased ability of Territory Partners outweighs the benefits provided by Territory Partners, or if they feel unsupported or undervalued by us and terminate their relationshipto conduct in-person visits with us, our growth and financial performanceveterinarians.
Our ability to generate leads through veterinary hospitals could be adversely affected.


The success ofnegatively impacted if our relationships with veterinary practices depends on the overall value we can provide to veterinarians. If the scope of our subscriptionpolicy is perceived to be inadequate, unreliable, cumbersome or otherwise does not provide sufficient value, or if our process for paying veterinary invoices is unsatisfactory to the veterinarians' clients because, for example, a service is not included in our subscription, member requests for reimbursement are denied or we fail to timely settleveterinarians and pay veterinary invoices, veterinarians may be unwilling to recommend us to their clients and they may encourage their existing clients who have subscribed to stop or to purchase a competing product. If veterinarians determine our subscription is unreliable, cumbersome or otherwise does not provide sufficient value, they may terminate their relationship with us or begin recommending a competing product, which could negatively impact our ability to increase our member base and grow our business.clients.
If we fail to establish new or are unable to maintain successful relationships with Territory Partners, veterinarians and other referral sources, or experience an increase in the rate at which any of these relationships are terminated, it could negatively impact our ability to increase and retain our member base and our financial results. If we are unable to maintain our existing member acquisition channels and/or continue to add new member acquisition channels, if the cost of our existing sources increases or does not scale as we anticipate, or if we are unable to continue to use any existing channels or programs in any jurisdiction, including our trial certificateexam day offer program, our member levels and salespet acquisition expenses may be adversely affected.
We seek to convert pet owners who visit our website and call our contact center into members. The rate at which we convert these visitors into members is a significant factor in the growth of our member base. A number of factors have influenced, and could in the future influence, the conversion rates for any given period, some of which are outside of our control. These factors include:
the pricing and competitiveness of our subscription, including its perceived value, simplicity, and fairness;
our ability to explain and educate consumers regarding the benefits and differences related to our products, including our offerings marketed by third parties, and any potential consumer confusion as we add more products;
changes in consumer shopping behaviors due to circumstances outside of our control, such as increased inflation and other economic conditions, the COVID-19 pandemic and containment efforts, and consumers’ ability or willingness to pay for our product;
legal or regulatory requirements, including those that make the experience on our website cumbersome or difficult to navigate or that hinder our ability to communicate with potential members quickly and in a way that is more conducive to conversion; and
system failures or interruptions in our website or contact center.
We have made and plan to continue to make substantial investments in features and enhanced functionalities for our website and support our contact center. These enhancements are designed to help appropriately direct pet owner traffic to the enrollment journey of their choice, increase member engagement, and improve member service. These activities do not directly generate revenue, however, and we may never realize any benefit from these investments. If the expenses that we incur in connection with these activities do not result in sufficient growth in members to offset the cost, our business, operating results and financial condition will be adversely affected.
We have historically experienced high average monthly retention rates. For example, our average monthly retention rate between 2010 and 2023 was 98.5%. We expect to continue to make significant expenditures relating to the retention of existing members.
14



If we do not retain our existing members or if our marketing expensesinitiatives do not result in enrolling more pets or result in enrolling pets that inherently have a lower retention rate, we may not be able to maintain our retention and new pet acquisition rates. Members we obtain through aggressive promotions or other channels that involve relatively less meaningful contact between us and the member are more likely to terminate their subscription. In the past, we have experienced reduced retention rates during periods of rapid member growth, as our retention rate generally has been lower during the first year of member enrollment. Members may choose to terminate their subscription for a variety of reasons, including, loss of a pet, increased subscription fees, perceived or actual lack of value, delays or other unsatisfactory experiences in how we review and process veterinary invoice payments, unsatisfactory member service, a change in the economic environment, a more attractive offer from a competitor, changes in our subscription or other reasons, including reasons that are outside of our control. Our cost of acquiring a new member is substantially greater than the cost involved in maintaining our relationship with an existing member. If we are not able to successfully retain existing members and limit cancellations, our revenue and operating margins will be adversely impacted and our business, operating results and financial condition would be harmed.
We rely significantly on Territory Partners, veterinarians and other third parties, including strategic partners, to generate leads.
In order for us to implement our business strategy and grow our revenue, we must effectively maintain and increase the number and quality of our relationships with Territory Partners, veterinarians and veterinary affiliates, including veterinarian purchasing groups and associations, existing members, complementary online and other businesses, animal shelters, breeders and other referral sources, and continue to scale and improve our processes, programs and procedures that support them. Those processes, programs and procedures could become increasingly complex and difficult to manage as we grow.
Veterinary leads represent our largest member acquisition channel. We spend significant time and resources attracting qualified Territory Partners and providing them with current information about our business and they, in turn, communicate the benefits of medical insurance for pets to veterinarians. Our relationship with our Territory Partners may be terminated at any time (for instance, if they feel unsupported or undervalued by us), and, if terminated, we may not recoup the costs associated with educating them about our subscription products, and the relationships with veterinarians developed by that Territory Partner would be unsupported until such time a new Territory Partner is installed. Sometimes a single relationship may be used to cover multiple territories so that a terminated relationship with a Territory Partner could significantly affect our company. Further, if we experience an increase in the rate at which Territory Partner relationships are terminated, we may not develop or maintain relationships with veterinarians as quickly as we have in the past or need to in order to execute our business strategy and our growth and financial performance could be adversely affected.
Territory Partners are independent contractors and, as such, may pose additional risks to our business.
Territory Partners are independent contractors and, accordingly, we do not directly provide the same direction, motivation and oversight over Territory Partners as we otherwise could if Territory Partners were our own employees. Further, Territory Partners may themselves employ or engage others; we refer to these partners and their associates, collectively, as our Territory Partners. We do not control a Territory Partner’s employment or engagement of others, and it is possible that their actions or the actions of their employees and/or contractors could create threatened or actual legal proceedings against us. Moreover, applicable law might prevent or limit our ability to subject our Territory Partners to non-compete obligations. Similarly, Territory Partners may not require, or applicable law may not permit or may limit a Territory Partner’s ability to subject their employees or service providers tonon-compete obligations.
Territory Partners may decide not to participate in our marketing initiatives and/or training opportunities, accept our introduction of new solutions or comply with our policies and procedures applicable to them, any of which may adversely affect our ability to develop relationships with veterinarians and grow our membership. Our sole recourse againstIf we terminate a contract with a Territory Partners who fail to perform is to terminate their contract, whichPartner, such termination could also trigger contractually obligated termination payments or result in disputes, including threatened or actual legal or regulatory proceedings.
We believe that Territory Partners are not and should not be classified as employees under existing interpretations of the applicable laws of the jurisdictions in which we operate. We do not pay or withhold any employment tax with respect to or on behalf of Territory Partners or extend any benefits to them that we generally extend to our employees, and we otherwise treat Territory Partners as independent contractors. Applicable authorities or the Territory Partners have in the past questioned and may in the future challenge this classification. Further, the applicable laws or regulations, including tax laws or interpretations, may change. If it were determined that we had misclassified any of our Territory Partners, we may be subjected to penalties and/or be required to pay withholding taxes, extend employee benefits, provide compensation for unpaid overtime, or otherwise incur substantially greater expenses with respect to Territory Partners. In addition, the costs associated with defending, settling, or resolving pending and future lawsuits or regulatory proceedings (including demands for arbitration) relating to the independent contractor status of Territory Partners could be material to our business.
Any of the foregoing circumstances could have a material adverse impact on our operating results and financial condition.
Our member base has grown rapidly in recent periods, and we may not be able to maintain the same rate of membership growth.
15
Our ability to grow our business and to generate revenue depends significantly on attracting new members. For the year ended December 31, 2017, we generated 90% of our revenue from subscriptions. In order to continue to increase our membership, we must continue to offer a superior value to our members. Our ability to continue to grow our membership will also depend in part on the effectiveness of our sales and marketing programs. Our member base may not continue to grow or may decline as a result of increased competition or the maturation of our business.


We may not maintain our current rate of revenue growth.
Our revenue has increased quickly and substantially in recent periods. We believe that our continued revenue growth will depend on, among other factors, our ability to:
improve our market penetration through efficient and effective sales and marketing programs to attract new members;
maintain high retention rates;
increase the lifetime value per pet to, in turn, enable us to spend more on sales and marketing programs;
maintain positive relationships with veterinarians and other referral sources, and convince them to recommend our subscription;
maintain positive relationships with and increase the number and efficiency of Territory Partners;
continue to offer a superior value with competitive features and rates;


accurately price our subscriptions in relation to actual member costs and operating expenses and achieve required regulatory approval for pricing changes;
provide our members with superior member service, including timely and efficient payment of veterinary invoices, and by recruiting, integrating and retaining skilled and experienced personnel who can appropriately and efficiently review veterinary invoices and process payments;
generate new and maintain existing relationships and programs in our other business segment;
recruit, integrate and retain skilled, qualified and experienced sales department professionals who can demonstrate our value proposition to new and existing members;
react to changes in technology and challenges in the industry, including from existing and new competitors;
increase awareness of and positive associations with our brand; and
successfully respond to any regulatory matters and defend any litigation.
You should not rely on our historical rate of revenue growth as an indication of our future performance.
Our use of capital may be constrained by risk-based capital regulations or contractual obligations.
Our subsidiary, American Pet Insurance Company, is subject to risk-based capital regulations that require us to maintain certain levels of surplus to support our overall business operations in consideration of our size and risk profile. We have in the past and may in the future fail to maintain the amount of risk-based capital required to avoid additional regulatory oversight, which was $22.2 million as of December 31, 2017. To comply with these regulations and our related contractual obligations, we may be required to maintain capital that we would otherwise invest in our growth and operations, which may require us to modify our operating plan or marketing initiatives, delay the implementation of new solutions or development of new technologies, decrease the rate at which we hire additional personnel and enter into relationships with Territory Partners, incur indebtedness or pursue equity or debt financings or otherwise modify our business operations, any of which could have a material adverse effect on our operating results and financial condition.
We are also subject to a contractual obligation related to our reinsurance agreement with Omega General Insurance Company (Omega). Under this agreement, we are required to fund a Canadian Trust account in accordance with Canadian regulations. As of December 31, 2017, the account held CAD $2.8 million.
Unexpected increases in the number or amounts of veterinary invoices received, or that we expect to receive, may negatively impact our operating results.
Unexpected changes in the number or amounts of veterinary invoices received, or that we expect to receive, may negatively impact our operating results. Rising costs of veterinary care and the increasing availability and usage of more expensive, technologically advanced medical treatments may increase the amounts of veterinary invoices we receive. Increases in the number of veterinary invoices we receive could arise from unexpected events that are inherently difficult to predict, such as a pandemic that spreads through the pet population, tainted pet food or supplies or an unusually high number of serious injuries or illnesses. We may experience volatility in the number of veterinary invoices we receive from time to time, and short-term trends may not continue over the longer term. The number of veterinary invoices may be affected by the level of care and attentiveness an owner provides to the pet, the pet’s breed and age and other factors outside of our control, as well as fluctuations in member retention rates and by new member initiatives that encourage an increase in veterinary invoices and other new member acquisition activities. A significant increase in the number or amounts of veterinary invoices could increase our cost of revenue and have a material adverse effect on our financial condition.
Our success depends on our ability to review, process, and pay veterinary invoices timely and accurately.
We must accurately evaluate and pay veterinary invoices timelyoperate in a manner that gives our members high satisfaction. Many factors can affect our ability to do this, including the training, experience and skill of our personnel, our ability to reduce the number of payment requests made for services not included in our subscription, the department’s culture and the effectiveness of its management, our ability to develop or select and implement appropriate procedures, supporting technologies and systems, and changes in our policy. Our failure to fairly pay veterinary invoices, accurately and in a timely manner, or to deploy resources appropriately, could result in unanticipated costs to us, lead to material litigation, undermine member goodwill and our reputation, and impair our brand image and, as a result, materially and adversely affect our competitiveness, financial results, prospects and liquidity.


We may not identify fraudulent or improperly inflated veterinary invoices.
It is possible that a member, or a third-party actually or purportedly on behalf of the member, could submit a veterinary invoice which we would then pay that appears authentic but in fact does not reflect services provided or products purchased for which the member paid. It is also possible that veterinarians will charge insured customers higher amounts than they would charge their non-insured clients for the same service or product. Such activity could lead to unanticipated costs to us and/or to time and expense to recover such costs. They could also lead to strained relationships with veterinarians and/or members, and could adversely affect our competitiveness, financial results and liquidity.
Changes in the Canadian currency exchange rate may adversely affect our revenue and operating results.
We offer our subscription in Canada, which exposes us to the risk of changes in the Canadian currency exchange rates. For the year ended December 31, 2017, approximately 20% of our total revenue was generated in Canada. Fluctuations in the relative strength of the Canadian economy and the Canadian dollar has in the past and could in the future adversely affect our revenue and operating results.
We are and will continue to be faced with many competitive challenges, any ofmarket which could adversely affect our prospects, operating results and financial condition.
We are and will continue to operate in a competitive market. For instance, we compete with pet owners that self-finance unexpected veterinary invoices with savings or credit, as well as traditional "pet insurance"“pet insurance” providers and relatively new entrants into our market. The vast majority of pet owners in the United States and Canada do not currently have medical insurance for their pets. We are focused primarily on expanding our share of the overall market, and we view our primary competitive challenge as educating pet owners on why our subscription is a better alternative to self-financing.
Additionally, there are traditional insurance companies that provide pet insurance products, either as a stand-alone product or along with a broad range of other insurance products.products, such as wellness. In addition, new entrants backed by large insurance companies have attempted to enterentered (and in some cases exited) the petmedical insurance for pets market in the past and more may do so again in the future. Further, traditional "pet insurance"“pet insurance” providers may consolidate or take other actions to mimic the efficiencies from our vertically-integrated structure or create other operational efficiencies, which could lead to increased competition. The success of any of these competitors would, in time, affect our prospects, operating results and financial condition.
Some of our current and potential competitors have longer operating histories, larger customer bases, greater brand recognition and significantly greater financial, technical, marketing and other resources than we do. Some of ourIn addition to competing for new enrollments, such competitors may be able to undertakedrive up pet acquisition costs and/or make offers that are more extensive marketing initiatives for their brands and services, devote more resources to website and systems development and make more attractive offers to potential employees, referral sources and third-party service providers.
Moreover, some of our existing competitors may consolidate or be acquired, or may enter into new alliances with each other or establish or strengthen cooperative relationships. Any such consolidation, acquisition, alliance or cooperative relationship could adversely affect our ability to compete effectively and result in our loss of market share and could result in a competitor with greater financial, technical, marketing, service and other resources, all of which could harm our business, financial condition, cash flows and results of operations.
To compete effectively, we believe we will need to continue to invest significant resources in sales and marketing, in improvingpet acquisition, improve our member service levels, inenhance the online experience and functionalities of our website and in other technologies and infrastructure. Failure to compete effectively against our current or future competitors could result in loss of current or potential members, subscription terminations or a reduction in member retention rates, which could adversely affect our pricing, lower our revenue, and prevent us from achievingmaintaining profitability and diminish our brand strength.
We depend in part on Internet search engines to attract potential new members to visit our website. If Internet search engines’ methodologies are modified or maintaining profitability. our search result page rankings decline for other reasons, our new member growth could decline, and our business and operating results could be harmed.
We endeavor to drive significant traffic to our website from consumers who search for pet medical insurance through Internet search engines such as Google, Bing and Yahoo!. A critical factor in attracting consumers searching for pet medical insurance on the Internet to our website is whether we are prominently displayed in response to Internet searches relating to medical insurance for pets. Algorithmic search result listings are determined and displayed in accordance with a set of formulas or algorithms developed by the particular Internet search engine, which may change from time to time, and paid search advertisements often receive the most prominent listing. If we are listed less prominently in, or removed altogether from, search result listings for any reason, the traffic to our websites would decline and we may not be able to compete effectively for membersreplace this traffic, which in the future against existing or new competitors, and the failure to do so could result in loss of existing or potential members, increased sales and marketing expenses or diminished brand strength, any of which could harm our business.
If we are not successful in cost-effectively converting visitors to our website and contact center into members, our business and operating results would be harmed.
Our growth depends in large part upon growth in our member base. We seek to convert consumers who visit our website and call our contact center into members. The rate at which consumers visiting our website and contact center seeking to enroll in our subscription are converted into members is a significant factor in the growth of our member base. A number of factors have influenced, and could in the future influence, the conversion rates for any given period, some of which are outside of our control. These factors include:
the competitiveness of our subscription, including its perceived value, simplicity, and fairness;
changes in consumer shopping behaviors due to circumstances outside of our control, such as economic conditions and consumers’ ability or willingness to pay for our product;
the quality of and changes to the consumer experience when speaking with us on the phone or using our website;
regulatory requirements, including those that make the experience on our website cumbersome or difficult to navigate or that hinder our ability to speak with potential members quickly and in a way that is conducive to converting leads, enrolling new pets, and/or resolving member concerns;
system failures or interruptions in the operation of our abilities to write policies or operate our website or contact center; and


changes in the mix of consumers who are referred to us through various member acquisition channels, such as veterinary referrals, existing members adding a pet and referring their friends and family members and other third-party referrals and direct-to-consumer acquisition channels.
Our ability to convert consumers into members can be impacted by a change in the mix of referrals received through our member acquisition channels. In addition, changes to our website or contact center, or other programs or initiatives we undertake, may adversely impact our ability to convert consumers into members at our current rate, or at all. These changes may have the unintended consequence of adversely impacting our conversion rates. A decline in the percentage of members who enroll in our subscription on our website or by calling our contact center also could result in increased member acquisition costs. To the extent the rate at which we convert consumers into members suffers, the growth rate of our member base may decline, whichturn would harm our business, operating results and financial condition.
We have made and plan If we decide to continueattempt to make substantial investments in features and functionality for our website and training and staffing for our contact center that are designed to generatereplace this traffic, increase member engagement and improve new and existing member service. These activities do not directly generate revenue, however, and we may never realize any benefit from these investments.be required to increase our pet acquisition expenditures, including by utilizing paid search advertising. Certain of our competitors have spent additional funds to promote their products in search results over us. If the expenses that we incur in connection with these activities do not result in sufficient growth in membersdecide to offset the cost,respond by purchasing search advertising, our pet acquisition costs would increase which may harm our business, operating results and financial conditioncondition.
Our actual veterinary invoice expense may exceed our current reserve established for veterinary invoices and may adversely affect our operating results and financial condition.
We maintain a recorded reserve for veterinary invoices that is based on our best estimates of the amount of veterinary invoices we expect to pay, inclusive of an estimate for veterinary invoices we have not yet received, after considering internal factors, including data from our proprietary data analytics platform, experience with similar cases, actual veterinary invoices paid, historical trends involving veterinary invoice payment patterns, patterns of receipt of veterinary invoices, seasonality, pending levels of unpaid veterinary invoices, veterinary invoice processing programs and contractual terms. We may also consider external factors, including changes in the law, court decisions, changes to regulatory requirements and economic conditions, including the current inflationary environment. Because reserves are estimates of veterinary invoices that have been incurred but are not yet submitted to us, setting appropriate reserves is an inherently uncertain and complex process that involves significant subjective judgment. Further, in the United States, we do not transfer or cede our risk as an insurer and, therefore, we maintain more risk than we would if we purchased reinsurance.
16



Rising costs of veterinary care and the increasing availability and usage of more expensive, technologically advanced medical treatments may increase the amount of veterinary invoices we receive, especially in the current inflationary environment. Similarly, industry trends may emerge that are difficult to identify or to predict their impact on us, such as consolidated ownership of veterinary hospitals that increase prices more rapidly than we estimate.
Increases in the number and amount of veterinary invoices we receive could arise from unexpected or other events that are inherently difficult to predict or estimate, such as a pandemic that spreads through the pet population, tainted pet food or supplies or an unusually high number of serious injuries or illnesses. We may experience volatility in the number of veterinary invoices we receive from time to time, and short-term trends may not continue over the longer term. The number or amount of veterinary invoices may be affected by the level of care and attentiveness an owner provides to the pet, the pet’s breed and age (at enrollment) and other factors outside of our control, as well as fluctuations in member retention rates and by new member initiatives that encourage an increase in veterinary invoices and other new member acquisition activities.
The ultimate cost of paying veterinary invoices and the related administration may vary materially from recorded reserves, and such variance may result in adjustments to the reserve for veterinary invoices, which could have a material effect on our operating results and resources available for acquiring additional members.
If more veterinary hospitals install and use our patented proprietary software, the number or amounts of veterinary invoices we receive is likely to increase.
Our patented proprietary software is designed to integrate directly with most practice management software systems used by veterinary hospitals and allow us to receive and pay veterinary invoices directly to the hospital. We believe that it is critical to our long-term success to improve the member experience so we encourage veterinary hospitals to install and use our software. We have found that installation and use of our patented software by a veterinary hospital could increase the number of invoices we receive from that hospital. As more veterinary hospitals install our patented software, we expect the number or amount of veterinary invoices to increase and result in an increase in our cost of revenue, which may have a material adverse effect on our financial condition.
Our use of capital may be constrained by minimum capital requirements or contractual obligations.
Our insurance subsidiaries are required to maintain minimum levels of surplus capital to support our overall business operations in consideration of our size and risk profile. We have in the past and may in the future fail to maintain the amount of risk-based capital required to avoid potentially costly additional regulatory oversight. We are also subject to a contractual obligation related to our reinsurance agreement with Omega, who currently writes our policies in Canada. Under this agreement, we are required to fund a Canadian trust account in accordance with Canadian regulations.
To comply with these regulations and contractual obligations, we may be required to maintain capital that we would otherwise invest in our growth and operations, which may require us to modify our operating plan or marketing initiatives, delay the implementation of new initiatives or development of new technologies, decrease the rate at which we hire additional personnel and enter into relationships with Territory Partners, incur indebtedness or pursue equity or debt financings or otherwise modify our business operations, any of which could have a material adverse effect on our operating results and financial condition.
Our success depends in part on our ability to review, process, and pay veterinary invoices timely and accurately.
We believe member satisfaction and retention depends in part on our ability to accurately evaluate and pay veterinary invoices in a timely manner. Many factors can affect our ability to do this, including the training, experience and skill of our personnel, our ability to reduce the number of payment requests made for services not included in our subscription, effectiveness of management, our ability to develop or select and implement appropriate procedures, supporting technologies and systems, changes in our policy and veterinarian compliance with our protocols and procedures. Our failure to pay veterinary invoices, accurately and in a timely manner, or to deploy resources appropriately, could result in unanticipated costs to us, lead to material litigation, undermine member goodwill and our reputation, and impair our brand image and, as a result, materially and adversely affect our competitiveness, financial results, prospects and liquidity.
In addition, we use artificial intelligence and machine learning to leverage data so we can automate the payment of veterinary invoices. Although we intend to increase the percentage of veterinary invoices paid without human intervention and process veterinary invoices in seconds, our efforts may be unsuccessful for a number of reasons. The data we gather is extensive, and the development, maintenance and operation of our data analytics engine is novel, expensive and complex. We may face unforeseen difficulties, including material performance problems, undetected defects or technical obstacles, for example, with new capabilities incorporating machine learning. If such problems, defects, or obstacles prevent our proprietary algorithms from operating properly, we may incorrectly pay or deny claims made by our customers. Such errors could result in existing customers canceling their policies, prospective customers declining to purchase our subscription, or improper payments that reduce our resources. Additionally, our artificial intelligence and machine learning algorithms may lead to unintentional bias or discrimination, which could subject us to legal or regulatory liability that has a material and adverse effect on our business, results of operations and financial condition.
17



State legislatures and insurance regulators have shown interest in insurance companies' use of external data and artificial intelligence in insurance practices, including underwriting, marketing and claims practices. The National Association of Insurance Commissioners ("NAIC") adopted Artificial Intelligence Principles in August 2020. In addition, a number of states have had legislative or regulatory initiatives relating to the use of external data and artificial intelligence in the insurance industry, such as bulletins issued by the California and Connecticut Departments of Insurance advising insurers of their obligations related to unfair discrimination when using data and artificial intelligence. There is also increasing focus on regulating the use of artificial intelligence and machine learning in Europe such as the proposal by the European Commission for regulation on artificial intelligence using a comprehensive risk-based governance framework. Increased focus on regulation in the United States and foreign jurisdictions could subject us to legal or regulatory liability that has a material and adverse effect on our business, results of operations and financial condition.
We may not identify fraudulent or improperly inflated veterinary invoices.
It is possible that we may pay a veterinary invoice which appears authentic but in fact reflects false products or prices. It is also possible that veterinarians will becharge insured customers higher amounts than they would charge their non-insured clients for the same service or product, or may alter medical records or exclude information from records. Such activity could lead to unanticipated costs to us and/or to time and expense to recover such costs. They could also lead to strained relationships with veterinarians and/or members, and could adversely affected.affect our competitiveness, financial results and liquidity.
If we are unable to maintain and enhance our brand recognition and reputation, our business and operating results will be harmed.
We believe that maintaining and enhancing our brand recognition and reputation is critical to our relationships with existing members, Territory Partners, veterinarians and other referral sources,others, and to our ability to attract new members, new Territory Partners, and additional supportive veterinarians and other referral sources.veterinarians. We also believe that the importance of our brand recognition and reputation will continue to increase as competition in our market continues to develop and mature. Our success in this area will depend on a wide range of factors, some of which are out of our control, including the following:
the efficacy and viability of our salespet acquisition programs and marketing programs;initiatives;
the perceived value of our subscription;
the quality of service provided, including the fairness, ease and timeliness of reviewing and paying veterinary invoices;
actions of our competitors, Territory Partners, veterinarians and other referral sources;others;
positive or negative publicity, including regulatory pronouncements and material on the Internet or social media;
regulatory and other government-related developments; and
litigation-related developments.
The promotion of our brand maywill require us to make substantial investments, and we anticipate that, as our market becomes increasingly competitive, these branding initiatives may become increasingly difficult and expensive. Our brand promotion activities may not be successful or yield increased revenue, and to the extent that these activities result in increased revenue, the increased revenue may not offset the expenses we incur and our operating results could be harmed. If we do not successfully maintain and enhance our brand, our business may not grow and our relationships with veterinarians and other referral sources could be terminated, which would harm our business, operating results and financial condition.
Furthermore, negative publicity, whether or not justified, relating to events or activities attributed to us, our employees, Territory Partners, our strategic partners, our affiliates, or others associated with any of these parties, may tarnish our reputation and reduce the value of our brands. Damage to our reputation and loss of brand equity may reduce demand for our services and have an adverse effect on our business, operating results, and financial condition. Moreover, any attempts to rebuild our reputation and restore the value of our brands may be costly and time consuming, and such efforts may not ultimately be successful.

18




Our business depends on our ability to maintain and scale the infrastructure necessary to operate our technology platform and could be adversely affected by a system failure.
Our business depends on our ability to maintain and scale the infrastructure necessary to operate our technology platform, which includes our analytics and pricing engine, systems for managing veterinary invoice payments, customer relationship management system, contact center phone system and website. We use these technology frameworks to price our subscriptions, enroll members, engage with current members and pay veterinary invoices. Our members review and purchase subscriptions through our website and contact center, and we receive and pay veterinarian invoices directly through Trupanion Express®. Our reputation and ability to acquire, retain and serve our members depends on the reliable performance of our technology platform and the underlying network systems and infrastructure, and on providing best-in-class member service, including through our contact center and website. As our member base continues to grow, the amount of information collected and stored on the systems and infrastructure supporting our technology platform will continue to grow, and we expect to require an increasing amount of network capacity, computing power and information technology personnel to develop and maintain our technology platform and service our departments involved in member interaction.

We have made, and expect to continue to make, substantial investments in equipment and related network infrastructure to handle the operational demands on our technology platform, including increasing data collection, software development, traffic on our website and the volume of calls at our contact center. The operation of the systems and infrastructure supporting our technology platform is expensive and complex and could experience operational failures. In the event that our data collection, member base or amount of traffic on these systems grows more quickly than anticipated, we may be required to incur significant additional costs to increase the capacityidentified material weaknesses in our systems. Any system failure that causes an interruption ininternal controls which, if not remediated appropriately or decreases the responsiveness of our services could impair our revenue-generating capabilities, harm our business and operating results and damage our reputation. In addition, any loss or mishandling of datatimely, could result in breach of confidence, competitive disadvantage or loss of members, and subject us to potential liability. Any failure of the systems and infrastructure that we rely on could negatively impact our enrollments as well as our relationship with members. If we do not maintain or expand the systems and infrastructure underlying our technology platform successfully, or if we experience operational failures, our reputation could be harmed and we could lose current and potential members, which could harm our operating results and financial condition.
We have made, and expect to continue to make, significant investments in new solutions and enhancements to our technology platform. These new solutions and enhancements may not be successful, and we may not recognize the expected benefits.
We have a team of product and engineering professionals dedicated in part to enhancing our technology platform and developing new solutions. We have made, and expect to continue to make, significant investments in these new solutions and enhancements. For example, we have made significant investments in Trupanion Express®, which is designed to facilitate the direct payment of invoices to veterinary practices. These development and implementation activities may not be successful, and we may incur delays or cost overruns or elect to curtail our currently planned expenditures related to them. Further, if or when these new solutions or enhancements are introduced, they may not be well received by veterinarians or by new or existing members, particularly if they are costly, cumbersome or unreliable. Even if they are well-received, they may be or become obsolete due to technological reasons or to the availability of alternative solutions in the marketplace. If new solutions and enhancements are not successful on a long-term basis, we may not recognize benefits from these investments, and our business and financial condition could be adversely affected.
If we failan inability to effectively manage our growth, our business, operating results and financial condition may suffer.
We have recently experienced, and expect to continue to experience, significant growth, which has placed, and may continue to place, significant demands on our management and our operational and financial systems and infrastructure. We expect that our growth strategy will require us to commit substantial financial, operational and technical resources. It may also result in increased costs, including unexpected increases in our underlying costs (such as member acquisition costs or increases in the number or amounts of veterinary invoices received) generated by our new business, which could prevent us from becoming profitable and could impair our ability to compete effectively for business. Additionally, we have in the past, and may in the future, experience increases in terminations as our membership grows, which negatively affects our retention rate. If we do not effectively manage growth at any time,timely complete our financial condition could be harmed and the quality of our services could suffer.
In order to successfully expand our business, we need to hire, integrate and retain highly skilled and motivated employees. We also need to continue to improve our existing systems for operational and financial management. These improvements could require significant capital expenditures and place increasing demands on our management. We may not be successful in managing or expanding our operations or in maintaining adequate financial and operating systems and controls. If we do not successfully implement improvements in these areas, our business, operating results and financial condition will be harmed.


Our operating results may vary, which could cause the trading price of our stock to fluctuate or decline, make period-to-period comparisons less meaningful, and make our future results difficult to predict.
We may experience fluctuations in our revenue, expenses and operating results in future periods. Our operating results may fluctuate in the future as a result of a number of factors, many of which are beyond our control. These fluctuations may lead analysts to change their long-term models for valuing our common stock, cause us to face short-term liquidity issues, impact our ability to retain or attract key personnel or cause other unanticipated issues, all of which could result in declines in our stock price. Moreover, these fluctuations may make comparing our operating results on a period-to-period basis less meaningful and make our future results difficult to predict. You should not rely on our past results as an indication of our future performance. In addition, if revenue levels do not meet our expectations, our operating results and ability to execute on our business plan are likely to be harmed. In addition to the other factors listed in this “Risk Factors” section, factors that could affect our operating results include the following:
our ability to retain our current members and grow our member base;
the level of operating expense we elect to incur related to sales and marketing and technology and development initiatives that are discretionary in nature;
the effectiveness of our sales and marketing programs;
our ability to improve veterinarians’ and other third-parties’ willingness to recommend our subscription;
the timing, volume and amount of veterinary invoices and the adequacy of our related reserve;
our ability to accurately price our subscription and achieve required regulatory pricing approvals;
regulatory limitations or other constraints on our ability or our willingness to implement pricing changes;
the level of demand for and cost of our subscription or competing products;
fluctuations in applicable foreign currency exchange rates;
the perceived value of our subscription to veterinarians and pet owners;
spending decisions by our members and prospective members;
our costs and expenses, including pet acquisition costs and costs to pay and process veterinary invoices;
our ability to expand the scope and efficiency of our Territory Partner group;
our ability to effectively manage our growth;
the effects of increased competition in our business;
our ability to keep pace with changes in technology and our competitors;
the impact of any security incidents or service interruptions;
costs associated with defending any regulatory action or litigation or with enforcing our intellectual property, contractual or other rights;
the impact of economic conditions on our revenue and expenses; and
changes in government regulation affecting our business.
Seasonal or periodic variations in the behavior of our members also may cause fluctuations in our financial results. Enrollment in our subscription tends to be discretionary in nature and may be sporadic, reflecting overall economic conditions, budgeting constraints, pet-buying patterns and a variety of other factors, many of which are outside our control. For example, we expect to experience some effects of seasonal trends in visits to veterinarians in the fourth quarter and in the beginning of the first quarter of each year in connection with the traditional holiday season. While we believe seasonal trends have affected and will continue to affect our quarterly results, our growth may have overshadowed these effects to date. We believe that our business will continue to be subject to seasonality in the future,statements, which may result in fluctuations in our financial results.
Duea loss of investor confidence and an adverse impact to these and other factors, our financial results for any quarterly or annual period may not meet our expectations or the expectations of investors or analysts that follow our stock and may not be meaningful indications of our future performance.price.


Our vertical integration may result in higher costs.
We manage all aspects of our business, including operating our own insurance subsidiary, implementing our own national independent referral group of Territory Partners, pricing our subscriptions with our in-house actuarial team, processing and paying veterinary invoices, operating our own contact center and owning our own brand. While we believe this vertically integrated approach reduces frictional costs and enhances members' experiences, third-party providers may, now or in the future, be able to replicate this model, partially or entirely, on a more efficient and effective basis. If our in-house services are or become less efficient or less effective than the same services provided by a third party, we may not realize the related cost savings and may be unable to provide a superior membership experience, which may have an adverse effect on our operating results.
Our forecasts of market growth may prove to be inaccurate, and even if the market for medical insurance for cats and dogs in North America achieves the forecasted growth, our business may not grow at similar rates, if at all.
Growth forecasts are subject to significant uncertainty and are based on assumptions and estimates, which may not prove to be accurate. Although we believe that the North American market for pet medical insurance will grow over time if consumers are offered a high-value product, the market in North America has been historically growing slowly, if at all, and may not be capable of growing further. Even if this market experiences significant growth, we may not grow our business at similar rates, or at all. For example, the market for medical insurance for cats and dogs in North America has been highly competitive and may become even more competitive in the future. Our growth is subject to many factors, including our success in implementing our business strategy and maintaining our position in a highly competitive market, which are subject to many risks and uncertainties.
We depend on key personnel to operate our business and, if we are unable to retain, attract and integrate qualified personnel, our ability to develop and successfully grow our business could be harmed.
Our success depends to a significant extent on the continued services of our current management team, including Darryl Rawlings, our founder and Chief Executive Officer. The loss of Mr. Rawlings or several other key executives or employees within a short time frame could have a material adverse effect on our business. We employ all of our executive officers and key employees on an at-will basis, and their employment can be terminated by us or them at any time, for any reason and without notice, subject, in certain cases, to severance payment rights. In order to retain valuable employees, in addition to salary and cash incentives, we have provided stock options and restricted stock that vest over time and may in the future grant equity awards tied to company performance. The value to employees of stock options and restricted stock that vest over time will be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to maintain their retention benefit or counteract offers from other companies. Additionally, if we were to lose a large percentage of our current employees in a relatively short time period, or our employees were to engage in a work stoppage or unionize, we may be unable to hire and train new employees quickly enough to prevent disruptions in our operations, which may result in the loss of members, Territory Partners or referral sources.
Our success also depends on our ability to attract, retain and motivate additional skilled management personnel. We plan to continue to expand our work force, which we believe will enhance our business and operating results. We believe that there is significant competition for qualified personnel with the skills and knowledge that we require. Many of the other companies with which we compete for qualified personnel have greater financial and other resources than we do. They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than those we have to offer. If we are unable to attract and retain the necessary qualified personnel to accomplish our business objectives, we may experience constraints that will significantly impede the achievement of our business objectives and our ability to pursue our business strategy. New hires require significant training and, in most cases, take significant time before they achieve full productivity. New employees may not become as productive as we expect, and we may be unable to hire or retain sufficient numbers of qualified individuals. If our recruiting, training and retention efforts are not successful or do not generate a corresponding increase in revenue, our business will be harmed.
If we cannot maintain our corporate culture as we grow, we could lose the innovation, teamwork and focus that contribute crucially to our business.
Our culture is fundamental to our success and defines who we are and how we operate our business. We were founded on a deep appreciation of the special relationship between pet owners, their beloved pets and their trusted veterinarians. We have invested substantial time, energy and resources in developing a culture that fosters teamwork, innovation, creativity and a focus on providing value for our members as well as for Territory Partners and veterinarians. As we develop our infrastructure while we grow, we may find it difficult to maintain these valuable aspects of our corporate culture. Any failure to preserve our culture could negatively impact our future success, including our ability to attract and retain personnel, encourage innovation and teamwork and effectively focus on and pursue our corporate objectives.


We depend on relationships with strategic partners, and our inability to maintain our existing and secure new relationships with strategic partners could harm our revenue and operating results.
A portion of our enrollment leads are attributable to a variety of different types of strategic partnership arrangements. These partnerships involve various risks, depending on their structure, including the following:
we may be unable to maintain or secure favorable relationships with strategic partners;
our strategic partners may not be successful in creating leads;
we may be unable to convert leads from our strategic partners into enrolled pets;
our strategic partners could terminate their relationships with us;
we may not experience a consistent correlation between revenues and expenditures related to the partnership, and
bad publicity and other issues faced by our strategic partners could negatively impact us.
Our business and financial condition is subject to risks related to our writing of policies pursuant to contractual relationships with unaffiliated third parties.
Our other business segment generally includes revenues and expenses involving contractual relationships with unaffiliated third parties and marketing to enterprises. We have relatively limited experience in writing policies for unaffiliated third parties. This business is not expected to grow at the same rate as our core business and may decline. Changes to this business may be volatile due to the nature of the relationships. Further, this business historically has had, and we expect it to continue to have, lower margins than our core business. As a result of this line of business, we are subject to additional regulatory requirements and scrutiny, which increase our costs, risks and may have an adverse effect on our operations. Further, administration of this business and any similar business in the future may divert our time and attention away from our core business, which could adversely affect our operating results in the aggregate.
For example, we have written pet insurance policies for general agents since 2012. These policies are subject to materially different terms and conditions than our subscription. Further, the unaffiliated general agents administer these policies and market them to consumers. For the year ended December 31, 2017, premiums from these policies accounted for 8.0% of our total revenue. These relationships can be terminated by either party and, if terminated, would result in a reduction in our revenue to the extent we cannot enter other relationships and generate equivalent revenues with different general agents. In addition, the general agents control trust accounts they maintain on our behalf. If the general agents make operating decisions that adversely affect its business or brand, our business or brand could also be adversely affected.
In Canada, our medical plan is written by Omega General Insurance Company. If Omega were to terminate its underwriting arrangement with us, our business could be adversely affected.
In Canada, our medical plan is written by Omega, and we assume all premiums written by Omega and the related veterinary invoice expense through an agency agreement and a fronting and administration agreement. These agreements may be terminated by either party with one year’s prior written notice. If Omega were to terminate our agreement or be unable to write insurance for regulatory or other reasons, we may have to terminate subscriptions with our existing members, or suspend member enrollment and renewals, in Canada until we entered into a relationship with another third party to write our subscription, which may take a significant amount of time and require significant expense. We may not be able to enter into a new relationship, and any new relationship would likely be on less favorable terms. Any delay in entry into a new relationship or suspension of member enrollment and renewals could have a material adverse effect on our operating results and financial condition.
If we are unable to implement and maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.
We are required to maintain internal control over financial reporting and to report any material weaknesses in such internal control. Section 404 of the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act) requires that we evaluate and determine the effectiveness of our internal control over financial reporting and provide a management report on the internal control over financial reporting, which must be attested to by our independent registered public accounting firmfirm. Maintaining adequate internal control over financial reporting is critical to effective and timely completion of our financial statements. We have reported material weaknesses in internal control in Part II, Item 9A. As a result, management concluded that our internal control over financial reporting was not effective as of December 31, 2023. We are currently implementing certain remedial measures and assessing others intended to remediate the extentmaterial weaknesses, but our efforts may not be successful. These measures will result in additional expenses associated with technology, finance personnel, training and other costs. If we no longer qualify forare unable to remediate the exemption providedmaterial weaknesses within a reasonable time or at all, or are otherwise unable to an emerging growth company, as defined by The Jumpstart Our Business Startups Actmaintain effective internal control over financial reporting or disclosure controls and procedures, our ability to record, process and report financial or other information accurately, and to prepare financial statements within required time periods, could be adversely affected, which could subject us to litigation or investigations requiring management resources and payment of 2012 (the JOBS Act).


legal and other expenses, negatively affect investor confidence in our financial statements and adversely impact our stock price.
We may not detect errors on a timely basis and our financial statements may be materially misstated. We have had in the past, and may have in the future identify other material weaknesses and significant deficiencies in our internal control over financial reporting.reporting, in addition to those identified as of December 31, 2023, which may result in our not detecting errors on a timely basis and our financial statements being materially misstated. If we or our independent registered public accounting firm identify future material weaknesses in our internal control over financial reporting, we are unable to comply with the requirements of Section 404 in a timely manner, we are unable to assert that our internal control over financial reporting is effective or our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock could be negatively affected. We could also become subject to investigations by the stock exchange on which our securities are listed, the SEC or other regulatory authorities, which could require additional financial and management resources.
Our business depends on our ability to maintain and scale the infrastructure necessary to operate our technology platform and could be adversely affected by a system failure, security breach, loss of data or cyberattack.
Our business depends on our ability to maintain and scale the infrastructure necessary to operate our technology platform, which includes our analytics and pricing engine, systems for managing veterinary invoice payments, customer relationship management system, billing system, contact center phone system and website. We use these technology frameworks to price our subscriptions, enroll members, engage with current members and pay veterinary invoices. Our members research and purchase subscriptions through our website and contact center, and for those veterinary hospitals who have installed our patented proprietary software, we receive and pay veterinary invoices directly to the hospitals through our patented software. Our reputation and ability to acquire, retain and serve our members and support our partners depends on the reliable performance of our technology platform and the underlying network systems and infrastructure, and on providing best-in-class member service, including through our contact center and website. As our member base continues to grow, the amount of information collected and stored on the systems and infrastructure supporting our technology platform will continue to grow, and we expect to require an increasing amount of network capacity, computing power and information technology personnel to develop and maintain our technology platform and service our departments involved in member interaction.
We have made, and expect to continue to make, substantial investments in equipment and related network infrastructure to handle the operational demands on our technology platform, including increasing data collection, software development, traffic on our website and the volume of calls at our contact center. The operation of the systems and infrastructure supporting our technology platform is expensive and complex and could experience operational failures. In the event that our data collection, member base or amount of traffic on these systems grows more quickly than anticipated, we may be required to incur significant additional costs to increase the capacity in our systems. Further, our development and implementation activities may not be successful, may not be well-received by veterinarians or by new or existing members, particularly if they are costly, cumbersome or unreliable, and we may incur delays or cost overruns or elect to curtail our currently planned expenditures related to them. Even if our system improvements are well-received, they may be or become obsolete due to technological reasons or the availability of alternative solutions in the marketplace. If new solutions and enhancements are not successful on a long-term basis, we may not realize benefits from these investments, and our business and financial condition could be adversely affected.
19



In addition, any system failure that causes an interruption in or decreases the responsiveness of our services could impair our revenue-generating capabilities, harm our business and operating results and damage our reputation. In addition, any loss or mishandling of data could result in breach of confidence, competitive disadvantage or loss of members, and subject us to potential liability. Any failure of the systems and infrastructure that we rely on could negatively impact our enrollments as well as our relationship with members. If we do not maintain or expand the systems and infrastructure underlying our technology platform successfully, or if we experience operational failures, our reputation could be harmed and we could lose current and potential members, which could harm our operating results and financial condition.
Computer viruses, hackers, employee misconduct, and other external hazards could expose our technology platform to security breaches, cyber-attacks or other disruptions. While we have implemented security measures designed to protect against breaches of security and other interference with our systems and networks, our systems and networks may be subject to breaches or interference and we, and our third-party service providers, will likely continue to experience cybersecurity incidents of varying degrees. Any such event may result in operational disruptions as well as unauthorized access to, the disclosure of, or loss of our proprietary information or our customers’ data and information, which in turn may result in legal claims, regulatory scrutiny and liability, reputational damage, the incurrence of costs to eliminate or mitigate further exposure, the loss of customers or affiliated advisors, or other damage to our business. In addition, the trend toward general public notification of such incidents could exacerbate the harm to our business, financial condition and results of operations. Even if we successfully protect our technology infrastructure and the confidentiality of sensitive data, we could suffer harm to our business and reputation if attempted security breaches are publicized. We cannot be certain that advances in criminal capabilities, discovery of new vulnerabilities, attempts to exploit vulnerabilities in our systems, data thefts, physical system or network break-ins or inappropriate access, or other developments will not compromise or breach the technology or other security measures protecting the networks and systems used in connection with our business.
Third parties to whom we outsource certain of our functions are also subject to these risks. While we review and assess our third-party providers’ cybersecurity controls, as appropriate, and make changes to our business processes to manage these risks, we cannot ensure that our attempts to keep such information confidential will always be successful. Moreover, our use of third-party services (e.g. cloud technology and software as a service) can make it more difficult to identify and respond to cyberattacks in any of the above situations due to the dynamic nature of these technologies.
If we fail to effectively manage our growth, our business, operating results and financial condition may suffer.
We have recently experienced, and expect to continue to experience, significant growth, which has placed, and may continue to place, significant demands on our management and our operational and financial systems and infrastructure. We expect that our growth strategy will require us to commit substantial financial, operational and technical resources and this commitment may also result in increased costs (such as member acquisition costs or costs associated with increases in the number or amounts of veterinary invoices received) generated by our business, which could prevent us from achieving profitability and remaining profitable and could impair our ability to compete effectively for business. If we do not effectively manage growth at any time, our financial condition could be harmed and the quality of our services could suffer.
In order to successfully expand our business, we need to hire, integrate and retain highly skilled and motivated employees and continue to improve our existing systems for operational and financial management. These improvements could require significant capital expenditures and place increasing demands on our management. If we do not successfully implement improvements in these areas, our business, operating results and financial condition will be harmed.
Emerging claim and coverage issues may adversely affect our business.
As industry practices and legal, judicial, social and other environmental conditions change, unexpected and unintended issues related to claims and coverage may emerge, including new or expanded theories of liability. These or other changes could impose new financial obligations on us by extending coverage beyond our underwriting intent or otherwise require us to make unplanned modifications to the products and services that we provide, or cause the delay or cancellation of products and services that we provide. In some instances, these changes may not become apparent until sometime after we have issued subscriptions that are affected by the changes. As a result, the full extent of liability under our subscriptions may not be known for many years after the subscription begins.
Our operating results may vary, which could make period-to-period comparisons less meaningful, and make our future results difficult to predict.
We have historically experienced, and may in the future experience, fluctuations in our revenue, expenses and operating results. Our operating results may fluctuate in the future as a result of a number of factors, many of which are beyond our control. These fluctuations may make comparing our operating results on a period-to-period basis less meaningful and make our future results difficult to predict. You should not rely on our past results as an indication of our future performance. In addition, if revenue levels do not meet our expectations, our operating results and ability to execute on our business plan are likely to be harmed.
20



Seasonal or periodic variations in the behavior of our members also may cause fluctuations in our financial results. Enrollment in our subscription tends to be discretionary in nature and may be sporadic, reflecting overall economic conditions, budgeting constraints, pet-buying patterns and a variety of other factors, many of which are outside our control.
Due to these and other factors, our financial results for any quarterly or annual period may not meet our expectations or the expectations of investors or analysts that follow our stock and may not be meaningful indications of our future performance.
Changes in the economy may affect consumer spending on our subscription and this may negatively impact our business, operating results and financial condition.
Our business may be affected by changes in the economic environment. Members may reduce or eliminate their spending during an economic downturn, resulting in an increase in subscription cancellations and a reduction in the number of new member enrollments. We may experience a material increase in cancellations or a material reduction in our member retention rate in the future, especially in the event of a prolonged recessionary period or a downturn in economic conditions. Conversely, consumers may have more income to pay veterinary costs out-of-pocket and less desire to purchase our subscription during a period of economic growth. In addition, media prices and other costs may change with changes in the economic environment, which could increase our new pet acquisition expenses. As a result, our business, operating results and financial condition may be significantly affected by changes in the economic environment.
We depend on key personnel to operate our business and, if we are unable to retain, attract and integrate qualified personnel, our ability to develop and successfully grow our business could be harmed.
Our success depends to a significant extent on the continued services of our current management team, such as Margi Tooth, our President, and Darryl Rawlings, our founder, Chief Executive Officer and Chairperson of the Board. The loss of key executives or employees within a short time frame could have a material adverse effect on our business. We employ all of our employees, including executive officers and key employees on an at-will basis, and their employment can be terminated by us or them at any time, for any reason and without notice, subject to severance payment obligations. In order to retain valuable employees, in addition to salary and cash incentives, we have provided stock options and restricted stock that vest over time. While we may in the future grant equity awards tied to company performance, if we do not achieve certain financial goals, we will not grant equity awards and this may affect our ability to retain employees. The value to employees of stock options and restricted stock that vest over time will be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to maintain their retention benefit or counteract offers from other companies. We would be adversely affected if we fail to adequately plan for the succession of our senior management and other key employees. Additionally, if we were to lose a large percentage of our current employees in a relatively short time period, or our employees were to engage in a work stoppage or unionize, we may be unable to hire and train new employees quickly enough to prevent disruptions in our operations, which may result in the loss of members, Territory Partners and/or referral sources.
Our success also depends on our ability to attract, retain and motivate additional skilled management personnel. We plan to continue to expand our work force, which we believe will enhance our business and operating results. As a result of COVID-19, we adopted hybrid work arrangements, which may result in decreased efficiency. Over time, hybrid work arrangements may also decrease the cohesiveness of our teams, which is critical to our corporate culture and to attracting, retaining and motivating skilled management personnel. We believe that there is significant competition for qualified personnel with the skills and knowledge that we require. Many of the other companies with which we compete for qualified personnel have greater financial and other resources than we do. New hires require significant training, capital expenditures and, in most cases, significant time before they achieve full productivity. New employees may not become as productive as we expect, and we may be unable to hire or retain sufficient numbers of qualified individuals. If we do not successfully hire and integrate new employees in accordance with our plans, our business, operating results and financial condition will be harmed.
We may continue to create, invest in or acquire businesses, products and technologies, which could divert our management’s attention, result in additional dilution to our stockholders, otherwise disrupt our operations or harm our operating results.
We have in the past created, invested in or acquired complementary businesses, products, technologies and new lines of business, and we may continue to do so in the future. Our ability to successfully evaluate and manage investment opportunities, or make and integrate acquisitions or products, is unproven. For example, we have invested in a pet food initiative, and we believe that pet food may be an important part of our offerings over the long term. We do not have experience manufacturing, selling, or distributing food products and pet food manufacturing facilities and pet food products are subject to many laws and regulations administered by the United States Department of Agriculture, the Federal Food and Drug Administration, the Occupational Safety and Health Administration, and other federal, state, local, and foreign governmental agencies relating to the production, packaging, labelling, storage, distribution, quality, and safety of food products and the health and safety of employees. We have also acquired technology intended to enable us to improve our back-end software and facilitate certain expansion efforts, but technology integration is complicated, expensive and time consuming, and it may not result in us realizing the intended benefits from the acquisition.
21



The pursuit of potential new products, investments or acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable opportunities, whether or not they are consummated. Further, even if we successfully invest in or acquire additional businesses or technologies, we may not achieve the anticipated benefits from the transaction. The investment or acquisition may also expose us to additional risks, including from unknowingly inheriting liabilities that are not adequately covered by contractual remedies. Acquisitions or investments could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our operating results.
If we do not spend our development budget efficiently or effectively on commercially successful and innovative offerings and products, we may not realize the expected benefits of our strategy. Further, our development efforts with respect to new products and offerings and integrations of acquired businesses could distract management from current operations, and will divert capital and other resources from our more established products and offerings. If an investment or acquisition fails to meet our expectations, our business, operating results and financial condition may suffer.
We may not realize the benefits of our current and planned strategic relationships.
Our growth strategy includes developing and maintaining strategic relationships with various third parties. For example, in October 2020, we entered into a Strategic Alliance Agreement and certain related agreements with Aflac Incorporated (Aflac). We generally pursue strategic relationships with industry leaders that may offer us expanded access to segments of the pet owner market. For these efforts to be successful, we must negotiate and enter into agreements with these third parties on terms that are attractive to us, and then successfully implement the arrangement, which requires integrating and coordinating their resources and capabilities with our own, which may present challenges relating to technology integration, marketing, regulatory matters, customer support, and other operational matters. These relationships may require several years to implement, may face delays or terminations, and may not be successfully implemented at all. We may be unsuccessful in entering into agreements with acceptable third parties, negotiating favorable terms in these agreements, or achieving the anticipated results over our desired time horizon. In addition, some of our historical strategic relationships have required us to agree to exclusivity, and or other terms that may limit our ability to pursue opportunities we might otherwise pursue. In connection with our strategic relationships, we have in the past and may in the future provide equity consideration, impose contractual holding periods for such securities, impose standstill obligations or include other requirements that terminate in the event the strategic relationship ceases, which may have an adverse effect on our stock price and otherwise cause our business to suffer.
Strategic relationships also involve various risks, depending on their structure, including the following:
our strategic partners may not be successful;
we may be unable to convert leads from our strategic referral partners into enrolled pets;
our strategic partners could terminate their relationships with us;
our strategic partners may acquire or form alliances with our competitors, thereby reducing or eliminating their business with us;
we may overpay strategic partners relative to the business the relationship generates; and
bad publicity and other issues faced by our strategic partners could negatively impact us.
If we are unsuccessful in our strategic relationships, we may not realize the intended benefits of these relationships, lose the investment we have made in these relationships, face difficulty entering into other relationships, and our business may suffer.
Our business and financial condition is subject to risks related to our writing of policies for unaffiliated third parties.
Our other business segment includes revenues and expenses related to underwriting policies on behalf of third parties that do not carry reference to the Trupanion brand. The contractual relationships with these third parties may be terminated by either party or the third party may choose to begin a relationship with a different underwriter. Any termination of these relationships could result in a reduction in our revenue. For the year ended December 31, 2023, premiums from policies sourced by general agents accounted for 34% of our total revenue, and one general agent sourced members whose premiums accounted for over 10% of our total revenue. Further, in administering or marketing a product to consumers, if an unaffiliated third party makes an operating decision that adversely affects its business or brand, our business or brand could also be adversely impacted. We expect to roll off a portion of our other business starting in 2025 subject to certain limitations in order to allow us to utilize capital for other purposes, but we do not control the timing or extent of this roll off and, accordingly, it may not proceed as we expect, which could cause our results to fluctuate or have other unexpected impacts on our business.
Changes to this business may be volatile due to the nature of the relationships. Further, this business historically has had, and we expect it to continue to have, significantly lower margins than our core business. As a result of this business, we are subject to additional regulatory requirements and scrutiny, which increase our costs and risks, and may have an adverse effect on our operations. Further, administration of this business and any similar business in the future may divert our time and attention away from our core business, which could adversely affect our operating results in the aggregate.
22



In Canada, our medical plan is written by Omega General Insurance Company. If Omega were to terminate its underwriting arrangement with us, our business could be adversely affected.
In Canada, our medical insurance for pets subscription is currently written by Omega, and we assume all premiums written by Omega and the related veterinary invoice expense through an agency agreement and a fronting and administration agreement. We expect to begin to underwrite our own products in Canada through our wholly-owned subsidiary, GPIC Insurance Company (GPIC). If Omega were to terminate our agreement or be unable to write insurance for regulatory or other reasons, in particular before GPIC is duly authorized to write insurance across all Canadian jurisdictions, we may have to terminate subscriptions with our existing Canadian members and/or suspend member enrollment and renewals in Canada. In addition, as we move business from Omega to GPIC, we may be required to contribute more risk-based capital than expected into GPIC.
We are expanding our operations internationally, and we may therefore become subject to a number of risks associated with international expansion and operations.
We are expanding our operations internationally and expect to continue exploring opportunities outside of North America. For instance, we have entered the Australian market in 2019 through a joint venture. In August 2022 we purchased Smart Paws, a managing general agent for pet insurance with operations based in Germany and Switzerland, and in November 2022 we acquired PetExpert, a managing general agent for pet insurance with operations based in the Czech Republic and Slovakia. We have limited history of marketing, selling, administering and supporting our subscription product for consumers outside of the North America. In general, international sales and operations may be subject to a number of risks, including the following:
regulatory rules and practices, foreign exchange controls, tariffs, tax laws and treaties that are different than those we operate under currently;
the costs and resources required to modify our subscription appropriately to suit the needs and expectations of residents and veterinarians in such foreign countries;
our data analytics platform may have limited applicability in foreign countries, which may impact our ability to develop adequate underwriting criteria and accurately price subscriptions in such countries;
increased expenses incurred in establishing and maintaining office space and equipment for our international operations;
technological incompatibility between our patented proprietary software and software used by veterinarians;
difficulties in modifying our business model or subscription in a manner suitable for any particular foreign country, including any modifications to our Territory Partner model to the extent we determine that our existing model is not suitable for use in foreign countries;
our lack of experience in marketing to consumers and veterinarians and online engagement in foreign countries, especially if doing so in a foreign language;
our relative lack of industry connections in many foreign countries;
our ability to locally hire, integrate and retain highly skilled and motivated employees and establish and improve systems for operational and financial management where appropriate;
difficulties in managing operations due to language barriers, distance and time zone differences, staffing, cultural differences and business infrastructure constraints, including difficulty in obtaining foreign and domestic visas;
the uncertainty of protection for intellectual property rights in some countries; and
general economic and political conditions in these foreign markets.
These and other factors could harm our ability to gain future international revenue and increase our expenses, which would materially impact our business and operating results. The expansion of our existing international operations and entry into additional international markets will require significant management attention and financial resources, which may detract from management attention and financial resources otherwise available to our existing business. Our failure to successfully manage our international operations and the associated risks effectively could limit the future growth of our business and could have an adverse effect on our operating results and financial condition.
Changes in foreign exchange rates may adversely affect our revenue and operating results.
In addition to the United States, we offer products in Canada, several European countries, and Australia, and we are pursuing operations in several other jurisdictions. These activities expose us to the risk of changes in currency exchange rates. For the year ended December 31, 2023, approximately 15% of our total revenue was generated in Canada. While we have not experienced material exposure to exchange rates in Australia or Europe, that may not continue. Fluctuations in the relative strength of the US dollar compared to the currencies of other jurisdictions in which we operate has in the past and could in the future adversely affect our revenue and operating results. Moreover, in the future, we may expand the number of countries in which we offer products and operate and this could increase our exposure to currency exchange rate fluctuations.
Owning multiple insurance subsidiaries may harm our results of operations.
23



We currently own one of the insurers through which we are issuing products - APIC, a New York domiciled insurer. We also own and have regulatory approvals for two new insurers domiciled respectively in Missouri and Nebraska, ZPIC Insurance Company and QPIC Insurance Company. We are currently pursuing so-called expansion applications for these entities in most United States jurisdictions. In addition, we own and are pursuing Canadian regulatory approvals for our Canadian insurer GPIC and we may also seek to acquire or establish other insurers.
Acquisitions and operations of these insurers presents a number of risks, including the following:
Acquiring or forming a new insurance subsidiary may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable opportunities, whether or not the acquisition or formation is completed.
Even if we are successful in forming or acquiring a new insurance subsidiary we may not achieve the anticipated benefits. We may incur additional costs if we decide to sell or dissolve any such subsidiary.
Each insurance entity will likely require a significant initial minimum capital contribution. It may take a longer period of time to achieve efficiency on these contributions, if ever.
Each insurance entity will be subject to additional regulatory scrutiny in the jurisdiction of incorporation and any additional jurisdictions in which the insurance subsidiary operates. Failure to comply with laws, regulations and guidelines applicable to a new insurance subsidiary could result in significant liability, result in the loss of revenue and otherwise harm our business, operating results and financial condition.
A supervisory regulator may increase the amount of capital we must hold in an insurance subsidiary, especially if it shows material growth. We may not have easy access to such capital, and using it for this purpose may prevent us from investing in our growth and operations, which may require us to modify our operating plan, delay new initiatives, interfere with personnel growth, incur indebtedness or pursue financings, or otherwise modify our operations, any of which could have a material adverse effect on our operating results and financial condition.
If the required minimum capital in one of our insurers falls below the required threshold, the responsible regulator may take action, or such a reduction may result in a breach of various contractual relationships, including, for example, with the unaffiliated general agents for which we write medical insurance for pets policies, which may give such parties the ability to cancel their contracts with us and/or sue us for damages related to our risk-based capital levels, which could have a material adverse effect on our financial condition.
We may not obtain required regulatory approvals in connection with potentially investing a portion of an insurer’s assets, for example in real property.
We may require additional capital to meet our risk-based capital requirements, pursue our business objectives and respond to business opportunities, challenges or unforeseen circumstances. If capital is not available to us at any time, our business, operating results and financial condition may be harmed.
We may require additional capital to meet our risk-based capital requirements, operate or expand our business or respond to unforeseen circumstances. Additional funds may not be available when we need them, on terms that are acceptable to us, or at all. For instance, our arrangement with Aflac requires that, before we issue or sell equity to another investor, we are required to provide Aflac an opportunity to purchase equity allowing them to maintain their ownership percentage. This requirement may introduce delays or prevent us from raising funds through the issuance of securities. If we raise additional funds through the issuance of equity or convertible securities, the percentage ownership of holders of our common stock could be significantly diluted and these newly issued securities may have rights, preferences or privileges senior to those of holders of our common stock. Further, volatility in the equity markets may have an adverse effect on our ability to obtain equity financing or the cost of such financing and, in the event we require additional debt financing, volatility in the debt markets may have an adverse effect on our ability to obtain debt financing or the cost of such financing. Similarly, our access to funds may be impaired if regulatory authorities or rating agencies take negative actions against us. If a combination of these factors were to occur, our internal sources of liquidity may prove to be insufficient and, in such case, we may not be able to successfully obtain additional financing on favorable terms. If funds are unavailable to us on reasonable terms when we need them, we may be unable to meet our risk-based capital requirements, train and support our employees, support Territory Partners, maintain the competitiveness of our technology, pursue business opportunities, service our existing debt, pay veterinary invoices or acquire new members, any of which could have an adverse effect on our business, operating results and financial condition.
If our security measures are breached and unauthorized access is obtained to our data, including our members’ data, we may lose our competitive advantage, our systems may be perceived as not being secure and we may incur third-party liability.
24



Our data repository contains proprietary information that we believe gives us a competitive advantage, including data on veterinary invoices received and other data with respect to members, Territory Partners, veterinarians and other third parties. We also collect and utilize demographic and other information from and about our members when they visit our website, call our contact center and apply for enrollment. Further, we use tracking technologies, including “cookies,” to help us manage and track our members’ interactions and deliver relevant advice and advertising. Security breaches could expose us to a risk of loss of our data and/or disclosure of this data, either publicly or to a third party who could use the information to gain a competitive advantage. Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. In the event of a loss of our systems or data, we could experience increased costs, or delays, legal liability and reputational harm, which in turn may harm our financial condition, damage our brand and result in the loss of members. Such a disclosure also could lead to litigation and possible liability.
In the course of operating our business, we may store and/or transmit our members’ confidential information, including credit card and bank account numbers and other private information. SecurityBecause the methods used to obtain unauthorized access to private information change frequently and may be difficult to detect for long periods of time, security breaches couldwould expose us to a risk of loss of this information, litigation and possible liability. Our payment services may beare similarly susceptible to credit card and other payment fraud schemes, including unauthorized use of credit cards, debit cards or bank account information, identity theft or merchant fraud.
If our security measures are breached as a result of third-party action, employee error, malfeasance or otherwise, and, as a result, someone obtains unauthorized access to our data, including data of our members, our reputation may be damaged, our business may suffer and we could incur significant liability. Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. If an actual or perceived breach of our security occurs, the public perception of the effectiveness of our security measures could be harmed and weharmed.
In addition, cyber-attacks or acts of terrorism could lose members, which would adversely affect our business.
Any legal liability, regulatory penalties or negative publicity we encounter, including based on the information on our website or that we otherwise distribute or provide, directly or through Territory Partners or other referral sources, could harmcause disruptions in our business operating resultsor the economy as a whole. Our servers and financial condition.
Any legal disputessystems may also be vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering with our computer systems, which could lead to interruptions, delays, loss of critical data or regulatory penalties involving usthe unauthorized disclosure of confidential member data. We currently have limited disaster recovery capability, and our business interruption insurance may be publicly announced,insufficient to compensate us for losses that may occur. Such disruptions could negatively impact our ability to run our business, which could materially harm our reputation and adversely affect our business. We also provide informationhave an adverse effect on our website, through our contact center and in other ways regarding pet health, the pet insurance industry in general and our subscription, including information relating to subscription fees, benefits, exclusions, limitations, availability and medical plan comparisons. A significant amount of both automated and manual effort is required to maintain the information on our website. Separately, from time to time, we use the information provided on our website and otherwise collected by us to publish reports designed to educate consumers. For example, we produce a significant amount of marketing materials regarding our subscription. If the information we provide on our website, through our contact centers or otherwise is not accurate or is construed as misleading, or if we improperly assist individuals in purchasing subscriptions, our members, competitors or others could attempt to hold us liable for damages, our relationships with veterinarians and other referral sources could be terminated and regulators could attempt to subject us to penalties, revoke our licenses to transact business in one or more jurisdictions or compromise the status of our licenses to transact our business in other jurisdictions, which could result in our loss of revenue. In the ordinary course of operating our business, we may receive complaints that the information we provided was not accurate or was misleading. These types of claims could be time-consuming and expensive to defend, could divert our management’s attention and other resources and could cause a loss of confidence in our business. As a result, whether or not we are able to successfully resolve these claims, they could harm our business, operating results and financial condition.
We are subject to a number of risks related to accepting automatic fund transfers and credit card and debit card payments.
We accept payments of subscription fees from our members through automatic fund transfers and payments via credit and debit card transactions.and mobile payment applications. For payments via credit and debit card payments,and mobile payment applications, we pay interchange and other fees, which may increase over time. An increase in the number of members who utilize credit and debit cards and mobile apps to pay their subscription fees or related credit and debit card fees would reduce our margins and could require us to increase subscription fees, which could cause us to lose members and revenue, or suffer an increase in our operating expenses, either of which could adversely affect our operating results.


If we, or any of our processing vendors or banks have problems with our billing software, or if the billing software malfunctions, it could have an adverse effect on our member satisfaction and could cause one or more of the major credit card companies or banks to disallow our continued use of their payment products. In addition, if our billing software fails to work properly and, as a result, we do not automatically charge our members’ credit cards on a timely basis or at all, or a bank withdraws the incorrect amount or fails to timely transfer the correct amount to us, we could lose revenue and harm our member experience, which could adversely affect our business and operating results. Moreover, a vendor could fail to process payments, or could process payments in the wrong amounts, which could result in us failing to collect premiums, could result in increased cancellations and could adversely affect our reputation.
We are also subject to payment card association operating rules, certification requirements and rules governing electronic funds transfers, including the Payment Card Industry Data Security Standard (PCI DSS), a security standard applicable to companies that collect, store or transmit certain data regarding credit and debit cards, holders and transactions. In the past we may not have been, weWe are currently compliant with PCI DSS in North America but our compliance efforts are not and in the future weongoing with respect to acquired businesses. We may not be fully or materially compliant with PCI DSS, or other payment card operating rules.rules in the future. Any failure to comply fully or materially with the PCI DSS now or at any point in the future may violate payment card association operating rules, federal and state laws and regulations, and the terms of our contracts with payment processors and merchant banks. Such failure to comply fully or materially also may subject us to fines, penalties, damages and civil liability, and may result in the loss of our ability to accept credit and debit card payments. In addition, there is no guarantee that PCI DSS compliance if we are able to become compliant, will prevent illegal or improper use of our payment systems or the theft, loss or misuse of data pertaining to credit and debit cards, credit and debit card holders and credit and debit card transactions.
25



If we fail to adequately control fraudulent credit card transactions,payment processing, we may face civil liability, diminished public perception of our security measures and significantly higher credit card-related costs, each of which could adversely affect our business, operating results and financial condition.
If we are unable to maintain our chargeback rate at acceptable levels, our credit card fees for chargeback transactions, or our fees for many or all categories of credit and debit card transactions, credit card companies and debit card issuers may increase our fees or terminate their relationship with us. Any increases in our credit card and debit card fees could adversely affect our operating results, particularly if we elect not to raise our subscription fees. The termination of our ability to process payments on any major credit or debit card would significantly impair our ability to operate our business.
We have limited experience owning an office building and may face unexpected costs.
In August 2018, we purchased our headquarters office building in Seattle, Washington, USA. Prior to this purchase, we had no experience owning an office building. It is difficult to predict all costs associated with maintaining the building and ensuring it is suitable for our use and that of other tenants and maintain compliance with all environmental and other regulations applicable to ownership of real estate. Following our transition to hybrid work arrangements, we have far fewer people working in our headquarters office, resulting in decreased utilization of our space. Failure to attract and retain tenants for our unused space will result in our not receiving rental income and could also cause a reduction in the value of the building. Tenants may also negotiate tenant improvements, requiring capital expenditures that may adversely impact our financial position. In addition, we may identify structural defects or other conditions, or we may determine that remodeling or renovations are necessary given our business operations and objectives. Managing tenants, maintaining the building, and otherwise facing the costs and responsibilities of being the owner of a building may be a distraction from our core business and cause our performance to suffer.
Environmental, social, and governance (ESG) issues may result in reputational harm and liability.
Companies across all industries are experiencing increased scrutiny and litigation related to their ESG practices, positions, and reporting. Investors, customers, regulators, employees, and other stakeholders have focused increasingly on ESG issues, including, among other things, climate change and greenhouse gas emissions, human and civil rights, and diversity, equity, and inclusion matters. Expectations surrounding appropriate corporate behavior in these areas are continually evolving and often reflect opposing viewpoints. Positions we may take (or choose not to take) on ESG issues may be unpopular with some of our current or potential employees, partners, or customers, which may in the future impact our ability to attract or retain employees, partners, or customers. Further, actions taken by our customers or partners, including through the use or misuse of our products, may result in reputational harm or possible liability to us.
Our disclosures on ESG matters, and any standards we may set for ourselves or a failure to meet these standards, may influence our reputation and the value of our brand. For example, we have elected to share publicly certain information about our ESG initiatives and information, and our commitment to the recruitment, engagement, and retention of a diverse board and workforce. In addition, California recently adopted two new climate-related bills, which require companies doing business in California that meet certain revenue thresholds to publicly disclose certain greenhouse gas emissions data and climate-related financial risk reports, and compliance with such requirements could require significant effort and resources. The SEC has also proposed disclosure requirements regarding, among other ESG topics, the impact our business has on the environment. Our business may face increased scrutiny related to these activities and our related disclosures, including from the investment community, and our failure to achieve progress or manage the dynamic public sentiment and legal landscape in these areas on a timely basis, or at all, could adversely affect our reputation, business, and financial performance.
Failure to adequately protect our intellectual property could substantially harm our business and operating results.
We rely on a combination of intellectual property rights, including trade secrets, patents, copyrights, trademarks and domain names, as well as contractual restrictions, to establish and protect our patented proprietary software and our intellectual property. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy our digital content, pricing analytics, technology, software, branding and functionality, or obtain and use information that we consider proprietary. Moreover, policing our proprietary rights is difficult and may not always be effective. IfAs we continue to expand internationally, we may need to enforce our rights under the laws of countries that do not protect proprietary rights to as great an extent as do the laws of the United States, which may be expensive and divert management’s attention away from other operations.
26



Our digital content is not protected by any registered copyrights or other registered intellectual property. Rather, our digital contentproprietary software is protected by statutorypatents. These patents may not be sufficient to maintain effective product exclusivity because patent rights are limited in time and common lawdo not always provide effective protection. Furthermore, our efforts to enforce or protect our patent rights user agreements that limit access tomay be ineffective, could result in substantial costs and usediversion of resources, could result in the invalidation of our data and by technological measures. Compliance with use restrictions is difficult to monitor, and our proprietary rights in our digital content databases may be more difficult to enforce than other forms of intellectual property rights.
We currently hold several registered trademarks, including “Trupanion”. Trademark protection may not always be available, or sought by us, in every country in which our subscription is available. Competitors may adopt names similar to ours, or purchase our trademarks and confusingly similar terms as keywords in Internet search engine advertising programs, thereby impeding our ability to build brand identity and possibly confusing members. Moreover, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate marks similar to our trademarks.
We may take action, including initiating litigation, to protect our intellectual propertypatent rights, and the integrity of our brand, and these efforts may prove costly, ineffective and increase the likelihood of counterclaims against us.


We currently hold the “Trupanion.com” Internet domain name and numerous other related domain names. Domain names generally are regulated by Internet regulatory bodies. If we lose the ability to use a domain name in the United States, Canada or any other country, we may be forced to acquire domain names at significant cost or, in the alternative, be forced to incur significant additional expenses to market our subscription, including the development of a new brand and the creation of new promotional materials, which could substantially harm our business and operating results. The regulationEven where our patents rights are enforced, legal remedies available for harm caused to us by infringing products may be inadequate to make us whole. Further, our successful assertion of domain namesour patent against one competing product is not necessarily predictive of our future success or failure in asserting the same patent against a second competing product. In addition, patents have a limited lifespan. In the United States, Canadathe natural expiration of a patent is generally 20 years after it is filed. Various extensions may be available. However, the life of a patent, and in other foreign countriesthe protection it affords, is subject to change. Regulatory bodies could establish additional top-level domains, appoint additional domain name registrars or modifylimited. Once the requirementspatent life has expired for holding domain names. As a result, we may notour software, our competitors will be able to acquire or maintain the domain names that utilize the “Trupanion” name in all of the countries in which we currently intend to conduct business.use our patented technology.
We seek to control access to our proprietary technology, software and documentation by entering into confidentiality and invention assignment agreements with our employees and partners, confidentiality agreements or license agreements with third parties, such as service providers, vendors, individuals and entities that may be exploring a business relationship with us, and terms of use with third parties, such as veterinary hospitals desiring to use our technology, software and documentation. These agreements may not prevent disclosure of intellectual property, trade secrets and/or other confidential information, and may not provide an adequate remedy in the event of misappropriation of trade secrets or any unauthorized disclosure of trade secrets and other confidential information. In addition, others may independently discover trade secrets and confidential information and, in such cases, we may not be able to assert any trade secret rights against such parties. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our intellectual property rights and related confidentiality, license and nondisclosure provisions, and failure to obtain or maintain trade secret protection, or our competitors being able to obtain our trade secrets or to independently develop technology similar to ours or competing technologies, could adversely affect our competitive business position.
Litigation or proceedings before the U.S. Patent and Trademark Office or other governmental authorities and administrative bodies in the United States and abroad may be necessary in the future to enforce our intellectual property rights, to protect our domain names and to determine the validity and scope of the proprietary rights of others. Our efforts to enforce or protect our proprietary rights may be ineffective, could result in substantial costs and diversion of resources and could substantially harm our operating results.
Assertions by third parties of infringement or other violation by us of their intellectual property rights could result in significant costs and substantially harm our business and operating results.
Third parties have in the past and may in the future claim that our services or technologies, including our proprietary software, infringe or otherwise violate their intellectual property rights. We may be subject to legal proceedings and claims, including claims of alleged infringement by us of the intellectual property rights of third parties. Any dispute or litigation regarding intellectual property could be expensive and time consuming, regardless of the merits of any claim, and could divert our management and key personnel from our operations.
If we were to discover or be notified that our services or our proprietary software potentially infringe or otherwise violate the intellectual property rights of others, we may need to obtain licenses from these parties in order to avoid infringement. We may not be able to obtain the necessary licenses on acceptable terms, or at all, and any such license may substantially restrict our use of the intellectual property. Moreover, if we are sued for infringement and lose the lawsuit, we could be required to pay substantial damages or be enjoined from offering the infringing services. Any of the foregoing could cause us to incur significant costs and prevent us from selling or properly administering subscriptions or performing under our other contractual relationships.
We rely on third parties to provide intellectual property and technology necessary for the operation of our business.
We utilize intellectual property and technology owned by third parties in developing and operating our technology platform and operating our business. From time to time, we may be required to renegotiate with these third parties or negotiate with other third parties to include or continue using their intellectual property or technology in our existing technology platform or business operations or in modifications or enhancements to our technology platform or business operations. We may not be able to obtain the necessary rights from these third parties on commercially reasonable terms, or at all, and the third-party intellectual property and technology we use or desire to use may not be appropriately supported, maintained or enhanced by the third parties. If we are unable to obtain the rights necessary to use or continue to use third-party intellectual property and technology in our operations, or if those third parties are unable to support, maintain and enhance their intellectual property and technology, we could experience increased costs or delays, which in turn may harm our financial condition, damage our brand and result in the loss of members.


Our technology platform and our data are also hosted by a third-party service provider. The terms under which such third-party service provider provides us services may change and we may be required to renegotiate with that third party. If we are unable to renegotiate satisfactory terms, we may not be able to transition to an alternative service provider without interrupting the availability of our technology platform and any interruption could materially and adversely affect our business. Additionally, if our third-party service provider experiences any disruptions, outages or catastrophes, or if it ceases to conduct business for any reason, we could experience an interruption in our business, which in turn may damage our brand, result in a loss of members and harm our financial condition.
The outcome of litigation or regulatory proceedings could subject us to significant monetary damages, restrict our ability to conduct our business, harm our reputation and otherwise negatively impact our business.
From time to time, we have been, and in the future may become, subject to litigation, claims and regulatory proceedings and inquiries, including market conduct examinations and investigations by state insurance regulatory agencies and threatened or filed lawsuits by, among others, government agencies, employees, competitors, shareholders, current or former members, or business partners.
We cannot predict the outcome of these actions or proceedings, and the cost of defending such actions or proceedings could be material. Further, defending such actions or proceedings could divert our management and key personnel from our business operations. If we are found liable in any action or proceeding, we may have to pay substantial damages or fines, or change the way we conduct our business, either of which may have a material adverse effect on our business, operating results, financial condition and prospects. More critically, an adverse result from a proceeding could require us to change the way we conduct our business, including our marketing and sales practices, and such a result may have a greater adverse effect on our business than monetary damages or fines. There may also be negative publicity associated with litigation or regulatory proceedings that could harm our reputation or decrease acceptance of our services. These claims may be costly to defend and may result in assessment of damages, adverse tax consequences and
27



harm to our reputation.
Covenants in the credit agreement governing our revolving line of credit may restrict our operations,Our current and if we do not effectively manage our business to comply with these covenants, our financial conditionfuture indebtedness could be adversely affected.
The credit agreement governing our revolving line of credit contains various restrictive covenants, including restrictions on our ability to dispose of our assets, change the name, location, office or executive management of our business, merge with or acquire other entities, incur other indebtedness, incur encumbrances, pay dividends or make distributions to holders of our capital stock, make investments, engage in transactions with our affiliates, permit withdrawals from APIC (with certain exceptions) and conduct operations in certain of our Canadian subsidiaries. Our credit agreement also contains certain financial covenants, including having APIC maintain statutory capital and surplus at all times of not less than the greater of the amount required by regulatory statute or 110% of the highest amount of statutory capital and surplus required in any state in which APIC is licensed; maintaining a minimum cash balance of $0.6 million in our account at Western Alliance Bank (WAB) and/or WAB affiliates and other cash or investments of $1.4 million in our accounts at Pacific Western Bank (PWB); maintaining all of our depository and operating accounts at PWB and/or WAB; maintaining certain investment accounts at PWB and/or PWB affiliates; achieving certain quarterly revenue levels and claims ratio thresholds; maintaining greater than negative $1.0 million net total of operating cash flow and capital expenditures quarterly; and remaining within certain monthly maximum EBITDA loss levels. EBITDA is defined as earnings, plus an amount equal to the sum of (i) tax, plus (ii) depreciation and amortization, plus (iii) interest and non-cash expenses, plus (iv) any non-cash stock-based compensation expense, plus (v) (gain)/loss from equity method investments. Our ability to meet these restrictive covenants can be affected by events beyond our control, and we have been in the past, and may be in the future, unable to do so. In addition, our failure to maintain effective internal controls to measure compliance with our financial covenants could affect our ability to take corrective actions on a timely basis and could result in our being in breach of these covenants. Our credit agreement provides that our breach or failure to satisfy certain covenants constitutes an event of default. Upon the occurrence of an event of default, our lenders could elect to declare any future amounts outstanding under our credit agreement to be immediately due and payable. If we are unable to repay those amounts, our financial condition could be adversely affected.
Any indebtedness we incur could adversely affect our business and limit our ability to expand our business or respond to changes, and we may be unable to generate sufficient cash flow to satisfy any of our debt service obligations.
In March 2022, we entered into a credit agreement with Piper Sandler Finance, LLC, as administrative agent, that provides us with up to $150.0 million of credit (the Credit Facility). As of December 31, 2017,2023, we had $9.5issued term loans totaling $135.0 million outstanding indebtedness under our revolving line of credit. We may incur indebtedness in the future, including any additional borrowings available under our revolving line of credit. Any substantialCredit Facility. Substantial indebtedness, and the fact that a substantial portion of our cash flow from operating activities could be needed to make payments on this indebtedness, could have adverse consequences, including the following:
reducing the availability of our cash flow for our operations, capital expenditures, future business opportunities and other purposes;
limiting our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate, which could place us at a competitive disadvantage compared to our competitors that may have less debt;
limiting our ability to borrow additional funds; and


increasing our vulnerability to general adverse economic and industry conditions.
Our ability to borrow any funds needed to operate and expand our business will depend in part on our ability to generate cash. Our ability to generate cash is subject to the performance of our business, as well as general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We may also need to use operating funds to support risk-based capital requirements and borrow additional funds to support our growth. If our business does not generate sufficient cash flow from operating activities or if future borrowings, under our Credit Facility or otherwise, are not available to us under our revolving credit facility or otherwise, in amounts sufficient to enable us to fund our liquidity needs, our operating results, financial condition and ability to expand our business and meet our risk-based capital requirements may be adversely affected.
Our financial resultsCovenants in our Credit Facility may be negatively affectedrestrict our operations, and if we do not effectively manage our business to comply with these covenants, our financial condition could be adversely affected.
Our Credit Facility contains various restrictive covenants, including limitations on our ability to incur other indebtedness or liens, make investments, and merge with or acquire other entities. Our Credit Facility also contains certain financial covenants, including minimum revenue and liquidity thresholds. Our ability to meet these restrictive covenants can be affected by events beyond our control. We are requiredalso obligated to pay income tax, premium tax, transaction taxinterest under the Credit Facility at a floating base rate plus an applicable margin, which rate will increase based on prevailing rates. Our Credit Facility provides that our breach or other taxes in jurisdictions wherefailure to satisfy various covenants and obligations constitutes an event of default. Upon the occurrence of an event of default, our lenders could elect to declare any future amounts outstanding under our Credit Facility to be immediately due and payable. The Credit Facility is secured by substantially all of our assets and those of our subsidiaries. If we are currently not collecting and reporting tax.unable to repay those amounts, our financial condition could be adversely affected.
We currently paymay have additional tax liabilities.
We are subject to income tax, premium tax, transaction tax and other taxes in certainthe U.S. and foreign jurisdictions. Judgment is required in determining our provision for income taxes, premium tax, transaction tax and other taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Further, we often make elections for tax purposes which may ultimately not be upheld. Although we believe our tax estimates are reasonable, the final determination of tax audits and any related litigation in the jurisdictions where we are subject to taxation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our consolidated financial statements in the period or periods in which we do business. A successful assertion by one or more jurisdictions that we should be paying income, premium, transaction or other taxes on our income or in connection with enrollment or intercompany services, or the enactment of new laws requiring the payment of income, premium, transfer or other taxes in connection with our business operations, including enrollment or intercompany services, could result in substantial tax liabilities.
If consumer acceptance of the Internet as an acceptable marketplace for our subscription does not continue to increase, our growth prospects will be harmed.
Our success depends in part on widespread consumer acceptance of the Internet as a marketplace for the purchase of medical insurance for cats and dogs. Internet use may not continue to develop at historical rates, and consumers may not continue to use the Internet to research, select and purchase insurance. In addition, the Internet may not be accepted as a viable resource for a number of reasons, including lack of security of information or privacy protection, possible disruptions, computer viruses or other damage to Internet servers or to users’ computers, and excessive governmental regulation.
Our success will depend, in large part, on third parties maintaining the Internet infrastructure to provide a reliable network backbone with the speed, data capacity, security and hardware necessary for reliable Internet access and services.
We depend in part on Internet search engines to attract potential new members to visit our website. If Internet search engines’ methodologies are modified or our search result page rankings decline for other reasons, our new member growth could decline, and our business and operating results could be harmed.
We derive a significant amount of traffic to our website from consumers who search for pet medical insurance through Internet search engines, such as Google, Bing and Yahoo!. A critical factor in attracting consumers searching for pet medical insurance on the Internet to our websitedetermination is whether we are prominently displayed in response to an Internet search relating to pet insurance. Algorithmic search result listings are determined and displayed in accordance with a set of formulas or algorithms developed by the particular Internet search engine, which may change from time to time. If we are listed less prominently in, or removed altogether from, search result listings for any reason, the traffic to our websites would decline and we may not be able to replace this traffic, which in turn would harm our business, operating results and financial condition. If we decide to attempt to replace this traffic, we may be required to increase our sales and marketing expenditures, including by utilizing paid search advertising, which would also increase our pet acquisition costs and harm our business, operating results and financial condition.
Changes in the economy may negatively impact our business, operating results and financial condition.
Our business may be affected by changes in the economic environment. Medical insurance for cats and dogs is a discretionary purchase, and members may reduce or eliminate their discretionary spending during an economic downturn, resulting in an increase in terminations and a reduction in the number of new member enrollments. We may experience a material increase in terminations or a material reduction in our member retention rate in the future, especially in the event of a prolonged recessionary period or a downturn in economic conditions. Conversely, consumers may have more income to pay veterinary costs out-of-pocket and less desire to purchase our subscription during a period of economic growth. In addition, media prices may increase during a period of economic growth, which could increase our sales and marketing expenses. As a result, our business, operating results and financial condition may be significantly affected by changes in the economic environment.


We may acquire other companies or technologies, which could divert our management’s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.
We may decide to acquire businesses, products and technologies. Our ability to successfully make and integrate acquisitions is unproven. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. Further, even if we successfully acquire additional businesses or technologies, we may not be able to migrate the policyholders to our subsciption, integrate the acquired personnel, operations and technologies successfully, or effectively manage the combined business following the acquisition. We also may not achieve the anticipated benefits from the acquired business or technology. In addition, we may unknowingly inherit liabilities from future acquisitions that arise after the acquisition and are not adequately covered by indemnities. Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our operating results. If an acquired business or technology fails to meet our expectations, our business, operating results and financial condition may suffer.made.
Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.
As of December 31, 2017,2023, we had U.S. federal net operating loss carryforwards of approximately $86.7$271.6 million that will begin to expire in 2027.2026. Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the Code), if a corporation undergoes an “ownership change,” the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes, such as research tax credits, to offset its post-change income and taxes may be limited. In general, an “ownership change” generally occurs if there is a cumulative change in our ownership by “5-percent stockholders” that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Pursuant to Sections 382 and 383 of the Code, annual use of our net operating loss carryforwards and credit carryforwards may be limited if we experience anby previous and future ownership change. We believe the utilization of approximately$0.5 millionof net operating losses are subject to limitation as a result of prior ownership changes based on our Section 382 study performed as of September 30, 2016. We note subsequent ownership changes may have already and may further affect the limitation in future years.changes.
We may explore opportunities to expand our operations globally, and we may therefore become subject to a number of risks associated with international expansion and operations.
28
As part of our growth plan, we expect to explore opportunities to expand our operations globally. We have no history of marketing, selling, administrating and supporting our subscription for consumers outside of the United States, Canada and Puerto Rico. International sales and operations are subject to a number of risks, including the following:


regulatory rules and practices, foreign exchange controls, tariffs, tax laws and treaties that are different than those we operate under in the United States, Canada and Puerto Rico and that carry a greater risk of unexpected changes;
the costs and resources required to modify our technology and sell our subscription in non-English speaking countries;
the costs and resources required to modify our subscription appropriately to suit the needs and expectations of residents and veterinarians in such foreign countries;
our data analytics platform may have limited applicability in foreign countries, which may impact our ability to develop adequate underwriting criteria and accurately price subscriptions in such countries;
increased expenses incurred in establishing and maintaining office space and equipment for our international operations;
technological incompatibility;
fluctuations in exchange rates between the U.S. dollar and foreign currencies in markets where we do business;
difficulties in attracting and retaining personnel with experience in international operations;
difficulties in modifying our business model in a manner suitable for any particular foreign country, including any modifications to our Territory Partner model to the extent we determine that our existing model is not suitable for use in foreign countries;
our lack of experience in marketing to consumers and veterinarians, and encouraging online marketing, in foreign countries;
our relative lack of industry connections in many foreign countries;
difficulties in managing operations due to language barriers, distance and time zone differences, staffing, cultural differences and business infrastructure constraints, including difficulty in obtaining foreign and domestic visas;
application of foreign laws and regulations to us, including more stringent or materially different insurance, employment, consumer and data protection laws;
the uncertainty of protection for intellectual property rights in some countries;


greater risk of a failure of foreign employees to comply with applicable U.S. and foreign laws, including antitrust regulations, the U.S. Foreign Corrupt Practices Act and any trade regulations ensuring fair trade practices; and
general economic and political conditions in these foreign markets.
These factors and other factors could harm our ability to gain future international revenue and, consequently, materially impact our business and operating results. The expansion of our existing international operations and entry into additional international markets will require significant management attention and financial resources, detracting from management attention and financial resources otherwise available to our existing business. Our failure to successfully manage our international operations and the associated risks effectively could limit the future growth of our business and could have an adverse effect on our operating results and financial condition.
A downgrade in the financial strength rating of our insurance company may have an adverse effect on our competitive position, the marketability of our subscription, and/or on our liquidity, access to and cost of borrowing, operating results and financial condition.
Although we do not believe that the financial strength rating of APIC is material for customers or to understand our business beyond what is already publicly available, financial strength ratings can be important factors in establishing the competitive position of insurance companies and generally have an effect on an insurance company’s business. On an ongoing basis, rating agencies review the financial performance and condition of APIC and could downgrade or change the outlook on its ratings due to, for example, a change in its statutory capital, a change in the rating agency’s determination of the amount of risk-based capital required to maintain a particular rating or a reduced confidence in management or its business strategy, as well as a number of other considerations that may or may not be under our control. The insurance financial strength rating of APIC is subject to quarterly review, and APIC may not retain the current rating. A downgrade in this or any future ratings could have a material effect on our sales, our competitiveness, the marketability of our subscription, our liquidity, access to and cost of borrowing, operating results and financial condition.
Our business is subject to the risks of earthquakes, floods, fires and other natural catastrophic events and to interruption by man-made problems such as computer viruses or terrorism.
Our systems and operations are vulnerable to damage or interruption from earthquakes, human error, intentional bad acts, hurricanes, floods, fires, power losses, telecommunications failures, hardware and system failures, terrorist attacks, acts of war, break-ins or similar events. For example, our corporate headquarters and facilities are located in Seattle, Washington near known earthquake fault zones and are vulnerable to significant damage from earthquakes. In addition, cyber-attacks or acts of terrorism could cause disruptions in our business or the economy as a whole. Our servers and systems may also be vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering with our computer systems, which could lead to interruptions, delays, loss of critical data or the unauthorized disclosure of confidential member data. We currently have limited disaster recovery capability, and our business interruption insurance may be insufficient to compensate us for losses that may occur. Such disruptions could negatively impact our ability to run our business, which could have an adverse effect on our operating results and financial condition.
Risks Related to Compliance with Laws and Regulations
We may not maintain the amount of risk-based capital required to avoid additional regulatory oversight, which may adversely affect our ability to operate our business.
Memberships in our U.S. subscription are written by APIC. APICOur business is an insurance company domiciled in the state of New Yorkheavily regulated, and licensed by the New York Department of Financial Services. Regulators in the states in which we do business impose risk-based capital requirements on APIC that generally are approved by the National Association of Insurance Commissioners to ensure APIC maintains reasonably appropriate levels of surplus to protect our members against adverse developments in APIC’s financial circumstances, taking into account the risk characteristics of our assets, liabilities and certain other items. Generally, the NY DFS will compare, on an annual basis as of December 31 or more often as deemed necessary, an insurer’s total adjusted capital and surplus against what is referred to as an “Authorized Control Level” of risk-based capital that is calculated based on a formula designed to estimate an insurer’s capital adequacy. There generally are five outcomes possible from this comparison, depending on the insurer’s level of risk-based capital as compared to the applicable Authorized Control Level.
No Action Level: Insurer’s total adjusted capital is equal to or greater than 200% of the Authorized Control Level.


Company Action Level: Insurer’s total adjusted capital is less than 200% but greater than 150% of the Authorized Control Level. When at this level, an insurer must prepare and submit a financial plan to the NY DFS for review and approval. Generally, a risk-based capital plan would identify the conditions that contributed to the Company Action Level and include the insurer’s proposed plans for increasing its risk-based capital in order to satisfy the No Action Level. The failure to provide the NY DFS with a risk-based capital plan on a timely basis or the inability of the NY DFS and the insurer to mutually agree on an appropriate risk-based capital plan could trigger a Regulatory Action Level outcome, subject to the insurer’s right to a hearing on the issue.
Regulatory Action Level: Insurer’s total adjusted capital is less than 150% but greater than 100% of the Authorized Control Level. When at this level, an insurer generally must provide a risk-based capital plan to the NY DFS and be subject to examination or analysis by the NY DFS to the extent it deems necessary, including such corrective actions as the NY DFS may require.
Authorized Control Level: Insurer’s total adjusted capital is less than 100% but greater than 70% of the Authorized Control Level. At this level, the NY DFS generally could take remedial actions that it determines necessary to protect the insurer’s assets, including placing the insurer under regulatory control.
Mandatory Control Level: Insurer’s total adjusted capital is less than 70% of the Authorized Control Level. At this level, the NY DFS generally is required to take steps to place the insurer under regulatory control, even if the insurer is still solvent.
As of December 31, 2017, APIC was required to maintain at least $22.2 million of risk-based capital to satisfy the No Action Level (the highest of the above levels). As of December 31, 2017, APIC maintained $37.2 million of risk-based capital. The NY DFS may increase the required levels of risk-based capital in the future, and we anticipate that we will need to maintain greater amounts of risk-based capital if our pet enrollment continues to grow.
Additionally, if our risk-based capital falls below the Company Action Level, we may be in breach of various contractual relationships, including, for example, with the unaffiliated general agents for which we write pet insurance policies, which may give such parties the ability to cancel their contracts with us and/or sue us for damages related to our risk-based capital levels, which could have a material adverse effect on our financial condition.
We may require additional capital to meet our risk-based capital requirements, pursue our business objectives and respond to business opportunities, challenges or unforeseen circumstances. If capital is not available to us at any time, our business, operating results and financial condition may be harmed.
We may require additional capital to meet our risk-based capital requirements, operate or expand our business or respond to unforeseen circumstances. Additional funds may not be available when we need them, on terms that are acceptable to us, or at all. If we raise additional funds through the issuance of equity or convertible securities, the percentage ownership of holders of our common stock could be significantly diluted and these newly issued securities may have rights, preferences or privileges senior to those of holders of our common stock. Further, volatility in the credit or equity markets may have an adverse effect on our ability to obtain debt or equity financing or the cost of such financing. Similarly, our access to funds may be impaired if regulatory authorities or rating agencies take negative actions against us. If a combination of these factors were to occur, our internal sources of liquidity may prove to be insufficient and, in such case, we may not be able to successfully obtain additional financing on favorable terms. If funds are unavailable to us on reasonable terms when we need them, we may be unable to meet our risk-based capital requirements, train and support our employees, support Territory Partners, maintain the competitiveness of our technology, pursue business opportunities, service our existing debt, pay veterinary invoices or acquire new members, any of which could have an adverse effect on our business, operating results and financial condition.
If we fail to comply with the numerous applicable laws and regulations that are applicable to the sale of medical insurance for cats and dogs, our business and operating results could be harmed.
The sale of medical insurance for cats and dogs which is considered a type of property and casualty insurance in most jurisdictions, is heavily regulated. In the United States, insurance is regulated by each state in which we operate, and it is challenging to comply with the United States, inrequirements of each of these jurisdictions along with the District of Columbia, in Puerto Rico and bydifferent Canadian federal provincial, and territorial governments. In the United States, state insurance regulators are charged with protecting policyholders and have broad regulatory, supervisory and administrative powers over our business practices. Becauserequirements. As we do business in all 50 states, the District of Columbia, all Canadian provinces and territories and Puerto Rico,expand internationally, compliance with insurance-related laws, rules and regulations isbecomes even more difficult and imposes significant costs on our business. Each jurisdiction’s insurance department typicallyapplicable regulator has thebroad supervisory power among other things, to:
grantover all insurance-related operations, which can include granting and revokerevoking licenses to transact insurance business;
conduct inquiries into the insurance-related activitiesbusiness, and conduct of agents and agencies and others in the sales, marketing and promotional channels;
require and regulate disclosure in connection with the sale and solicitation of insurance policies;


authorize how, by which personnel and under what circumstances insurance premiums can be quoted and published and an insurance policy sold;
approve which entities or individuals can be paid commissions from carriers and the circumstances under which they may be paid;
regulate the content of insurance-related advertisements, including web pages, and other marketing practices;
approve policy forms, require specific benefits and benefit levels and regulate premium rates;
imposeimposing fines and other penalties; and
impose continuing education requirements.
While the U.S. federal government does not directly regulate the insurance industry, federal legislation and administrative policies can also affect us. Congress and various federal agencies periodically discuss proposals that would provide for federal oversight of insurance companies. We cannot predict whether any such laws will be enacted or the effect that such laws would have on our business. We also do business in all ten provinces and three territories of Canada. The provincial and territorial insurance regulators have the power to regulate the market conduct of insurers and insurance intermediaries, and the licensing and supervision of insurance agents, and brokers, along with enforcement rights, including the right to assess administrative monetary penalties in certain provinces.
Insurance companies are also regulated at the federal level in Canada, and the Insurance Companies Act prohibits a foreign entity from insuring risks in Canada unless it is authorized by an Order made by the Superintendent of Financial Institutions (Canada) permitting it to do so.penalties.
Due to the complexity, periodic modification and differing interpretations of insurance laws and regulations, we have not always been, and we may not always be, in compliance with them. New insuranceA regulator’s interpretation of existing laws or regulations and guidelines also may not be compatible with the manner in which we market and sell subscriptions in all of our jurisdictions and member acquisition channels, including over the Internet.change without notice. Failure to comply with insurance laws, regulations and guidelines or other laws and regulations applicable to our business could result in significant liability, additional department of insurance licensing requirements, the revocation of licenses in a particular jurisdiction or our inability to sell subscriptions,insurance products, which could significantly increase our operating expenses, result in the loss of our revenue and otherwise harm our business, operating results and financial condition.
Moreover, because adverse regulatory actions in one jurisdiction may be required to be reported to other jurisdictions, an adverse regulatory action in one jurisdiction could result in penalties and adversely affect our license status or reputation in other jurisdictions, including due to the current requirement that adverse regulatory actions in one jurisdiction be reported to other jurisdictions. Even if the allegations in any regulatory or other action against us ultimately are determined to be unfounded, we could incur significant time and expense defending against the allegations, and any related negative publicity could harm consumer and third-party confidence in us, which could significantly damage our brand.
In addition, we have received, and may in the future receive, inquiries from regulators regarding our marketing and business practices. These inquires may include investigations regarding a number of our business practices, including the manner in which we market and sell subscriptions,products, the manner in which we write policies for any unaffiliated general agent, and whether any amounts we pay to hospitals or hospital groups (e.g., for electronic claims processing) is appropriate. Any modification of our marketing or business practices in response to regulatory inquiries could harm our business, operating results or financial condition and lead to reputational harm.
A regulatory environmentNew laws may be adopted that limits rate increases may adversely affect our operating results and financial condition.
Many states, including New York, have adoptedExisting laws or are considering proposed legislation that,and regulations impose limits on, for instance, our ability to enact price increases for our products, among other things, limit thethings. New laws may be adopted that could further affect our business, for example our ability of insurance companies to effect rate increases, to cancel or not issue existing policies, to use artificial intelligence or machine learning, or to cancel, reducemarket our products in various ways. Implementing changes in order to comply with new laws or not renew existing policies,regulations could also be time-consuming and many state regulators have the power to reduce, or to disallow increasescostly.
We may be affected by mandatory participation in premium rates. Most states, including New York, require licensure and regulatory approval prior to marketing new insurance products. Our practice has been to regularly reevaluate the price of our subscriptions, with any pricing changes implemented at least annually, subject to the review and approval of the state regulators, who may reduce or disallow our pricing changes. Such review has often in the past resulted, and may in the futureplans that could result in delayed implementation of pricing changes and prevent uscontributions from making changesinsurance subsidiaries we believe are necessary to achieve our targeted payout ratio, which could adversely affect our operating results and financial condition. In addition, we may be prevented by regulators from limiting significant pricing changes, requiring us to raise rates more quickly than we otherwise may desire. This could damage our reputation with our members and reduce our retention rates, which could significantly damage our brand, result in the loss of expected revenue and otherwise harm our business, operating results and financial condition.own.


In addition to regulating rates, certainCertain states have enacted laws that require a property-casualty insurer, which includes a pet insurance company, conducting business in that state to participate in assigned risk plans, reinsurance facilities, joint underwriting associations (JUAs), Fair Access to Insurance Requirements (FAIR) plans and wind pools. In these markets, if the state reinsurance facilities, wind pools, FAIR plans or JUAs recognize a financial deficit, they may in turn have the ability to assess participating insurers, adversely affecting our operating results and financial condition if we are a part of such state reinsurance facilities, wind pools, FAIR plans or JUAs. Additionally, certain statesjurisdictions require insurers to participate in guaranty funds for impaired or insolvent insurance companies. These funds periodically assess losses against all insurance companies doing business in the state.jurisdiction. Our operating results and financial condition could be adversely affected by any of these factors.
Regulations that require individuals or entities that sell medical insurance for cats and dogs or process claims to be licensed may be interpreted to apply to our business more broadly than we expect them to, which could require us to modify our business practices, create liabilities, damage our reputation, and harm our business.
29



Insurance regulatorsregulations generally require that each individual who transacts petsells, solicits or negotiates insurance business on our behalf must maintain a valid license in onethe jurisdiction in which the activity occurs. Regulations also generally prohibit paying an insurance commission to an unlicensed person or more jurisdictions. Regulatorsentity. Regulations may also require certain individuals who process claims to be licensed. These requirements are subject to a variety of interpretations between jurisdictions. We may not interpret and apply the requirements in the same manner as all applicable regulators, and, even if we have, the requirements or regulatory interpretations of those requirements may change. Regulators have in the past and/or may in the future determine that certain of our personnel or referral sourcesthird parties were performing licensable activities without the required license. If such persons were not in fact licensed in any such jurisdiction, we could become subject to conviction for an offense or the imposition of an administrative penalty, and liable for significant penalties. Regulators may also deem payments we make to an unlicensed entity or person to be improper. We would also likely be required to modify our business practices and/or sales and marketingpet acquisition programs, or license the affected individuals, which may be impractical or costly and time-consuming to implement. Any modification of our business or marketing practices in response to regulatory licensing requirements could harm our business, operating results or financial condition.
Most insurance legislation requires entities that solicit the sale of pet insurance to be validly licensed in the applicable jurisdiction. If an insurance regulator were to determine that any entity soliciting the sale of a subscription on our behalf did not hold the required license, we may have to modify our business practices or marketing efforts, or license the affected entities, which may be costly and time-consuming to implement.
We are subject to numerous laws and regulations, and compliance with one law or regulation may result in non-compliance with another.
We are subject to numerous laws and regulations that are administered and enforced by a number of different governmental authorities, each of which exercises a degree of interpretive latitude, including, in the United States, state insurance regulators, state securities administrators, state attorneys general and federal agencies including the SEC, Internal Revenue Service and the U.S. Department of Justice. Consequently, we are subject to the risk that compliance with any particular regulator’s or enforcement authority’s interpretation of a legal issue may not result in compliance with another’s interpretation of the same issue, particularly when compliance is judged in hindsight. In addition, there is risk that laws and regulations or any particular regulator’s or enforcement authority’s interpretation of a legal issue may change over time to our detriment, or that changes in the overall legal environment may, even absent any particular regulator’s or enforcement authority’s interpretation of a legal issue changing, cause us to change our views regarding the actions we need to take from a legal risk management perspective, thus necessitating changes to our practices that may, in some cases, increase our costs and limit our ability to grow or to improve the profitabilityour results of our business.operations. Further, in some cases, these laws and regulations are designed to protect or benefit the interests of a specific constituency rather than a range of constituencies. For example, state insurance laws and regulations generally are intended to protect or benefit purchasers or users of insurance products, not holders of securities, which generally is the jurisdiction of the SEC. In many respects, these laws and regulations limit our ability to grow or to improve the profitabilityour results of our business.
Regulation of the sale of medical insurance for cats and dogs is subject to change, and future regulations could harm our business and operating results.
The laws and regulations governing the offer, sale and purchase of medical insurance for cats and dogs are subject to change, and future changes may be adverse to our business. For example, if a jurisdiction were to increase our risk-based capital requirements or alter the requirements for obtaining or maintaining an agent’s license in connection with the enrollment of a member, it could have a material adverse effect on our operations. Some states in the United States have adopted, and others are expected to adopt, new laws and regulations related to the insurance industry. It is difficult to predict how these or any other new laws and regulations will impact our business, but, in some cases, changes in insurance laws, regulations and guidelines may be incompatible with various aspects of our business and require that we make significant modifications to our existing technology or practices, which may be costly and time-consuming to implement and could also harm our business, operating results and financial condition.


Failure to comply with federal, state and provincial laws and regulations relating to privacy and security of personal information, and civil liabilities relating to breaches of privacy and security of personal information, could create liabilities for us, damage our reputation and harm our business.
A variety of U.S. and Canadian federal, state and provincial laws and regulations govern the collection, use, retention, sharing and security of personal information. We collect and utilize demographic and other information from and about our members when they visit our website, call our contact center and apply for enrollment. Further, we use tracking technologies, including “cookies,” to help us manage and track our members’ interactions and deliver relevant advice and advertising. Claims or allegations that we have violated applicable laws or regulations related to privacy and data security could in the future result in negative publicity and a loss of confidence in us by our members, and our participating service providers or team members, and may subject us to fines by credit card companies and the loss of our ability to accept credit and debit card payments. In addition, we have posted privacy policies and practices concerning the collection, use and disclosure of member data on our website. Several Internet companies have incurred penalties for failing to abide by the representations made in their privacy policies and practices. In addition, our use and retention of personal information could lead to civil liability exposure in the event of any disclosure of such information due to hacking, viruses, inadvertent action or other use or disclosure. Several companies have been subject to civil actions, including class actions, relating to this exposure.
We have incurred, and will continue to incur, expenses to comply with privacy and security standards and protocols for personal information imposed by law, regulation, self-regulatory bodies, industry standards and contractual obligations. Such laws, standards and regulations, however, are evolving and subject to potentially differing interpretations, and federal, state and provincial legislative and regulatory bodies may expand current or enact new privacy laws or regulations regarding privacy matters.are frequently enacted. We are unable to predict what additional legislation, standards or regulation in the area of privacy and security of personal information could be enacted or its effect on our operations and business.
Government regulationLaw and regulations of the Internet, email and emailtexting could adversely affect our business.
TheMany laws governing general commerce on the Internet remain unsettled and it may take years to fully determine whether and how existing laws such as those governing insurance, intellectual property, privacy and taxation apply to the Internet. In addition, the growth and development of the market for electronic commerce and Internet-related pet insurance advertisements and transactions may prompt calls for more stringent consumer protection laws that may impose additional burdens on companies conducting business and selling subscriptions over the Internet. Any new laws or regulations or new interpretations of existing laws or regulations relating to the Internet could harm our business and we could be forced to incur substantial costs in order to comply with them, which would harm our business, operating results and financial condition.
30



Additionally, we use phone solicitation, email, and texting to market our services to potential members andand/or as a means of communicating with our existing members. The laws and regulations governing the use of phone solicitation, email, for commercial purposesand texting continue to evolve, and the growth and development of the market for commerce over the Internet may lead to the adoption of additional legislation. Failure to comply with existing or new laws regarding phone solicitation, text or electronic communications with members could lead to significant damages. We have incurred, and will continue to incur, expenses in our efforts to comply with electronic messaging laws. If new laws or regulations are adopted, or existing laws and regulations are interpreted, to impose additional restrictions on our ability to send email to our members or potential members, we may not be able to communicate with them in a cost-effective manner. In addition to legal restrictions on the use of email for commercial purposes, Internet and email service providers and others attempt to block the transmission of unsolicited email, commonly known as “spam.” Many service providers have relationships with organizations whose purpose it is to detect and notify the Internet and email service providers of entities that the organization believes isare sending unsolicited email. If an Internet or email service provider identifies messaging and email from us as “spam” as a result of reports from these organizations or otherwise, we could be placed on a restricted list that will block our emails to members or potential members. If we are restricted or unable to communicate by phone, text or email with our members and potential members as a result of legislation, blockage or otherwise, our business, operating results and financial condition would be harmed.
Applicable insurance laws regarding the change in control of our company may impede potential acquisitions that our stockholders might consider to be desirable.
We are subject to statutes and regulations of the state of New York that generally require that any person or entity desiring to acquire direct or indirect control of APIC obtain prior regulatory approval. These laws may discourage potential acquisition proposals and may delay, deter or prevent a change in control of our company, including through transactions, and in particular unsolicited transactions, that some of our stockholders might consider to be desirable. Similar laws or regulations may also apply in other states in which we may operate.


Our segregated account in Bermuda, WICL segregated account AX, could be adversely impacted by regulatory compliance of aan unaffiliated third party.
Wyndham Insurance Company (SAC) Limited (WICL) is a class 3 insurer regulated by the Bermuda Monetary Authority (BMA). WICL'sWICL’s ability to continue operations and pay dividends could impact the ability of our segregated account to do the same. WICL'sWICL’s failure to meet regulatory requirements set forth by the BMA could result in our inability to transact business with WICL segregated account AX. Further, WICL could be limited from allowing dividends to be paid out of segregated account AX in the event of adverse regulatory actions.
We will continueOur accounting is becoming more complex, and relies upon estimates or judgments relating to incur significantly increased costsour critical accounting policies. If our accounting is erroneous or based on assumptions that change or prove to be incorrect, our operating results could fall below the expectations of securities analysts and devote substantialinvestors, resulting in a decline in our stock price.
The preparation of financial statements in conformity with GAAP requires management time as a result of operating as a public company.
As a public company, we incur significant legal, accountingto make estimates and other expensesassumptions that we did not incur as a private company. For example, we are subject toaffect the reporting requirements ofamounts reported in the Exchange Act,consolidated financial statements and are requiredaccompanying notes, and also to comply with the applicablemany complex requirements of the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act and the JOBS Act, as well as rules and regulations subsequently implemented by the SEC and the stock exchange on which our common stock is listed, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Compliance with these requirements has and may continue to increase our legal and financial compliance costs and will make some activities more time consuming and costly. In addition, from time to time, our management and other personnel need to divert attention from operational and other business matters tostandards. We devote substantial timeresources to these public company requirements. In particular, we have and will continue to incur significant expenses and devote substantial management effort toward ensuring compliance with theaccounting requirements of Section 404 of the Sarbanes-Oxley Act, which will increase when we are no longer an emerging growth company, as defined by the JOBS Act. We cannot predict or estimate the amount of additional costs we may incur as a result of being a public company or the timing of such costs.
We are an emerging growth company and we cannotbase our estimates on our best judgment, historical experience, information derived from third parties, and on various other assumptions that we believe to be certain ifreasonable under the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.
We are an emerging growth company. Undercircumstances, the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselvesresults of this exemption from new or revised accounting standardswhich form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue and therefore, we will be subject to the same new or revised accounting standards as other public companiesexpenses that are not emerging growth companies.
Forreadily apparent from other sources. However, various factors are causing our accounting to become complex, such as long as we continue to be an emerging growth company, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies including, but not limited to, reduced disclosure obligations regarding executive compensationour investments in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stockstrategic opportunities and our stock price may be more volatile.
We generally will remain an emerging growth company until the earliest of (i) the end of the fiscal year in which the market valueexpansion into foreign markets. The ongoing evolution of our common stock that is held by non-affiliates exceeds $700 millionbusiness, international expansion, and entry into complementary businesses, such as of June 30, (ii) the end of the fiscal year in which we have total annual gross revenue of $1 billion or more during such fiscal year, (iii) the date on which we issue more than $1 billion in non-convertible debt in a three-year period or (iv) December 31, 2019, which is the end of the year in which the fifth anniversary of our IPO would occur.
pet food, may compound these complexities. Our reported financialoperating results may be adversely affected by changesif we make accounting errors or our judgments prove to be wrong, assumptions change or actual circumstances differ from those in accounting principles generally acceptedour assumptions, which could cause our operating results to fall below the expectations of securities analysts and investors or guidance we may have provided, resulting in the United States.a decline in our stock price and potential legal claims. Significant judgments, assumptions and estimates used in preparing our consolidated financial statements include those related to revenue recognition, reserve for veterinary invoices, business combinations, and income taxes.
Generally accepted accounting principles in the United States are subject to interpretation by the Financial Accounting Standards Board, the SEC and various bodies formed to promulgate and interpret appropriate accounting principles. A change in these principles or interpretations could have a significant effect on our reported financial results, could affect the reporting of transactions completed before the announcement of a change and could affect our compliance with financial debt covenants.
Risks Related to Ownership of Our Common Stock
Our actual operating results may differ significantly from our guidance.
From time to time we have released, and may continue to release, guidance in our quarterly earnings conference call, quarterly earnings releases, or otherwise, regarding our future performance that represents our management’s estimates as of the date of release. This guidance, which includes forward-looking statements, has been and will be based on projections prepared by our management. These projections are not prepared with a view toward compliance with published guidelines of the American Institute of Certified Public Accountants, and neither our independent registered public accountantsaccounting firm nor any other independent expert or outside party compiles or examines the projections. Accordingly, no such person expresses any opinion or any other form of assurance with respect to the projections. In addition, from time to time we have provided, and may continue to provide, information regarding how we think about the drivers of and our method of calculating our intrinsic value, including related statements regarding discounted cash flows and underlying assumptions (such as pet enrollment, revenue per pet, lifetime values of a pet, pet acquisition costs, and other costs and expenses).

31




ProjectionsThese statements are based upon a number of assumptions and estimates that, while presented with numerical specificity, are inherently subject to significant business, economic and competitive uncertaintiesrisks and contingencies,uncertainties, many of which are beyond our control, including those described in these “Risk Factors” and are based upon specific assumptions with respect to future business decisions, some of which will change. We intend toelsewhere in this report. When we state possible outcomes as high and low ranges, whichthese are intended to provide a sensitivity analysis as variables are changed but are not intended to imply that actual results could not fall outside of the suggested ranges.
The principal reason that we release guidance and other information regarding our view of the drivers and calculation method of our intrinsic value is to provide a basis for our management to discuss our business and outlook with analysts and investors. We do not accept any responsibility for any projections or reports published by any such third parties.
Guidance is necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying the guidance furnished by usthese statements will not materialize or will vary significantly from actual results. Accordingly, our guidance isthese statements are only an estimateestimates of what management believes is realizablereasonable as of the date of release. Actual results may vary from our guidance and the variations may be material. In light of the foregoing, we urge investors are urged not to rely upon our guidance or other information regarding our view of the drivers and calculation method of our intrinsic value in making an investment decision regarding our common stock. In addition, we do not accept any responsibility for any projections or reports published by any such third parties, and we urge you not to place undue reliance on those statements.
Any failure to successfully implement our operating strategy or the occurrence of any of the events or circumstances set forth in this report, or the other reports we file from time to time, could result in the actual operating results being different from our guidance, and the differences may be adverse and material.
Future securities issuances could result in significant dilution to our stockholders and impair the market price of our common stock.
Future issuances of shares of our common stock, or the perception that these sales may occur, could depress the market price of our common stock and result in dilution to existing holders of our common stock. Acquisitions, strategic investments, partnerships, or alliances could also result in dilutive issuances of equity securities. In addition, we may issue options, restricted stock units, or other stock-based awards to those providing services to us, and to the extent outstanding or future options are exercised or restricted stock units or other stock-based awards are settled for shares of our common stock, there will be further dilution. These equity incentives are generally granted under our 2014 Equity Incentive Plan, which provides for automatic annual increases in the number of shares or our common stock available for issuance under the plan equal to 4% of our issued and outstanding shares of common stock, or any lesser number determined by our board of directors. Our board of directors most recently approved a 4% increase in 2022. The amount of dilution could be substantial depending upon the size of our future issuances of securities or exercises or settlement of stock-based awards. Furthermore, we may issue additional equity securities that could have rights senior to those of our common stock, such as pursuant to the “blank check” preferred stock contained in our certificate of incorporation. As a result, purchasers of our common stock bear the risk that future issuances of debt or equity securities may reduce the value of and dilute their ownership interest.
If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our stock price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that securities or industry analysts publish about us or our business. If one or more of the securities or industry analysts who publish research about us or our business downgrade our stock or publish inaccurate or unfavorable evaluations of our company or our stock, the price of our stock could decline. If one or more of these analysts cease coverage of our company, our stock may lose visibility in the market, which in turn could cause our stock price to decline.
The market price of our common stock has been and is likely to continue to be volatile, and you may be unable to sell your shares at or above the price at which you purchased them.
The market price of our common stock has been and is likely to continue to fluctuate widely. Factors affecting the market price of our common stock include:
variations in our operating results, earnings per share, cash flows from operating activities, and key operating metrics, and how those results compare to analyst expectations;
forward-looking guidance that we provide to the public and industry and financial analysts related to future revenue and profitability,results of operations, and any change in that guidance or our failure to achieve the results reflected in that guidance;
the net increases in the number of members, either independently or as compared with published expectations of industry, financial or other analysts that cover our company;
changes in the estimates of our operating results or changes in recommendations by securities analysts that elect to follow our common stock;
announcements of changes to our subscription, strategic alliances, acquisitions or significant agreements by us or by our competitors;
announcements by us or by our competitors of mergers or other strategic acquisitions, or rumors of such transactions involving us or our competitors;
recruitment or departure of key personnel;
factors relating to our other business segment;
issuance of common stock or other securities to certain partners;
32



the economy as a whole and market conditions in our industry;
trading activity by a limited number of stockholders who together beneficially own a majority of our outstanding common stock;
publications and public statements by financial analysts and other finance industry professionals and activists;
the number of shares of our stock trading on a regular basis; and
any other factors discussed in these risk factors.
In addition, if the market for stock in our industry or the stock market in general experiences uneven investor confidence, the market price of our common stock could decline for reasons unrelated to our business, operating results or financial condition. The market price of our common stock might also decline in reaction to events that affect other companies within, or outside, our industry even if these events do not directly affect us. Some companies that have experienced volatility in the trading price of their stock have been the subject of securities class action litigation. If we are the subject of such litigation, it could result in substantial costs and a diversion of our management’s attention and resources.


We do not intend to pay dividends on our common stock and, therefore, any returns will be limited to the value of our stock.
We have never declared or paid any cash dividends on our common stock. WeOther than potential repurchases of our common stock, we currently intend to retain all available funds and any future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. In addition, our ability to pay cash dividends on our common stock is limited by the terms of our credit agreement, APIC’s ability to pay dividends is limited by New York state insurance laws, and WICL Segregated Account AX'sAX’s ability to pay dividends is limited by our agreements with WICL as well as WICL'sWICL’s regulatory requirements. Any return to stockholders will therefore be limited to the increase, if any, of our stock price.
Our directors and principal stockholders own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.
Our directors, five percent or greater stockholders and their respective affiliates beneficially hold a significant amount of our outstanding voting stock. Therefore, these stockholders have the ability to influence us through this ownership position. These stockholders may be able to determine all matters requiring stockholder approval. For example, these stockholders may be able to control elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you or other stockholders may feel are in your or their best interest as one of our stockholders.
Provisions in our restated certificate of incorporation, restated bylaws and Delaware law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the market price of our common stock.
Our restated certificate of incorporation and restated bylaws contain provisions that could depress the market price of our common stock by acting to discourage, delay or prevent a change in control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions, among other things:
establish a classifiedpermit the CEO to also serve as the chair of the board of directors so that not all members of our board are elected at one time;directors;
permit only the board of directors to establish the number of directors and fill vacancies on the board;
provide that directors may only be removed “for cause” and only with the approval of two-thirds of our stockholders;
require super-majority voting to amend some provisions in our restated certificate of incorporation and restated bylaws;
authorize the issuance of “blank check” preferred stock that our board could use to implement a stockholder rights plan (also known as a “poison pill”);
eliminate the ability of our stockholders to call special meetings of stockholders;
prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;
prohibit cumulative voting; and
establish advance notice requirements for nominations for election to our board or for proposing matters that can be acted upon by stockholders at annual stockholder meetings.
In addition, Section 203 of the Delaware General Corporation Law may discourage, delay or prevent a change in control of our company. Section 203 imposes certain restrictions on mergers, business combinations and other transactions between us and holders of 15% or more of our common stock. Moreover, applicable insurance laws require that any person or entity acquiring direct or indirect control of an insurer obtain prior regulatory approval, which may impede potential acquisitions.

We have an Employee Severance and Change in Control Plan that applies to each employee of our company. This plan provides certain benefits to our employees in the event there is a change in control of our company and an employee is terminated under certain conditions. Potential acquirers may determine that the possible payments and acceleration of equity under this plan make an acquisition of our company unattractive.


33




Item 1B. Unresolved Staff Comments
None.
Item 1C. Cybersecurity
As part of its oversight of our company, our board of directors is involved in overseeing our risk management program. Cybersecurity is an important component of overall enterprise risk management (“ERM”). Our cybersecurity processes are fully integrated into our ERM program and are based on recognized frameworks established by the National Institute of Standards and Technology, the International Organization for Standardization and industry standards and regulations, including the NYDFS Cybersecurity Regulation and PCI DSS. We address cybersecurity risks through an approach that focuses on preserving the confidentiality, integrity, and availability of our assets, including the information we collect and store, by identifying, preventing, and mitigating cybersecurity threats and effectively responding to cybersecurity incidents as they occur.
Risk Management and Strategy
Our cybersecurity risk management program focuses on the following key areas:
Technical Safeguards. We utilize technical safeguards that are designed to protect our assets from cybersecurity threats. These safeguards include firewalls, intrusion prevention and detection systems, Managed Detection and Response, antimalware and access controls solutions, which we evaluate and improve through security assessments and threat intelligence.
Incident Response and Recovery Planning. We have established and maintained incident response and recovery plans that address how we respond to cybersecurity incidents, and we test and evaluate these plans on a regular basis.
Third-Party Risk Management. We maintain a risk-based approach to identifying and overseeing cybersecurity risks presented by third parties, including software and services vendors, Territory Partners and other external users of our systems and those of third parties that could adversely impact our business in the event of a cybersecurity incident.
Education. We provide regular, mandatory training for all team members regarding general security concepts, cybersecurity, and physical threats. The training is designed to equip team members to identify and properly respond to a variety of cybersecurity threats and risks, as well as to communicate our processes.
Governance. We maintain a management Risk Committee that assists with our ERM function. We also utilize a virtual Chief Information Security Officer (“vCISO”) and other members of senior management and our IT team to support our risk management program. Our board of directors receives regular reports regarding our ERM function to support its oversight responsibilities, and we ensure our business units receive appropriate updates that may impact operations.
Collaboration. Our processes are designed to identify, prevent, and mitigate cybersecurity threats and incidents and provide for prompt escalation when appropriate. This approach is cross-functional, drawing on the skills and experiences of our diverse team, and it is designed to allow management to make timely decisions regarding public disclosure and business matters.
We periodically assess and test our cybersecurity processes. These efforts include a wide range of activities, such as audits, assessments, tabletop exercises, threat modeling and vulnerability testing focused on evaluating the effectiveness of our cybersecurity measures and planning. We regularly engage independent third parties to assess our cybersecurity measures, including audits and reviews of our information security control environment and operating effectiveness. The results of such assessments are reported to management's Risk Committee and to our board of directors. We adjust our cybersecurity documentation, processes, and practices as necessary based on the information provided by these assessments, audits, and reviews.
Governance
Our board of directors, in coordination with our internal Risk Committee, oversees our ERM function, including the management of risks arising from cybersecurity threats. Our board of directors receives regular updates on cybersecurity matters from management's Risk Committee and from the Information Security Committee, which is comprised of Information Technology and Security leadership and oversees operational aspects of our cybersecurity program. Those updates to our board of directors address a wide range of topics that may include information on recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, and information security considerations with respect to our partners and third parties. Our board of directors and management's Risk Committee also receive prompt information regarding any cybersecurity incident that meets established reporting thresholds and ongoing updates on any such incident until it has been addressed. Our Information Security Committee and vCISO annually report on the status of our cybersecurity program and meet with our board of directors to discuss our approach to cybersecurity and risk management.
34



Our Information Security Committee and vCISO, in coordination with management's Risk Committee, work collaboratively to implement a program designed to protect our assets from cybersecurity threats and to promptly respond to any cybersecurity incidents in accordance with our incident response and recovery plans. To facilitate the success of our cybersecurity risk management program, we deploy multidisciplinary teams to address cybersecurity threats and to respond to cybersecurity incidents. Through ongoing communications with these teams, our Information Security Committee monitors the prevention, detection, mitigation, and remediation of cybersecurity threats and incidents in real-time and report such threats and incidents to management's Risk Committee when appropriate.
Our vCISO has served in various information technology, security, and privacy roles for over 25 years, including as the Chief Information Security Officer for several large public companies. Our vCISO holds undergraduate and graduate degrees in business administration and law, including specialties in information systems management and legal risk and compliance. Additionally, he has attained professional certifications in information security, auditing and assessment, and threat intelligence.
Cybersecurity threats, including those related to previous cybersecurity incidents, have not materially affected and are not reasonably likely to affect us, our business strategy, operations, or financial condition.
Item 2. Properties
Our principal executive offices are located at 6100 4th Avenue South, Seattle, Washington. The lease for our principal office is for 89,900We purchased the building in August 2018 and occupy 120,124 square feet and expires in July 2026. This lease includes provisions that increase our principal office space to a total of 107,642 square feet in 2018. We also occupy 1,600 square feet of office space in Vancouver, British Columbia pursuant to a lease that expires in March 2022.feet.
Item 3. Legal Proceedings
Information with respect to this item may be found in Note 79 of Item 8, "Financial“Financial Statements and Supplementary Data"Data”, under the caption, "Legal Proceedings"“Legal Proceedings” which information is incorporated herein by reference.
Item 4. Mine Safety Disclosures
Not applicable.

35




PART II
Item 5. Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

Recent Sales of Unregistered Securities
Pursuant to a marketing agreement between us and a strategic distributor, we agreed to issue shares of our common stock to the distributor as partial consideration for sales made through the distributor’s marketing channels of white-label pet insurance and wellness products that we create and administer under the agreement. The number of shares we issue is determined quarterly, based on a percentage of revenue from such product sales divided by the volume weighted average price per share for the preceding quarter or, if lower, for the three months ended December 5, 2021. The shares we issue are subject to various restrictions, including a minimum holding period of two years and customary transfer restrictions for shares acquired in a private placement. During the quarter ended December 31, 2023, we issued 2,000 shares of our common stock to the distributor in respect of product sales that occurred in the quarter ended September 30, 2023. We offered and sold these shares in reliance upon the exemption from the registration set forth under Section 4(a)(2) of the Securities Act, and the regulations promulgated thereunder relating to sales by an issuer not involving any public offering, and in reliance on similar exemptions under applicable state laws.
Market for our Common Stock
Our common stock began trading on the New York Stock Exchange (NYSE) under the symbol “TRUP” on July 18, 2014. Prior to that time, there was no public market for our common stock. On June 17, 2016, we voluntarily transferred the listing of our common stock from the NYSE to the NASDAQ Global Market of the NASDAQ Stock Market LLC (NASDAQ) where our common stock continues to be traded under the symbol “TRUP”. The following table sets forth the high and low intra-day sales price per share for our common stock on the NASDAQ and NYSE for the period indicated:
 Fiscal Year 2017 Fiscal Year 2016
 High Low High Low
1st Quarter$16.99
 $13.91
 $9.85
 $7.82
2nd Quarter$23.16
 $14.39
 $15.92
 $9.54
3rd Quarter$26.93
 $21.00
 $16.93
 $13.52
4th Quarter$32.68
 $26.08
 $17.18
 $14.75
Dividend Policy
We have never declared or paid cash dividends on our capitalcommon stock. Under our credit agreement, we are restricted from paying any dividends or making any distributions on accountOther than potential repurchases of our capital stock. Wecommon stock, we currently intend to retain all available funds and any future earnings for use in the development, operation and expansion of our business and do not intend to declareanticipate declaring or paypaying any cash dividends infor the foreseeable future. Any further determination to pay dividends on our capitalcommon stock will be at the discretion of our board of directors, subject to applicable laws, and restrictions in our outstanding credit agreement, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors considers relevant.
Holders of Record
As of February 7, 2018,19, 2024, there were 4329 registered stockholders of record of our common stock. The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, whose shares are held of record by banks, brokers, and other financial institutions.
Securities Authorized for Issuance under Equity Compensation Plans
The information called for by this item is incorporated by reference to our Proxy Statement for the Annual Meeting of Stockholders to be held in 2018.2024. See Part III, Item 12 “Security Ownership of Certain Beneficial Owners and Management.Management and Related Stockholder Matters.
Stock Performance Graph
The following shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference into any of our other filings under the Exchange Act or the Securities Act, except to the extent we specifically incorporate it by reference into such filing.


This chart compares the stockholder return on an investment of $100 atover the close of market on July 18, 2014five years from December 31, 2018 through December 31, 2023 for (1) our common stock, (2) the S&P Small Cap 600 Index, (3) the NASDAQ-100 Technology Sector Index, and (4) the Russell 2000 Index. All values assume the reinvestment of any dividends; however, no dividends have been declared on our common stock to date. The stockholder return on the following graph is not necessarily indicative of future performance.
36



 7/18/2014 12/31/2014 12/31/2015 12/31/2016 12/31/2017
Trupanion Inc.$100.00
 $60.79
 $85.61
 $136.14
 $256.75
S&P Small Cap 600 Index$100.00
 $104.67
 $101.16
 $126.19
 $140.99
NASDAQ-100 Technology Sector Index$100.00
 $108.80
 $106.25
 $131.81
 $180.16
Russell 2000 Index$100.00
 $104.61
 $98.63
 $117.85
 $133.34
3974


12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
Trupanion Inc.$100.00 $146.22 $476.17 $525.18 $189.06 $121.36 
S&P Small Cap 600 Index$100.00 $120.86 $132.43 $165.89 $137.00 $156.02 
NASDAQ-100 Technology Sector Index$100.00 $147.71 $204.70 $259.92 $156.13 $260.26 
Russell 2000 Index$100.00 $124.38 $147.61 $167.82 $131.64 $151.51 



37



Item 6. Selected Financial Data
The selected statements of operations, balance sheet, and other data presented below should be read with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes included elsewhere in this report. The selected statements of operations and balance sheet data are derived from our audited consolidated financial statements included elsewhere in this report and our previously audited financial statements that are not included herein. Our historical results are not necessarily indicative of the results to be expected in any future period.[Reserved]
38

  Year Ended December 31,
  2017 2016 2015 2014 2013
  (in thousands)
Consolidated statements of operations data:          
Revenue:          
Subscription business $218,354
 $173,356
 $133,406
 $103,502
 $76,413
Other business 24,313
 14,874
 13,557
 12,408
 7,416
Total revenue 242,667
 188,230
 146,963
 115,910
 83,829
Cost of revenue: 
 
 
 
 
Subscription business(1)
 176,883
 141,321
 109,428
 85,169
 61,394
Other business 22,734
 13,621
 12,306
 10,867
 6,791
Total cost of revenue 199,617
 154,942
 121,734
 96,036
 68,185
Gross profit: 
 
 
 
 
Subscription business 41,471
 32,035
 23,978
 18,333
 15,019
Other business 1,579
 1,253
 1,251
 1,541
 625
Total gross profit 43,050
 33,288
 25,229
 19,874
 15,644
Operating expenses: 
 
 
 
 
Technology and development(1)
 9,768
 9,534
 11,215
 9,899
 4,888
General and administrative(1)
 16,820
 15,205
 15,558
 14,312
 8,652
Sales and marketing(1)
 19,104
 15,247
 15,231
 11,608
 9,091
Total operating expenses 45,692
 39,986
 42,004
 35,819
 22,631
Operating loss (2,642) (6,698) (16,775) (15,945) (6,987)
Interest expense 533
 218
 325
 6,726
 609
Other (income) expense, net (1,244) (58) (9) (1,487) 671
Loss before income taxes (1,931) (6,858) (17,091) (21,184) (8,267)
Income tax (benefit) expense (428) 38
 114
 (7) (92)
Net loss $(1,503) $(6,896) $(17,205) $(21,177) $(8,175)

(1)Includes stock-based compensation expense as follows:


  Year Ended December 31,
  2017 2016 2015 2014 2013
  (in thousands)
Cost of revenue $594
 $275
 $263
 $315
 $230
Technology and development 216
 246
 404
 461
 351
General and administrative 1,887
 1,893
 1,889
 2,755
 680
Sales and marketing 722
 532
 446
 553
 677
Total stock-based compensation expense $3,419
 $2,946
 $3,002
 $4,084
 $1,938


  December 31,
  2017 2016 2015 2014 2013
  (in thousands)
Consolidated balance sheet data:          
Cash and cash equivalents $25,706
 $23,637
 $17,956
 $53,098
 $14,939
Short-term investments 37,590
 29,570
 25,288
 22,371
 16,088
Working capital 40,692
 34,729
 30,016
 62,111
 13,710
Total assets 105,859
 82,345
 70,917
 98,306
 51,653
Warrant liabilities 
 
 
 
 4,900
Current and long-term debt 9,324
 4,767
 
 14,900
 26,099
Total liabilities 57,425
 37,630
 25,561
 39,031
 52,928
Common stock and additional paid-in capital 134,511
 129,574
 122,844
 119,045
 5,769
Convertible preferred stock 
 
 
 
 31,724
Accumulated deficit (82,784) (81,281) (74,385) (57,180) (36,003)
Total stockholders' equity (deficit) 48,434
 44,715
 45,356
 59,275
 (32,999)
  Year Ended December 31,
  2017 2016 2015 2014 2013
Other operational data(1):
          
Total subscription pets enrolled (at period end) 371,683
 323,233
 272,636
 215,491
 168,405
Total pets enrolled (at period end) 423,194
 343,649
 291,818
 232,450
 182,497
Monthly average revenue per pet $52.07
 $47.82
 $45.04
 $44.14
 $42.56
Lifetime value of a pet (LVP) $727
 $631
 $591
 $591
 $619
Average pet acquisition cost (PAC)(2)
 $152
 $123
 $132
 $121
 $104
Average monthly retention 98.63% 98.60% 98.64% 98.69% 98.65%
(1) For more information about how we calculate total subscription pets enrolled, total pets enrolled, monthly average revenue per pet, lifetime value of a pet, average pet acquisition cost and average monthly retention, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Operating Metrics.”
(2) Average pet acquisition cost is calculated in part based on net acquisition cost, a non-GAAP financial measure. For more information about net acquisition cost and a reconciliation of sales and marketing expenses to net acquisition cost, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures.”




Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations
Please read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included under Part II, Item 8 of this Annual Report on Form 10-K.
This section of this Form 10-K generally discusses 2023 and 2022 items and year-to-year comparisons between 2023 and 2022. Discussions of 2021 items and year-to-year comparisons between 2022 and 2021 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022.
Overview
We provide medical insurance for cats and dogs throughoutin the United States, Canada, Continental Europe, and Puerto Rico. OurAustralia. Through our data-driven, vertically-integrated approach, enables us to provide pet owners with what we believe is the highestdevelop and offer high value medical insurance for their pets,products, priced specifically for each pet’s unique characteristics.characteristics and coverage level. Our growing and loyal membermembership base provides us with highly predictable and recurring revenue. We operate our business similar to other subscription-based businesses, with a focus on maximizing the lifetime value of each pet while sustaining a favorable ratio of lifetime value relative to pet acquisition cost, based on our desired return on investment.
We operate in two business segments: subscription business and other business. We generate revenue in our subscription business segment primarily fromby subscription fees from direct-to-consumer products. We operate our subscription business segment similar to other subscription-based businesses, with a focus on achieving a target margin prior to our new pet acquisition expense and acquiring as many pets as possible at our targeted average estimated internal rate of return. Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties, and, in Canada, low and medium ARPU products marketed under the brand names Furkin and PHI Direct. We provide a full suite of services and support for these products and they are designed to align with the target margin profile of our medical insurance,subscription business segment. Within our subscription business segment we also offer products in Continental Europe, which we market to consumers. Fees are paid at the beginning of each subscription period, which automatically renews on a monthly basis. We generate revenue in ourcurrently underwritten using third-party underwriters.
Our other business segment is comprised of revenue from other product offerings, with third parties with whom we generally have a business-to-business relationship. This business segment has a different margin profile than our subscription segment and includes revenue from writing policies on behalf of third parties where we doand revenue from other products and insurance software solutions. This segment of our business is not undertakepart of our core business strategy and generally has a lower margin. Over time it is reasonable to expect changes to this segment which may impact the marketing, and have more ofrevenue contribution due to a business-to-business relationship. Our other business segment consists of companiespartner or organizations that choosepartners rolling off to provide medical insurance for cats and dogs as a benefit to their employees or members, and contracts include multiple pets. The policies in our other business segment may be materially different from our subscription business. Our ultimate goal is to build the Trupanion brand by continuing to offer the highest value proposition in the industry and maintain strong alignment with the veterinary community. We believe our activities in our other business segment benefit the overall market for pet medical insurance by expanding upon product options and distribution models within other market niches.new underwriters.
We generate leads for our subscription business through both third-party referrals and direct-to-consumersegment from a diverse set of member acquisition channels, which we then convert into members through our contact center, website and contact center.other direct-to-consumer activities. These channels include leads from third-parties such as veterinarians and referrals from existing members. Veterinary practiceshospitals represent our largest referral source. We engage a national referral group ofour “Territory Partners” to have face-to-face visits with veterinarians and their staff. Territory Partners. These independent contractorsPartners are dedicated to cultivating direct veterinary relationships and building awareness of the benefits of our subscriptionhigh quality medical insurance to veterinarians and their clients. Veterinarians then educate pet owners, who visit our website or call our contact center to learn more about, and potentially enroll in, Trupanion. We pay Territory Partners fees based on activity in their regions. We also receive a significant number of new leads from existing members adding pets and referring their friends and family members. Our direct-to-consumer acquisition channels serve as important resources for pet owner education and drive new member leads and conversion. We continuouslymonitor average pet acquisition cost to evaluate the efficiency in acquiring new members and measure effectiveness ofbased on our member acquisition channels and marketing initiatives based upon theirtargeted return on investment, which we measure by comparing the ratio of the lifetime value of a pet generated through each specific channel or initiative to the related acquisition cost.investment.

39



Key Operating Metrics
The following tables set forth ourtotal pets enrolled and key operating metrics for our subscription business for the periodsyears ended December 31, 2017, 20162023, 2022 and 2015,2021, and for each of the last eight fiscal quarters.
 Year Ended December 31,
 202320222021
Total Business:
Total pets enrolled (at period end)1,714,473 1,537,573 1,176,778 
Subscription Business:
Total subscription pets enrolled (at period end)991,426 869,862 704,333 
Monthly average revenue per pet$65.26 $63.82 $63.56 
Lifetime value of a pet, including fixed expenses$419 $641 $717 
Average pet acquisition cost (PAC)$228 $289 $287 
Average monthly retention98.49 %98.69 %98.74 %
 Year Ended December 31,
 2017 2016 2015
Three Months EndedThree Months Ended
Dec. 31, 2023Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
Total Business:
Total pets enrolled (at period end)
Total pets enrolled (at period end)
Total pets enrolled (at period end)1,714,4731,712,1771,679,6591,616,8651,537,5731,439,6051,348,1451,267,253
Subscription Business:
Total subscription pets enrolled (at period end) 371,683
 323,233
 272,636
Total pets enrolled (at period end) 423,194
 343,649
 291,818
Total subscription pets enrolled (at period end)
Total subscription pets enrolled (at period end)991,426969,322943,958906,369869,862808,077770,318736,691
Monthly average revenue per pet $52.07
 $47.82
 $45.04
Lifetime value of a pet (LVP) $727
 $631
 $591
Lifetime value of a pet, including fixed expenses
Average pet acquisition cost (PAC) $152
 $123
 $132
Average monthly retention 98.63% 98.60% 98.64%Average monthly retention98.49 %98.55 %98.61 %98.65 %98.69 %98.71 %98.74 %98.75 %


 Period Ended
 Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
Total subscription pets enrolled (at period end)371,683
 359,102
 346,409
 334,909
 323,233
 312,282
 299,856
 287,123
Total pets enrolled (at period end)423,194
 404,069
 383,293
 364,259
 343,649
 334,070
 320,896
 307,298
Monthly average revenue per pet$53.17
 $52.95
 $51.47
 $50.50
 $49.17
 $48.37
 $47.39
 $46.12
Lifetime value of a pet (LVP)$727
 $701
 $654
 $637
 $631
 $624
 $622
 $603
Average pet acquisition cost (PAC)$184
 $151
 $143
 $128
 $133
 $120
 $118
 $123
Average monthly retention98.63% 98.61% 98.57% 98.58% 98.60% 98.61% 98.64% 98.65%
Total subscription pets enrolled. Total subscription pets enrolled reflects the number of pets in active memberships at the end of each period presented. We monitorand total subscription pets enrolled because it providesinclude pet enrollments in European markets, where policies are currently underwritten by third parties and Trupanion is acting as an indication ofinsurance broker. Per pet metrics, however, exclude these European policies, as their revenue is currently earned from commissions, as opposed to the growthgross underwriting premiums earned by the remainder of our subscription business.
Total pets enrolled. Total pets enrolled reflects the number of subscription pets or pets enrolled in one of the insurance products offered in our other business segment at the end of each period presented. We monitor total pets enrolled because it provides an indication of the growth of our consolidated business.
Total subscription pets enrolled. Total subscription pets enrolled reflects the number of pets in active memberships at the end of each period presented. We monitor total subscription pets enrolled because it provides an indication of the growth of our subscription business.
Monthly average revenue per pet. Monthly average revenue per pet is calculated as amounts billed in a given monthperiod for subscriptions divided by the total number of subscription pet months in the period. Total subscription pet months in a period represents the sum of all subscription pets enrolled for each month during the period. We monitor monthly average revenue per pet because it is an indicator of the per pet unit economics of our subscription business.


Lifetime value of a pet.
40



Lifetime value of a pet, (LVP)including fixed expenses. Lifetime value of a pet, including fixed expenses, is a business operating metric that we believe reflects the lifetime value we might expect from a new pet enrollment. We calculate LVPcalculated based on gross profitsubscription revenue less cost of revenue from our subscription business segment for the 12 months prior to the period end date excluding stock-based compensation expense related to cost of revenue from our subscription business segment, sign-up fee revenue and the change in deferred revenue between periods,periods. This amount is also reduced by the fixed expenses related to our subscription business, which are the pro-rata portion of general and administrative and technology and development expenses, less stock-based compensation, based on revenues. This amount, on a per pet basis, is multiplied by the implied average subscriber life in months. Implied average subscriber life in months is calculated as the quotient obtained by dividing one by one minus the average monthly retention rate. We monitor LVPlifetime value of a pet, including fixed expenses, to assess how much lifetimeestimate the value we might expect from new pets over their implied average subscriber life in months, and to evaluateif they behave like the average pet in that respective period. When evaluating the amount of sales and marketingpet acquisition expenses we may want to incur to attract new pet enrollments.enrollments, we refer to the lifetime value of a pet, including fixed expenses, as well as our estimated internal rate of return calculation for an average pet, which also includes an estimated surplus capital charge, to inform the amount of acquisition spend in relation to the estimated payback period.
Average pet acquisition cost. Average pet acquisition cost (PAC) is calculated as net acquisition cost divided by the total number of new subscription pets enrolled in that period. Net acquisition cost, a non-GAAP financial measure, is calculated in a reporting period as sales and marketingnew pet acquisition expense, excluding stock-based compensation expense, and other business segment sales and marketing expense, offset by sign-up fee revenue. We exclude stock-based compensation expense because the amount varies from period to period based on number of awards issued and market-based valuation inputs. We offset sign-up fee revenue because it is a one-time charge to new members collected at the time of enrollment used to partially offset initial setup costs, which are included in sales and marketingnew pet acquisition expenses. We exclude other business segment sales and marketingpet acquisition expense because that does not relate to subscription enrollments. We monitor average pet acquisition cost to evaluate the efficiency of our sales and marketing programs in acquiring new members and measure effectiveness using the ratio of our lifetime value of a pet to average pet acquisition cost, based on our desiredtargeted return on investment.
Average monthly retention. Average monthly retention is measured as the monthly retention rate of enrolled subscription pets for each applicable period averaged over the 12 months prior to the period end date. As such, our average monthly retention rate as of December 31, 20172023 is an average of each month’s retention from January 1, 20172023 through December 31, 2017.2023. We calculate monthly retention as the number of pets that remain after subtracting all pets that cancel during a month, including pets that enroll and cancel within that month, divided by the total pets enrolled at the beginning of that month. We monitor average monthly retention because it provides a measure of member satisfaction and allows us to calculate the implied average subscriber life in months.

41




Non-GAAP Financial Measures
In addition to our results determined in accordance with U.S. GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that using net acquisition cost to calculate and present certain of our other key metrics is helpful to our investors and an important tool for financial and operational decision-making and evaluating our operating results over different periods of time. Measuring net acquisition cost by removing stock-based compensation expense and other business segment sales and marketing expense offset by sign-up fee revenue provides for a more comparable metric across periods.
This measure, which is a non-GAAP financial measure, may not provide information that is directly comparable to that provided by other companies in our industry. In addition, this measure excludes stock-based compensation expense, which has been, and is expected to continue to be for the foreseeable future, a significant recurring component of our sales and marketing expense. The presentation and utilization ofthese non-GAAP financial measures, when taken collectively, may be helpful to investors in providing consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not meant to be considered in isolation, or as a substitute for, the directly comparable financial measures prepared in accordance with GAAP.
We calculate these non-GAAP financial measures by excluding certain non-cash or non-recurring expenses. We exclude non-recurring transactions and restructuring expenses as they are not indicative of our operating performance. We exclude stock-based compensation as it is non-cash in nature. Although stock-based compensation expenses are expected to remain recurring expenses for the foreseeable future, we believe excluding them allows investors to make meaningful comparisons between our recurring core business operating results and those of other companies. We define non-GAAP development expenses as operating expenses incurred to develop new products and offerings that are pre-revenue. We define non-GAAP fixed expenses as the total of technology and development expense and general and administrative expense, less stock-based compensation expense, non-recurring transaction and restructuring expense, and development expenses related to exploring and developing new products and offerings that generally are in the pre-revenue stage or not at scale.

42



The following tables reflectpresent the reconciliation of our non-GAAP financial measures from corresponding GAAP measures for the periods presented (in thousands):
Year Ended December 31,
202320222021
Veterinary invoice expense$831,055 $649,737 $486,062 
Less:
Stock-based compensation expense(1)
(3,450)(4,054)(4,538)
Other business cost of paying veterinary invoices(287,858)(212,857)(129,614)
Subscription cost of paying veterinary invoices (non-GAAP)$539,747 $432,826 $351,910 
% of subscription revenue75.7 %72.5 %71.1 %
Other cost of revenue$146,534 $133,257 $108,583 
Less:
Stock-based compensation expense(1)
(1,544)(2,232)(2,610)
Other business variable expenses(75,756)(72,453)(57,367)
Subscription variable expenses (non-GAAP)$69,234 $58,572 $48,606 
% of subscription revenue9.7 %9.8 %9.8 %
Technology and development expense$21,403 $25,133 $16,866 
General and administrative expense60,207 39,379 31,893 
Less:
Stock-based compensation expense(1)
(19,869)(17,135)(11,918)
Non-recurring transaction or restructuring expenses (2)
(4,175)(372)(82)
Development expenses(3)
(5,100)(7,789)(3,719)
Fixed expenses (non-GAAP)$52,466 $39,216 $33,040 
% of total revenue4.7 %4.3 %4.7 %
New pet acquisition expense$77,372 $89,500 $78,647 
Less:
Stock-based compensation expense(1)
(7,000)(9,116)(9,160)
Other business pet acquisition expense(200)(541)(499)
Subscription acquisition cost (non-GAAP)$70,172 $79,843 $68,988 
% of subscription revenue9.8 %13.3 %13.9 %
(1)Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses. We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $1.3 million for the year ended December 31, 2023.

(2)Consists of business acquisition transaction expenses, severance and legal costs due to certain executive departures, and a $3.8 million non-recurring settlement of accounts receivable in the first quarter of 2023 related to uncollected premiums in connection with the transition of underwriting a third-party business to other insurers.
(3)As we enter the next phase of our growth, we expect to invest in initiatives that are pre-revenue, including adding new products and international expansion. These development expenses are costs related to product exploration and development that are pre-revenue and historically have been insignificant.

43



Three Months Ended
Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
Veterinary invoice expense$217,739 $212,441 $206,738 $194,137 $176,083 $171,112 $157,616 $144,926
Less:
Stock-based compensation expense(1)
(885)(870)(856)(839)(899)(960)(1,022)(1,173)
Other business cost of paying veterinary invoices(77,572)(72,694)(72,443)(65,149)(59,946)(58,197)(50,378)(44,336)
Subscription cost of paying veterinary invoices (non-GAAP)$139,282 $138,877 $133,439 $128,149 $115,238 $111,955 $106,216 $99,417 
% of subscription revenue72.7 %75.9 %77.0 %77.6 %72.7 %73.5 %72.8 %71.1 %
Other cost of revenue$38,054 $38,179 $34,455 $35,846 $36,277 $32,589 $33,212 $31,179 
Less:
Stock-based compensation expense(1)
(386)(282)(428)(448)(414)(433)(754)(631)
Other business variable expenses(19,301)(20,482)(17,230)(18,743)(20,591)(17,346)(18,010)(16,506)
Subscription variable expenses (non-GAAP)$18,367 $17,415 $16,797 $16,655 $15,272 $14,810 $14,448 $14,042 
% of subscription revenue9.6 %9.5 %9.7 %10.1 %9.6 %9.7 %9.9 %10.0 %
Technology and development expense$5,969 $5,302 $5,232 $4,900 $6,955 $6,553 $6,396 $5,229 
General and administrative expense13,390 12,664 13,136 21,017 10,472 10,314 9,227 9,366 
Less:
Stock-based compensation expense(1)
(3,797)(3,754)(3,497)(8,821)(5,019)(4,805)(4,085)(3,226)
Non-recurring transaction or restructuring expenses (2)
— (8)(65)(4,102)(193)(179)— — 
Development expenses(3)
(1,683)(1,594)(925)(898)(2,084)(2,435)(2,012)(1,258)
Fixed expenses (non-GAAP)$13,879 $12,610 $13,881 $12,096 $10,131 $9,448 $9,526 $10,111 
% of total revenue4.7 %4.4 %5.1 %4.7 %4.1 %4.0 %4.3 %4.9 %
New pet acquisition expense$17,189 $17,772 $20,769 $21,642 $22,457 $22,434 $22,982 $21,627 
Less:
Stock-based compensation expense(1)
(1,567)(1,679)(1,722)(2,032)(2,079)(2,108)(2,601)(2,328)
Other business pet acquisition expense(77)(10)(62)(51)(65)(181)(186)(109)
Subscription acquisition cost (non-GAAP)$15,545 $16,083 $18,985 $19,559 $20,313 $20,145 $20,195 $19,190 
% of subscription revenue8.1 %8.8 %11.0 %11.8 %12.5 %13.2 %13.9 %13.7 %
(1)Trupanion employees may elect to take restricted stock units in lieu of cash payment for their bonuses. We account for such expense as stock-based compensation in accordance with GAAP, but we do not include it in any non-GAAP adjustments. Stock-based compensation associated with bonuses was approximately $0.7 million for the three months ended December 31, 2023.

(2)Consists of business acquisition transaction expenses, severance and legal costs due to certain executive departures, and a $3.8 million non-recurring settlement of accounts receivable in the first quarter of 2023 related to uncollected premiums in connection with the transition of underwriting a third-party business to other insurers.
(3)As we enter the next phase of our growth, we expect to invest in initiatives that are pre-revenue, including adding new products and international expansion. These development expenses are costs related to product exploration and development that are pre-revenue and historically have been insignificant.
44



When determining our PAC, we calculate net acquisition cost for a more comparable metric across periods. Net acquisition cost, a non-GAAP financial measure, is calculated in a reporting period as GAAP new pet acquisition expense, excluding stock-based compensation expense, other business segment expense, and pet acquisition expense for commission-based policies, offset by sign-up fee revenue. We exclude stock-based compensation expense because the amount varies from period to salesperiod based on the number of awards issued and marketingmarket-based valuation inputs. We exclude other business segment pet acquisition expense because it does not relate to subscription enrollments. We exclude pet acquisition expense for commission-based policies because the revenue of these products is earned from commissions from a third party underwriter, as opposed to the gross underwriting premiums earned by the remainder of our subscription business. We offset sign-up fee revenue because it is a one-time charge to new members collected at the time of enrollment used to partially offset initial setup costs, which are included in new pet acquisition expenses.
The following tables reconcile GAAP new pet acquisition expense to non-GAAP net acquisition cost (in thousands):
for the years ended December 31, 2023, 2022, and 2021, and for each of the last eight fiscal quarters:
Year Ended December 31,
 Year Ended December 31, 202320222021
 2017 2016 2015
Sales and marketing expense $19,104
 $15,247
 $15,231
New pet acquisition expense
Net of sign-up fee revenue (2,169) (2,073) (1,983)
Excluding:      
Stock-based compensation expense (722) (532) (446)
Other business segment sales and marketing expense (218) (218) (80)
Stock-based compensation expense
Stock-based compensation expense
Other business pet acquisition expense
Pet acquisition expense for commission-based policies
Net acquisition cost $15,995
 $12,424
 $12,722

Three Months Ended
Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
Sales and marketing expense$5,781
 $4,862
 $4,372
 $4,089
 $3,951
 $3,892
 $3,564
 $3,840
Three Months EndedThree Months Ended
Dec. 31, 2023Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
New pet acquisition expense
Net of sign-up fee revenue(550) (558) (517) (544) (526) (525) (495) (527)
Excluding:               
Stock-based compensation expense(172) (165) (198) (187) (113) (172) (165) (82)
Other business segment sales and marketing expense(56) (51) (63) (48) (62) (63) (55) (38)
Stock-based compensation expense
Stock-based compensation expense
Other business pet acquisition expense
Pet acquisition expense for commission-based policies
Net acquisition cost$5,003
 $4,088
 $3,594
 $3,310
 $3,250
 $3,132
 $2,849
 $3,193
Components of Operating Results
General
We operate in two business segments: subscription business and other business. OurWe generate revenue in our subscription business segment primarily by subscription fees from direct-to-consumer products. We operate our subscription business segment similar to other subscription-based businesses, with a focus on achieving a target margin prior to our pet acquisition expense and acquiring as many pets as possible at our targeted average estimated internal rate of return. Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties and, in Canada, low and medium ARPU products marketed under the brand names Furkin and PHI Direct. We provide a full suite of services and support for these products and they are designed to align with the target margin profile of our subscription business segment. Within our subscription business segment we also offer products in Continental Europe, which are currently underwritten using third-party underwriters.
Our other business segment is comprised of revenue from other product offerings with third parties with whom we generally have a business-to-business relationship. This business segment has different margin profile than our subscription segment and includes revenue from writing policies on behalf of third parties and expenses related to monthly subscriptions for pet medicalrevenue from other products and insurance which we market to consumers. When we do not directly market and sell to consumers, we classify the related revenue and expenses in our other business segment.software solutions.
45



Revenue
We generate revenue in our subscription business segment primarily from subscription fees for our pet medical insurance. Fees are paid at the beginning of each subscription period, which automatically renews on a monthly basis.period. In most cases, our members authorize us to directly charge their credit card, debit card or bank account through automatic funds transfer. Subscription revenue is recognized on a pro rata basis over the monthly enrollment term. Membership may be canceled at any time without penalty, and we issue a refund for the unused portion of the canceled membership. We also generate a portion of our subscription business segment revenue through commissions earned in our European markets, where policies are currently underwritten by third parties and Trupanion is acting as an insurance broker.
We generate revenue in our other business segment primarily from writing policies on behalf of third parties where we do not undertake the direct consumer marketing. This segment also includes the writing of policiesrevenue from other products and insurance software solutions that may be materiallyhave a different margin profile from our subscription.


subscription business.
Cost of Revenue
Cost of revenue in each of our segments is comprised of the following:
Veterinary invoice expense
Veterinary invoice expense includes our costs to review and pay veterinary invoices, administer the payments, and provide member services, and other operating expenses directly or indirectly related to this process. We also accrue for veterinary invoices that have been incurred but not yet received.received and for the estimated internal costs of processing those invoices. This also includes amounts paid by unaffiliated general agents on our behalf, and an estimate of amounts incurred and not yet paid for our other business segment.
Other cost of revenue
Other cost of revenue for the subscription business segment includes direct and indirect member service expenses, Territory Partner renewal fees, credit card transactionpayment processing fees and premium tax expenses. Other cost of revenue for the other business segment includes the commissions we pay to unaffiliated general agents, costs to administer the programs in the other business segment and premium taxes on the sales in this segment.
Operating Expenses
Our operating expenses are classified into threefour categories: technology and development, general and administrative, new pet acquisition expense, and salesdepreciation and marketing.amortization. For each category, except depreciation and amortization, the largest component is personnel costs, which include salaries, employee benefit costs, bonuses and stock-based compensation expense.
Technology and Developmentdevelopment
Technology and development expenses primarily consist of personnel costs and related expenses for our technology staff, which includes information technology development and infrastructure support, including third-party servicesservices. It also includes expenses associated with development in new geographies and depreciation of hardwarenew products and capitalized software.offerings.
General and Administrativeadministrative
General and administrative expenses consist primarily of personnel costs and related expenses for our finance, actuarial, human resources, regulatory, legal and general management functions, as well as facilities and professional services.
Sales and MarketingNew pet acquisition expense
Sales and marketingNew pet acquisition expenses primarily consist of the costcosts, including personnel costs, to educate veterinarians and consumers about the benefits of Trupanion, to generate leads and to convert leads into enrolled pets, as well as print, online and promotional advertising costs,costs.
Depreciation and employeeamortization
Depreciation and amortization expenses consist of depreciation of property, equipment, and software developed for internal use, as well as amortization of finite-lived intangible assets.
Gain (loss) from investment in joint venture
Gain (loss) from investment in joint venture consists of the share of income and losses from our equity method investment in a joint venture, as well as income and expenses associated with administrative services provided to the joint venture.
46



Stock-based compensation
Stock-based compensation is included in the cost and related costs. Salesexpense line items above. Stock-based compensation will vary depending on corporate performance and marketing expenses are driven primarily by investments to acquire new members.terms of the awards under our equity incentive plan. For example, when we have delivered strong performance, stock-based compensation may increase as a result of incentive-based awards under our equity incentive plan.


Factors Affecting Our Performance
Average monthly retention. Our performance depends on our ability to continue to retain our existing and newly enrolled pets and is impacted by our ability to provide a best-in-class value and member experience. Our ability to retain enrolled pets depends on a number of factors, including the actual and perceived value of our services and the quality of our member experience, the ease and transparency of the process for reviewing and paying veterinary invoices for our members, the rate of veterinary inflation and of our pricing adjustments, and the competitive environment. In addition, other initiatives across our business may temporarily impact retention and make it difficult for us to improve or maintain this metric. For example, if the number of new pets enrolled increases at a faster rate than our historical experience, our average monthly retention rate could be adversely impacted, as our retention rate is generally lower during the first year of member enrollment.
Investment in pet acquisition. We have made and plan tomay continue to make significant investments to grow our member base. Our net acquisition cost and the number of new members we enroll depends on a number of factors, including the amount we have available and we elect to invest in sales and marketingpet acquisition activities in any particular period in the aggregate and by channel, the frequency of existing members adding a pet or referring their friends or family, the effectiveness of our sales execution and marketing initiatives, changes in costs of media, the mix of our sales and marketingpet acquisition expenditures and the competitive environment. Our average pet acquisition cost has in the past significantly varied, and in the future may significantly vary, from period to period based upon specific marketing initiatives and the actual or expected relationship to LVP and estimated rates of return on pet acquisition spend. We also regularly test new member acquisition channels and marketing initiatives, which may be more expensive than our traditional marketing channels and may increase our average acquisition costs. We continually assess our sales and marketingpet acquisition activities by monitoring the ratio of LVP to PAC and theestimated return on PAC spend both on a detailed level by acquisition channel and in the aggregate.
Timing of price adjustments. Our subscription business’s cost-plus model depends on our ability to estimate our operating costs and expenses, including veterinary invoice expenses, and to adjust our pricing to achieve our target returns. We regularly reevaluate and adjust the price of our subscriptions, with a goal of achieving our targeted payout ratio, subject to the review and approval of regulators where applicable. This makes it important for us to accurately estimate our costs and to promptly implement pricing adjustments, which generally roll onto our book of insured pets over the succeeding twelve months following any applicable regulatory approval. As a result, we may have timing mismatches during which our pricing does not reflect our current expense profile. In periods of rapid increases in veterinary invoice expenses, including periods of significant inflation, this timing mismatch may have a significant impact on our margin profile.
Timing of initiatives. Over time, we plan to implement new initiatives to improve our member experience, make modifications to our subscription plan, introduce new coverage plans, pursue pet food or other adjacent opportunities, improve our technology, increase the number of veterinary hospitals using our patented direct pay software, and find other ways to maintain a strong value proposition for our members. These initiatives will sometimes be accompanied by price adjustments, in order to compensate for an increase in benefits received by our members. The implementation of such initiatives could impact our expense profile and result in us incurring expenses that may not always directly coincide with the timing of price adjustments,revenue increases, resulting in fluctuations in revenue and gross profitprofitability in our subscription business segment.
Geographic mixMix of sales. The relative mix of our business between the United Statesby geography, pet age, species, breed, and Canadaother factors impacts the monthly average revenue per pet we receive. Prices forFor example, prices from our plan in Canada are generally higher than in the United States (in local currencies), which is consistent withplans could vary depending on the relative cost of veterinary care in each country.different countries or areas or whether the pet is a dog or a cat. As our revenue has grown faster in the United States compared to Canada, this geographic shift in the mix of business has reduced the growth inbetween products and geographies changes, our metrics, such as our monthly average revenue per pet. In addition, as our mix of revenue changes between the United Statespet, and Canada, our exposure to foreign exchange fluctuations will be impacted. We expect our international business, additional product offerings and "Powered by Trupanion" plans to grow and, in turn, we expect these effects to increase.
Other business segment. Our other business segment primarily includes revenue and expenses relatedother product offerings that have been, materially different from those in our subscription business segment. We expect this difference to policies written on behalfcontinue. In addition, we expect the growth rate of third parties. Thisthis segment includes the writing of policies that mayto be materially different from our subscription.subscription business segment. We do not undertake marketing efforts for and are not the primary interface with the customers of the third parties for whom we write other business segment policies. Our relationships in our other business segment are generally subject to termination provisions and are non-exclusive. Accordingly, we cannot controlhave limited influence on the volume of business even if a contract is not terminated.of this segment. Loss of an entire program via contract termination could result in the associated policies and revenuesrevenue being lost over a period of 12 to 18 months, which could have a material impact on our results of operations. In some cases, we have structured exclusive relationships, but those relationships have been and may continue to be subject to limitations on the number of enrolled pets as to which we will write policies for the third party. We may enter into additional relationships in this segment in the future, to the extentif we believe they will be profitable to us,beneficial, which could also impact our operating results.


47



Results of Operations
The following tables set forth our results of operations for the periods presented both in absolute dollars and as a percentage of total revenue for those periods. The period-to-period comparison of financial results is not necessarily indicative of future results.
Year Ended December 31,
202320222021
(in thousands)
Revenue:
Subscription business$712,906 $596,610 $494,862 
Other business395,699 308,569 204,129 
Total revenue1,108,605 905,179 698,991 
Cost of revenue:
Subscription business(1)
613,686 497,684 407,664 
Other business363,903 285,310 186,981 
Total cost of revenue977,589 782,994 594,645 
Operating expenses:
Technology and development(1)
21,403 25,133 16,866 
General and administrative(1)
60,207 39,379 31,893 
New pet acquisition expense(1)
77,372 89,500 78,647 
Depreciation and amortization12,474 10,921 11,965 
Total operating expenses171,456 164,933 139,371 
Gain (loss) from investment in joint venture(219)(253)(171)
Operating loss(40,659)(43,001)(35,196)
Interest expense12,077 4,267 10 
Other expense (income), net(7,701)(3,072)14 
Loss before income taxes(45,035)(44,196)(35,220)
Income tax expense (benefit)(342)476 310 
Net loss$(44,693)$(44,672)$(35,530)
 Year Ended December 31,
 2017 2016 2015
 (in thousands)
Revenue:     
Subscription business$218,354
 $173,356
 $133,406
Other business24,313
 14,874
 13,557
Total revenue242,667
 188,230
 146,963
Cost of revenue:     
Subscription business(1)
176,883
 141,321
 109,428
Other business22,734
 13,621
 12,306
Total cost of revenue199,617
 154,942
 121,734
Gross profit:     
Subscription business41,471
 32,035
 23,978
Other business1,579
 1,253
 1,251
Total gross profit43,050
 33,288
 25,229
Operating expenses:     
Technology and development(1)
9,768
 9,534
 11,215
General and administrative(1)
16,820
 15,205
 15,558
Sales and marketing(1)
19,104
 15,247
 15,231
Total operating expenses45,692
 39,986
 42,004
Operating loss(2,642) (6,698) (16,775)
Interest expense533
 218
 325
Other (income) expense, net(1,244) (58) (9)
Loss before income taxes(1,931) (6,858) (17,091)
Income tax (benefit) expense(428) 38
 114
Net loss$(1,503) $(6,896) $(17,205)
(1) Includes stock-based compensation expense as follows:


Year Ended December 31,
2017 2016 2015
(in thousands)
Year Ended December 31,Year Ended December 31,
2023202320222021
(in thousands)(in thousands)
Cost of revenue$594
 $275
 $263
Technology and development216
 246
 404
General and administrative1,887
 1,893
 1,889
Sales and marketing722
 532
 446
New pet acquisition expense
Total stock-based compensation expense$3,419
 $2,946
 $3,002
48




Year Ended December 31,
 202320222021
(as a percentage of revenue)
Revenue100 %100 %100 %
Cost of revenue88 87 85 
Operating expenses:
Technology and development
General and administrative
New pet acquisition expense10 11 
Depreciation and amortization
Total operating expenses15 18 20 
Gain (loss) from investment in joint venture— — — 
Operating loss(4)(5)(5)
Interest expense— — 
Other expense (income), net(1)— — 
Loss before income taxes(4)(5)(5)
Income tax expense (benefit)— — — 
Net loss(4)%(5)%(5)%

Stock-based compensation expense:Year Ended December 31,
202320222021
(as a percentage of revenue)
Cost of revenue— %%%
Technology and development— — 
General and administrative
New pet acquisition expense
Total stock-based compensation expense%%%


 Year Ended December 31,
 202320222021
(as a percentage of subscription revenue)
Subscription business revenue100 %100 %100 %
Subscription business cost of revenue86 83 82 


49

 Year Ended December 31,
 2017 2016 2015
 (as a percentage of revenue)
Revenue100 % 100 % 100 %
Cost of revenue82
 82
 83
Gross profit18
 18
 17
Operating expenses:     
Technology and development4
 5
 8
General and administrative7
 8
 11
Sales and marketing8
 8
 10
Total operating expenses19
 21
 29
Operating loss(1) (4) (12)
Interest expense
 
 
Other (income) expense, net(1) 
 
Loss before income taxes(1) (4) (12)
Income tax (benefit) expense
 
 
Net loss(1)% (4)% (12)%


 Year Ended December 31,
 2017 2016 2015
 (as a percentage of subscription revenue)
Subscription business revenue100% 100% 100%
Subscription business cost of revenue81
 82
 82
Subscription business gross profit19% 18% 18%

Comparison of the years ended December 31, 2017, 20162023, 2022, and 20152021
Revenue
 Year Ended December 31,% Change
 2023202220212023 vs. 20222022 vs. 2021
 (in thousands, except percentages, pet and per pet data)
Revenue:
Subscription business$712,906 $596,610 $494,862 19%21%
Other business395,699 308,569 204,129 2851
Total revenue$1,108,605 $905,179 $698,991 2229
Percentage of Revenue by Segment:
Subscription business64 %66 %71 %
Other business36 34 29 
Total revenue100 %100 %100 %
Total pets enrolled (at period end)1,714,473 1,537,573 1,176,778 1231
Total subscription pets enrolled (at period end)991,426 869,862 704,333 1424
Monthly average revenue per pet$65.26 $63.82 $63.56 2
Average monthly retention98.49 %98.69 %98.74 %
 Year Ended December 31, Change
 2017 2016 2015 2017 vs. 2016 2016 vs. 2015
 (in thousands, except percentages, pet and per pet data)
Revenue:         
Subscription business$218,354
 $173,356
 $133,406
 26% 30%
Other business24,313
 14,874
 13,557
 63 10
Total revenue$242,667
 $188,230
 $146,963
 29 28
Percentage of Revenue by Segment:      
 
Subscription business90% 92% 91% 
 
Other business10
 8
 9
 
 
Total revenue100% 100% 100% 
 
       
 
Total subscription pets enrolled (at period end)371,683
 323,233
 272,636
 15 19
Total pets enrolled (at period end)423,194
 343,649
 291,818
 23 18
Monthly average revenue per pet$52.07
 $47.82
 $45.04
 9 6
Average monthly retention98.63% 98.60% 98.64%    




Year ended December 31, 20172023 compared to year ended December 31, 2016. 2022. Total revenue increased by $54.4$203.4 million, or 22%, to $242.7$1,108.6 million for the year ended December 31, 2017, or 29%.2023. Revenue from our subscription business segment increased by $45.0$116.3 million, or 19%, to $218.4$712.9 million for the year ended December 31, 2017, or 26%.2023. This increase in subscription business revenue was primarily due todriven by a 15%17% increase in total subscription pet months (the sum of pets enrolled as of December 31, 2017 compared to December 31, 2016,for each month during a period) for policies underwritten by Trupanion and increaseda 2% increase in monthly average revenue per pet of 9% for the same period. Increases in pricing were due to the increased cost of veterinary care and more accurately pricing to our cost-plus margin structure by subcategory.pet. Revenue from our other business segment increased $9.4by $87.1 million to $24.3$395.7 million, or 28%, for the year ended December 31, 2023. This increase was primarily driven by a 24% increase in pet months and a 5% increase in monthly average revenue per pet in this segment.

50



Cost of Revenue
 Year Ended December 31,% Change
 2023202220212023 vs. 20222022 vs. 2021
 (in thousands, except percentages, pet and per pet data)
Cost of Revenue:
Subscription business:
Veterinary invoice expense$543,196 $436,880 $356,448 24%23%
Other cost of revenue70,490 60,804 51,216 1619
Total cost of revenue613,686 497,684 407,664 2322
Other business:
Veterinary invoice expense287,859 212,857 129,614 3564
Other cost of revenue76,044 72,453 57,367 526
Total cost of revenue363,903 285,310 186,981 2853
Percentage of Revenue by Segment:
Subscription business:
Veterinary invoice expense76 %73 %72 %
Other cost of revenue10 10 10 
Total cost of revenue86 83 82 
Other business:
Veterinary invoice expense73 69 63 
Other cost of revenue19 23 28 
Total cost of revenue92 92 92 
Total pets enrolled (at period end)1,714,473 1,537,573 1,176,778 1231
Total subscription pets enrolled (at period end)991,426 869,862 704,333 1424
Monthly average revenue per pet$65.26 $63.82 $63.56 2

Year ended December 31, 2023 compared to year ended December 31, 2022. Total cost of revenue for our subscription business segment increased $116.0 million, or 23%, to $613.7 million for the year ended December 31, 2017, or 63%, due to an increase in enrolled pets in this segment.2023.
Year ended December 31, 2016 compared to year ended December 31, 2015. Total revenue increased by $41.3 million to $188.2 million for the year ended December 31, 2016, or 28%. Revenue for our subscription business segment increased by $40.0 million to $173.4 million for the year ended December 31, 2016, or 30%.
This increase in subscription business revenue was primarily due todriven by a 19% increase in total subscription pets enrolled as of December 31, 2016 compared to December 31, 2015, and increased average revenue per pet of 6% for the same period. Increases in pricing were due to the increased cost of veterinary care. Revenue from our other business segment increased $1.3 million to $14.9 million for the year ended December 31, 2016, or 10%, due to an increase in enrolled pets in this segment.

Cost of Revenue
 Year Ended December 31, Change
 2017 2016 2015 2017 vs. 2016 2016 vs. 2015
 (in thousands, except percentages, pet and per pet data)
Cost of Revenue:         
Subscription business:         
Veterinary invoice expense$155,554
 $124,636
 $95,420
 25% 31%
Other cost of revenue21,329
 16,685
 14,008
 28 19
Total cost of revenue176,883
 141,321
 109,428
 25 29
              Gross profit41,471
 32,035
 23,978
 29 34
Other business:      
 
Veterinary invoice expense14,568
 8,898
 7,904
 64 13
Other cost of revenue8,166
 4,723
 4,402
 73 7
Total cost of revenue22,734
 13,621
 12,306
 67 11
              Gross profit1,579
 1,253
 1,251
 26 
          
Percentage of Revenue by Segment:        
Subscription business:         
Veterinary invoice expense71% 72% 72%    
Other cost of revenue10
 10
 10
    
Total cost of revenue81
 82
 82
    
              Gross profit19
 18
 18
    
Other business:         
Veterinary invoice expense60
 60
 58
    
Other cost of revenue34
 32
 32
    
Total cost of revenue94
 92
 91
    
              Gross profit6
 8
 9
    
          
Total subscription pets enrolled (at period end)371,683
 323,233
 272,636
 15 19
Total pets enrolled (at period end)423,194
 343,649
 291,818
 23 18
Monthly average revenue per pet$52.07
 $47.82
 $45.04
 9 6


Year ended December 31, 2017 compared to year ended December 31, 2016. Cost of revenue for our subscription business segment was $176.9$106.3 million, or 81% of revenue, for the year ended December 31, 2017, compared to $141.3 million, or 82%24%, of revenue for the year ended December 31, 2016. This $35.6 million increase in subscription cost of revenue was primarily the result of a 15% increase in subscription pets enrolled, resulting in a 25% increase in veterinary invoice expense and related internal processing costs. As a percentage$9.7 million, or 16%, increase in other cost of revenue. The 24% increase in veterinary invoice expense was driven by a 17% increase in total subscription pet months for policies underwritten by Trupanion and a 7% increase in veterinary invoice expense per pet. The 16% increase in other cost of revenue thesewas primarily driven by general increases in costs decreasedattributable to 71% for the year ended December 31, 2017 from 72% for the year ended December 31, 2016, due to the increasegrowth in monthly averageour membership, in line with revenue per pet outpacing thegrowth in this segment. Subscription business cost of veterinary care for certain subcategories as we more accurately priced those subcategories. Costrevenue increased from 83% to 86% of revenue year-over-year.

Total cost of revenue for our other business segment increased $9.1by $78.6 million, or 28%, to $22.7$363.9 million for the year ended December 31, 2017, due to an2023. The increase was primarily driven by a $75.0 million, or 35%, increase in enrolled petsveterinary invoice expense and a $3.6 million, or 5%, increase in other cost of revenue. The 35% increase in veterinary invoice expense was primarily driven by a 24% increase in pet months in this segment.segment and a 9% increase in veterinary invoice expense per pet. The 5% increase in other cost of revenue was primarily driven by general increases in premium-based expenses. Cost of revenue for the other business segment remained at a constant 92% of revenue year-over-year.

51



Technology and Development Expenses
Year Ended December 31,% Change
2023202220212023 vs. 20222022 vs. 2021
(in thousands, except percentages)
Technology and development$21,403 $25,133 $16,866 (15)%49%
Percentage of total revenue%%%

Year ended December 31, 20162023 compared to year ended December 31, 2015. Cost of revenue for our subscription business segment was $141.32022. Technology and development expenses decreased by $3.7 million, or 82% of revenue, for the year ended December 31, 2016, compared15%, to $109.4 million, or 82% of revenue, for the year ended December 31, 2015. This $31.9 million increase in subscription cost of revenue was primarily the result of a 19% increase in subscription pets enrolled, resulting in a 31% increase in veterinary invoice expense and related internal processing costs. As a percentage of revenue, these costs were 72% for the years ended December 31, 2016 and 2015. Average revenue per pet increased for the year ended December 31, 2016, however the impact of this on gross margin was offset by an increase in compensation expense by $2.1 million, or 17%, related to increases in headcount to service growth and improve member experience. Cost of revenue for our other business segment increased $1.3 million to $13.6$21.4 million for the year ended December 31, 2016,2023. This decrease was primarily due to ana decrease of $5.0 million in development expense as several initiatives that were pre-revenue in the prior year were launched and have begun generating revenue. Expenses associated with these initiatives are now recorded within the income statement based on the underlying nature of the expense. This decrease was partially offset by a $1.1 million increase in enrolled petsgeneral compensation and other employee-related expenses and a $0.9 million increase in this segment.
IT system hosting expenses. Technology and Developmentdevelopment expenses decreased from 3% to 2% of total revenue year over year

General and Administrative Expenses
Year Ended December 31,% Change
2023202220212023 vs. 20222022 vs. 2021
(in thousands, except percentages)
General and administrative$60,207 $39,379 $31,893 53%23%
Percentage of total revenue%%%
 Year Ended December 31, Change
 2017 2016 2015 2017 vs. 2016 2016 vs. 2015
 (in thousands, except percentages)
Technology and development$9,768
 $9,534
 $11,215
 2% (15)%
Percentage of total revenue4% 5% 8%    


Year ended December 31, 20172023 compared to year ended December 31, 2016. Technology2022. General and developmentadministrative expenses increased $0.2by $20.8 million, or 2%53%, to $9.8$60.2 million for the year ended December 31, 2017. This2023. The increase in expense was primarily due to a $0.5$4.8 million increase in amortization expensestock-based compensation related to projects placed into service in late 2016. This was offset bycharges after certain executive departures and a $0.3$3.8 million decrease in infrastructureincrease related costs compared to the same periodnegotiated settlement of uncollected premiums in connection with the prior year.transition of underwriting a third-party business to other insurers. Additionally, there was a $6.4 million increase in general compensation and other employee-related expenses, a $2.2 million increase in professional services and consulting expenses, a $1.4 million increase in year-over-year expenses related to a full year of Smart Paws and Pet Expert operations in 2023, and a $0.9 million increase in licensing and regulatory fees. General and administrative expenses increased from 4% to 5% of total revenue year over year, partially due to certain non-recurring expenses.


New Pet Acquisition Expense
Year Ended December 31,% Change
2023202220212023 vs. 20222022 vs. 2021
(in thousands, except pet and per pet data)
New pet acquisition expense$77,372 $89,500 $78,647 (14)%14%
Percentage of total revenue%10 %11 %
Subscription Business:
Total subscription pets enrolled (at period end)991,426 869,862 704,333 1424
Average pet acquisition cost (PAC)$228 $289 $287 (21)1

Year ended December 31, 20162023 compared to year ended December 31, 2015. Technology and development expenses2022. New pet acquisition expense decreased $1.7by $12.1 million, or 15%14%, to $9.5$77.4 million for the year ended December 31, 2016.2023. This decrease was partially dueattributable to a $2.7 million decrease in professional servicesexpenses to generate leads and compensationconversion, as we focused on growth in our more efficient channels. New pet acquisition expense andas a percentage of revenue was 7% for the year ended December 31, 2023 compared to 10% in the same period last year, as we were able to stay disciplined with our discretionary pet acquisition spend, while still managing to grow total enrolled subscription pets, excluding those related costs as headcount decreased 36% in this department. This was partially offsetto managing general agent policies, by a $1.2 million increase in depreciation expense, driven by several projects being placed into service during 2016.13%.
General and Administrative Expenses
52



 Year Ended December 31, Change
 2017 2016 2015 2017 vs. 2016 2016 vs. 2015
 (in thousands, except percentages)
General and administrative$16,820
 $15,205
 $15,558
 11% (2)%
Percentage of total revenue7% 8% 11%    
Depreciation and Amortization
Year Ended December 31,% Change
2023202220212023 vs. 20222022 vs. 2021
(in thousands, except percentages)
Depreciation and amortization$12,474 $10,921 $11,965 14%(9)%
Percentage of total revenue%%%
Year ended December 31, 20172023 compared to year ended December 31, 2016. General2022. Depreciation and administrative expensesamortization expense increased by $1.6 million, or 11%14%, to $16.8$12.5 million for the year ended December 31, 2017. This was2023 primarily due to an increasedriven by the amortization of $1.0 million related to higher rent and occupancy costs after our move to a new building in the third quarter of 2016. General and administrative expenses decreased from 8% to 7% as a percentage of revenue for the year ended December 31, 2017, as we experienced scale in our support functions.acquired intangibles.

Total Other Expense (Income), Net

Year Ended December 31,% Change
2023202220212023 vs. 20222022 vs. 2021
(in thousands, except percentages)
Interest expense$12,077 $4,267 $10 183%42,570%
Other expense (income), net(7,701)(3,072)14 151(22,043)
Total other (income) expense, net$4,376 $1,195 $24 266%4,879%
Percentage of total revenue— %— %— %
Year ended December 31, 20162023 compared to year ended December 31, 2015. General and administrative expenses decreased $0.42022. Total other expense (income), net increased by $3.2 million or 2%, to $15.2$4.4 million for the year ended December 31, 2016. This was2023 primarily due to a decreasean increase in personnel costs and related expenses of $0.6 million resulting from lower incentive compensation while headcount remained consistent. General and administrative expenses decreased from 11% to 8% as a percentage of revenue forinterest expense incurred on the year ended December 31, 2016, as we experienced scaleCredit Facility, which was partially offset by an increase in interest earned on our support functions.investment portfolio.
Sales and Marketing ExpensesStock-Based Compensation
 Year Ended December 31, Change
 2017 2016 2015 2017 vs. 2016 2016 vs. 2015
 
(in thousands, except pet and per pet data)

Sales and marketing$19,104
 $15,247
 $15,231
 25% —%
Subscription Business:         
     Total subscription pets enrolled (at period end)371,683
 323,233
 272,636
 15 19
Average pet acquisition cost (PAC)$152
 $123
 $132
 24 (7)
Year ended December 31, 20172023 compared to year ended December 31, 2016. Sales2022. Stock-based compensation is included in the cost and marketing expense increased $3.9 million, or 25%, to $19.1line items in the consolidated statements of operations, discussed above. Stock-based compensation expense in total was $33.2 million for the year ended December 31, 2017. PAC increased 24%2023, down from December 31, 2016, to $152 for the year ended December 31, 2017, as a result of $1.8$33.4 million in additional testingthe prior year period. The amount of new marketing initiatives. Additionally,stock-based compensation recognized largely reflects the timing and related expenses increased by $2.0 million due to a 21% increase in headcount in the year ended December 31, 2017.
Year ended December 31, 2016 compared to year ended December 31, 2015. Sales and marketing expenses remained consistent at $15.2 million for the years ended December 31, 2016 and 2015. PAC decreased 7% from December 31, 2015 to $123 for the year ended December 31, 2016. Headcount within the sales and marketing department increased by 30% in the year ended December 31, 2016. This cost was offset by a decrease in the use of third-party vendors. Our core sales and marketing initiatives remained consistent each year.
Total Other (Income) Expense, Net
  Year Ended December 31,
  2017 2016 2015
  (in thousands)
Interest expense $533
 $218
 $325
Other (income) expense, net (1,244) (58) (9)
Total other (income) expense, net $(711) $160
 $316
Year ended December 31, 2017 compared to year ended December 31, 2016. Total other (income) expense, net improved by $0.9 million primarily due to a $1.0 million gain related to the salevesting of our equity method investment in the second quarter of 2017.
Year ended December 31, 2016 compared to year ended December 31, 2015. Total other (income) expense, net decreased $0.2 million primarily due to a $0.1 million decrease in interest expense resulting from a lower outstanding average loan balance.


Income Tax (Benefit) Expense
  Year Ended December 31,
  2017 2016 2015
  (in thousands, except percentages)
Income tax (benefit) expense $(428) $38
 $114
Effective tax rate 22.2% (0.6)% (0.7)%
Year ended December 31, 2017 compared to year ended December 31, 2016. On December 22, 2017, the U.S. government enacted the Tax Cuts and Jobs Act (the Tax Act). The Tax Act makes broad and complex changes to the Code, including, but not limited to, reducing the corporate tax rate to 21% effective January 1, 2018. As a result, we have recorded a decrease of $0.6 millionannual performance grants, calculated according to our net deferred tax liability recorded on our consolidated balance sheet, with a corresponding adjustment to income tax benefit for the year ended December 31, 2017. This tax benefit represents our best estimate of the impact of the Tax Act in accordance with our understanding of the Tax Act and available guidance as of our date of filing. As we complete our analysis, we may identify newly relevant information or adjust our interpretation of the requirements as additional guidance on the Tax Act becomes available. If an adjustment is required, it may materially change our income tax benefit or expense in the period in which the adjustment is made.equity incentive plan.
The Tax Act makes additional significant changes to the Code, such as, (1) imposing a mandatory one-time tax on accumulated earnings of foreign subsidiaries and transitioning U.S. international taxation from a worldwide tax system to a territorial system with base erosion rules; (2) imposing changes on the utilization of net operating losses; (3) other general changes to the taxation of corporations, including changes to cost recovery rules, changes to the deductibility of interest expense, and elimination of the performance-based compensation exception for executive compensation; therefore, the overall impact of the Tax Act on our future results of operations is uncertain at this time. We intend to continue to reinvest all of our foreign earnings indefinitely outside of the U.S.
Year ended December 31, 2016 compared to year ended December 31, 2015. The effective tax rate remained consistent for the years ended December 31, 2016 and 2015 due to our full valuation allowance on our reported deferred tax assets.
53







Quarterly Results of Operations
The following tables contain selected quarterly financial information for the years ended December 31, 20172023 and 2016.2022. The unaudited quarterly information has been prepared on a basis consistent with the audited consolidated financial statements and includes all adjustments that we consider necessary for a fair presentation of the information shown. These quarterly operating results for any fiscal quarter are not necessarily indicative of the operating results for any full fiscal year or future period.
Consolidated Statements of Operations Data:Three Months EndedConsolidated Statements of Operations Data:Three Months Ended
Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
(in thousands)
Dec. 31, 2023Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
(in thousands)(in thousands)
Revenue:               
Subscription business
Subscription business
Subscription business$58,991
 $56,493
 $52,641
 $50,229
 $47,422
 $44,629
 $42,162
 $39,143
Other business7,554
 6,625
 5,634
 4,500
 3,918
 3,730
 3,670
 3,556
Total revenue66,545

63,118

58,275

54,729

51,340

48,359

45,832

42,699
Cost of revenue:               
Subscription business(1)
47,831
 45,215
 42,591
 41,246
 38,528
 36,432
 34,158
 32,203
Subscription business(1)
Subscription business(1)
Other business6,977
 6,096
 5,333
 4,328
 3,594
 3,427
 3,408
 3,192
Total cost of revenue54,808

51,311

47,924

45,574

42,122

39,859

37,566

35,395
Gross profit:               
Subscription business11,160

11,278

10,050

8,983

8,894

8,197

8,004

6,940
Other business577

529

301

172

324

303

262

364
Total gross profit11,737

11,807

10,351

9,155

9,218

8,500

8,266

7,304
Operating expenses:               
Technology and development(1)
2,572
 2,471
 2,322
 2,403
 2,744
 2,339
 2,164
 2,287
Technology and development(1)
Technology and development(1)
General and administrative(1)
4,546
 4,017
 4,245
 4,012
 4,177
 3,811
 3,495
 3,722
Sales and marketing(1)
5,781
 4,862
 4,372
 4,089
 3,951
 3,892
 3,564
 3,840
New pet acquisition expense(1)
Depreciation and amortization
Total operating expenses12,899

11,350

10,939

10,504

10,872

10,042

9,223

9,849
Operating (loss) income(1,162)
457

(588)
(1,349)
(1,654)
(1,542)
(957)
(2,545)
Gain (loss) from investment in joint venture
Operating income (loss)
Interest expense163
 124
 109
 137
 81
 66
 41
 30
Other (income) expense, net(5) (99) (1,112) (28) (19) 16
 (38) (17)
(Loss) income before income taxes(1,320)
432

415

(1,458)
(1,716)
(1,624)
(960)
(2,558)
Income tax (benefit) expense(482) 26
 4
 24
 7
 13
 4
 14
Net (loss) income$(838)
$406

$411

$(1,482)
$(1,723)
$(1,637)
$(964)
$(2,572)
Other expense (income), net
Income (loss) before income taxes
Income tax expense (benefit)
Net income (loss)
(1) Includes stock-based compensation expense as follows (in thousands):


Three Months Ended
Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
(in thousands)
Three Months EndedThree Months Ended
Dec. 31, 2023Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
(in thousands)(in thousands)
Cost of revenue$162
 $170
 $149
 $113
 $60
 $83
 $66
 $66
Technology and development50
 57
 59
 50
 88
 67
 36
 55
General and administrative471
 503
 482
 431
 470
 454
 476
 493
Sales and marketing172
 165
 198
 187
 113
 172
 165
 82
New pet acquisition expense
Total stock-based compensation expense$855
 $895
 $888
 $781
 $731
 $776
 $743
 $696
54




Three Months Ended
Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
Other Financial and Operational Data:
Total Business:
Total pets enrolled (at period end)1,714,473 1,712,177 1,679,659 1,616,865 1,537,573 1,439,605 1,348,145 1,267,253 
Subscription Business:
Total subscription pets enrolled (at period end)991,426 969,322 943,958 906,369 869,862 808,077 770,318 736,691 
Monthly average revenue per pet$67.07 $65.82 $64.41 $63.58 $63.11 $63.80 $64.26 $64.21 
Lifetime value of a pet, including fixed expenses$419 $428 $470 $541 $641 $673 $713 $730 
Average pet acquisition cost (PAC)$217 $212 $236 $247 $283 $268 $309 $301 
Average monthly retention98.49 %98.55 %98.61 %98.65 %98.69 %98.71 %98.74 %98.75 %

Three Months Ended
Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
(as a percentage of revenue)
Revenue100 %100 %100 %100 %100 %100 %100 %100 %
Cost of revenue86 88 89 90 86 87 87 85 
Operating expenses:
Technology and development
General and administrative
New pet acquisition expense10 10 10 
Depreciation and amortization
Total operating expenses13 14 16 20 17 18 19 19 
Gain (loss) from investment in joint venture— — — — — — — — 
Operating income (loss)— (1)(5)(10)(4)(5)(6)(4)
Interest expense— 
Other expense (income), net— (1)(1)(1)(1)— — — 
Income (loss) before income taxes(1)(1)(5)(10)(4)(5)(6)(4)
Income tax expense (benefit)— — — — — — — — 
Net income (loss)(1)%(1)%(5)%(10)%(4)%(6)%(6)%(4)%
Three Months Ended
Dec. 31, 2023Sept. 30, 2023Jun. 30, 2023Mar. 31, 2023Dec. 31, 2022Sept. 30, 2022Jun. 30, 2022Mar. 31, 2022
(as a percentage of subscription revenue)
Subscription business revenue100 %100 %100 %100 %100 %100 %100 %100 %
Subscription business cost of revenue83 86 87 88 83 84 84 82 
55

 Period Ended
 Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
Other Financial and Operational Data(2):
               
Total subscription pets enrolled (at period end)371,683
 359,102
 346,409
 334,909
 323,233
 312,282
 299,856
 287,123
Total pets enrolled (at period end)423,194
 404,069
 383,293
 364,259
 343,649
 334,070
 320,896
 307,298
Monthly average revenue per pet$53.17
 $52.95
 $51.47
 $50.50
 $49.17
 $48.37
 $47.39
 $46.12
Lifetime value of a pet (LVP)$727
 $701
 $654
 $637
 $631
 $624
 $622
 $603
Average pet acquisition cost (PAC)(3)
$184
 $151
 $143
 $128
 $133
 $120
 $118
 $123
Average monthly retention98.63% 98.61% 98.57% 98.58% 98.60% 98.61% 98.64% 98.65%

 Three Months Ended
 Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
 (as a percentage of revenue)
Revenue100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 %
Cost of revenue82
 81
 82
 83
 82
 82
 82
 83
Gross profit18
 19
 18
 17
 18
 18
 18
 17
Operating expenses:               
Technology and development4
 4
 4
 4
 5
 5
 5
 5
General and administrative7
 6
 7
 7
 8
 8
 8
 9
Sales and marketing9
 8
 8
 8
 8
 8
 8
 9
Total operating expenses19
 18
 19
 19
 21
 21
 20
 23
Operating (loss) income(2) 1
 (1) (3) (3) (3) (2) (6)
Interest expense
 
 
 
 
 
 
 
Other (income) expense, net
 
 (2) 
 
 
 
 
(Loss) income before income taxes(2) 1
 1
 (3) (3) (3) (2) (6)
Income tax benefit(1) 
 
 
 
 
 
 
Net (loss) income(1)% 1 % 1 % (3)% (3)% (3)% (2)% (6)%

 Three Months Ended
 Dec. 31, 2017 Sept. 30, 2017 Jun. 30, 2017 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
 (as a percentage of subscription revenue)
Subscription business revenue100% 100% 100% 100% 100% 100% 100% 100%
Subscription business cost of revenue81
 80
 81
 82
 81
 82
 81
 82
Subscription business gross profit19% 20% 19% 18% 19% 18% 19% 18%


Liquidity and Capital Resources
The following table summarizes our cash flows for the periods indicated (in thousands):
Year Ended December 31,
202320222021
Net cash provided by (used in) operating activities$18,638 $(8,000)$7,458 
Net cash provided by (used in) investing activities7,639 (67,516)(51,913)
Net cash provided by (used in) financing activities59,126 60,743 (1,125)
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash, net424 (1,459)252 
Net change in cash, cash equivalents, and restricted cash$85,827 $(16,232)$(45,328)
 Year Ended December 31,
 2017 2016 2015
Net cash provided by (used in) operating activities$9,666
 $5,006
 $(10,425)
Net cash used in investing activities(13,056) (6,508) (9,923)
Net cash provided by (used in) financing activities5,081
 7,672
 (14,208)
Effect of exchange rates on cash and cash equivalents378
 111
 (586)
Net change in cash, cash equivalents, and restricted cash$2,069
 $6,281
 $(35,142)
Our primary sources of liquidity are cash provided by operations and available borrowings on our line of credit. Our primary requirements for liquidity are paying veterinary invoices, funding operations and capital requirements, investing in new member acquisition, investing in enhancements to our member experience, and servicing debt.
As We have certain contractual obligations in the normal course of December 31, 2017, we had $63.3 million of cash, cash equivalents,business, including obligations and short-term investments and $18.7 million available undercommitments relating to our line of credit, which excludes $1.8 million reserved under the credit agreement for an outstanding letter of credit and other ancillary services. Most of the assets in APIC and WICL Segregated Account AX are subject to certain capital and dividend rules and regulations prescribed by jurisdictions in which they are authorized to operate. As of December 31, 2017, total assets and liabilities held outside of our insurance entities totaled $42.7 million and $20.4 million, respectively, including $19.2 million of cash and cash equivalents that are segregated from other operating funds and held in trust for the paymentCredit Facility, non-cancellable vendor purchase agreements, as well as future payments of veterinary invoicesinvoices. Refer to Note 10, Reserve for Veterinary Invoices, included in Item 8 of Part II of this 10-K, for further details on behalfanticipated cash outflows.
Most recently, our primary sources of liquidity have been cash provided by operations and available borrowings from our subsidiaries.
Credit Facility. We believe our cash and cash equivalents, short-term investments and line of creditthese sources are sufficient to fund our operations and capital requirements for the next 12 months. As we continue to grow and consider strategic opportunities, however, we may explore additional financing to fund our operations and growth or to meet capital requirements. Financing could include equity, equity-linked, or debt financing. Additional financing may not be available to us on acceptable terms, or at all. As our capital surplus grows relative to the rate of growth of our business, we may also generate cash, via dividends or other methods, from one or more of our underwriting entities.
As of December 31, 2023, we had $277.2 million in cash, cash equivalents and short-term investments, of which $230.6 million was held by our insurance entities. Outside of insurance entities, we held $46.6 million in cash, cash equivalents and short-term investments with an additional $15.0 million available under our Credit Facility. Our insurance entities maintained $241.3 million of capital surplus, which was $64.1 million in excess of the estimated risk-based capital requirement of $177.2 million. The ability to distribute any portion of this estimated $64.1 million excess to our parent company, and the timing of any distribution, may be subject to regulatory limitations.
In April 2021, our board of directors approved a share repurchase program, pursuant to which we may, between May 2021 and May 2026, repurchase outstanding shares of our common stock. While our board of directors has approved the program, any repurchase activity is subject to quarterly assessment and board approval, based on various factors including available cash, our stock price relative to our estimated intrinsic value, forecasted operating results, and available opportunities to deploy capital. We repurchased no shares under this program during the year ended December 31, 2023.
Operating Cash Flows
We derive operatingNet cash flows from the sale of our subscription plans, which is used to pay veterinary invoices and other cost of revenue. Additionally, cash is used to support the growth of our business by reinvesting to acquire new pet enrollments and to fund projects that improve our members' experience. Cash provided by operating activities was $9.7$18.6 million for the year ended December 31, 20172023 compared to $8.0 million net cash used by operating activities for the year ended December 31, 2022. This increase was primarily driven by an increase in cash collections from members, a decrease in acquisition costs, and timing differences in other working capital activities. Cash increases from working-capital were primarily driven by an increase in our reserve for veterinary invoices. Changes in accounts receivable and deferred revenue were primarily related to annual policies with monthly payment terms within our other business segment.
Investing Cash Flows
Net cash provided by operatinginvesting activities of $5.0was $7.6 million for the year ended December 31, 2016. The increase2023, primarily consisting of $24.3 million in cash providedsales and maturities of investment securities, net of purchases, offset by operating activities$18.3 million of $4.7 million wascapital expenditures primarily duerelated to the $4.1 million decrease in operating loss, drivendevelopment of internal-use software focused on member experience, claims processing, and internal policy management improvements. Net cash used by higher revenue and decreased operating expenses as a percentage of revenue as we increased scale in our technology and general and administrative departments.
Cash provided by operatinginvesting activities was $5.0$67.5 million for the year ended December 31, 2016 compared2022, primarily consisting of $33.8 million in purchases of investment securities, net of sales and maturities, $17.1 million of capital expenditures primarily related to the development of internal-use software, and $15.0 million in net cash used in operatingpaid for business acquisitions.
Financing Cash Flows
Net cash provided by financing activities of $10.4was $59.1 million for the year ended December 31, 2015. The increase in cash provided by operating activities2023, primarily consisting of $15.4 million was primarily due to the $10.1 million decrease in operating loss, driven by higher revenue and decreased operating expenses as a percentage of revenue as we increased scale in our technology and general and administrative departments. Additionally, we reduced spend as a percentage of revenue in our sales and marketing department.
Investing Cash Flows
Net cash used in investing activities for each of the periods presented was primarily related to the net purchase of investments to increase our statutory capital. As of December 31, 2017, we had $40.8$60.1 million in short-term and long-term investmentsproceeds from the Credit Facility, partially offset by $1.7 million in our insurance entities, APIC and WICL Segregated Account AX. These investments are held to satisfy statutory requirements. Our regulators may increaserepayments on the required levels of risk-based capital in the future, and we anticipate that we will need to maintain greater amounts of risk-based capital if our pet enrollment continues to grow.
Financing Cash Flows
CashCredit Facility. Net cash provided by financing activities was $5.1$60.7 million and $7.7 million for the years ended December 31, 2017 and 2016, respectively. The decrease of $2.6 million was primarily due to a decrease of $1.2 million in proceeds from exercises of stock options. We also paid an additional $0.5 million for tax withholding on restricted stock.
Cash used in financing activities for the year ended December 31, 2015 was $14.2 million. For2022, primarily consisting of $69.1 million in proceeds from the year ended December 31, 2016, cash providedCredit Facility, partially offset by financing activities increased by $21.9$5.8 million primarily due to borrowings under our linein repurchases of credit of $5.0 million, as compared to payments on our line of credit of $14.9 million, for the years ended December 31, 2016 and 2015, respectively.common stock.

56




Long-Term Debt
Pacific Western Bank Loan and Security Agreement
In December 2016, we entered into a syndicated loan agreementOur Credit Facility provides us with Pacific Western Bank (PWB) and Western Alliance Bank (WAB) that increased our previous facility from $20.0up to $150.0 million to $30.0 million. The agreement was amended during the current year to extend the maturity date to December 2019. We refer to the restated and amended loan and security agreement as our PWB credit facility. The maximum amount available to us under the PWB credit facility, inclusive of any amounts outstanding under the revolving line of credit, is the lesser of $30.0 million or the total amount of cash and securities held by our insurance subsidiaries (APIC and WICL), less $1.8 million for obligations we have outstanding from PWB and/or WAB for other ancillary services and our letter of credit. Interest on the PWB credit facility accrues at a variable annual rate equal to the greater of 4.5% or 1.25% plus the prime rate (5.75% at December 31, 2017).
The PWB credit facility requires us to maintain certain financial and non-financial covenants, including maintaining a minimum cash balance of $0.6 million in our account at WAB and/or WAB affiliates and other cash or investments of $1.4 million in our accounts at PWB. As of December 31, 2017,2023, we were in compliance with each of the financial and non-financial covenants.
Our obligationsissued term loans totaling $135.0 million under the PWB credit facility areCredit Facility. The Credit Facility is secured by substantially all of our assets and a pledge of certainthose of our subsidiaries’ stock. subsidiaries. Refer to Note 11, Debt, included in Item 8 of this report, for further details.
Regulation
As of December 31, 2017, we had $9.52023, our insurance entities collectively held $101.0 million in aggregate borrowings outstanding undercash and cash equivalents, to be used for operating expenses of our insurance entities, $129.6 million in short-term investments and $268.0 million in other current assets. Most of the PWB credit facility.assets in our insurance entities are subject to certain capital and dividend rules and regulations prescribed by jurisdictions in which they are authorized to operate.
American Pet Insurance Company (APIC)
Contractual Obligations
We enterThe majority of our investments are held by our insurance entities to satisfy risk-based capital requirements of the National Association of Insurance Commissioners (NAIC). The NAIC requirements provide a method for analyzing the minimum amount of risk-based capital (statutory capital and surplus plus other adjustments) appropriate for an insurance company to support its overall business operations, taking into long-term contractual obligationsaccount the risk characteristics of the company’s assets, liabilities and commitmentscertain other items. An insurance company found to have insufficient statutory capital based on its risk-based capital ratio may be subject to varying levels of additional regulatory oversight depending on the level of capital inadequacy. APIC must hold certain capital amounts in order to comply with the normal coursestatutory regulations and, therefore, we cannot use these amounts for general operating purposes without regulatory approval. As our business grows, the amount of capital we are required to maintain to satisfy our risk-based capital requirements also generally will increase, though risk-based capital requirements also take our overall rate of growth into consideration. Recently, our other business primarily debt obligationssegment growth has slowed and, non-cancellable operating leases. For enforceablecurrently, we expect that to continue, which would reduce our capital requirements. APIC was required to maintain at least $137.6 million and legally binding contracts, our contractual cash obligations$142.4 million of risk-based capital as of December 31, 20172023 and 2022, respectively. APIC maintained $199.6 million and $162.2 million of risk-based capital surplus as of December 31, 2023 and 2022, respectively. The increase of capital surplus at APIC during the year was primarily due to retained earnings from APIC's underwriting profit and a capital contribution of $3.8 million, partially offset by an ordinary dividend of $7.6 million distributed to the parent entity in December 2023.
ZPIC Insurance Company (ZPIC), QPIC Insurance Company (QPIC), and GPIC Insurance Company (GPIC)
In 2021, we established two new wholly-owned insurance subsidiaries, ZPIC and QPIC, domiciled in Missouri and Nebraska, respectively, and in 2023 we established a new wholly-owned insurance subsidiary, GPIC, domiciled in Canada. We have funded required statutory capital to each of these new subsidiaries. As of December 31, 2023, neither ZPIC, QPIC nor GPIC have begun underwriting any insurance policies, accordingly, each of these entities are set forth below (in thousands):    
  Total 
Less Than
1 Year
 1-3 Years 3-5 Years 
More Than
5 Years
Long-term debt obligations(1)
 $9,500
 $
 $9,500
 $
 $
Operating lease obligations(2)
 19,201
 1,876
 4,151
 4,455
 8,719
Capital leases(3)
 519
 519
 
 
 
Other obligations(4)
 1,625
 927
 681
 17
 
Total $30,845
 $3,322
 $14,332
 $4,472
 $8,719
currently overcapitalized relative to traditional risk-based capital requirements. We formed these insurance subsidiaries to provide us flexibility as to the insurance entity we use to market and write policies.
(1) Consists of our revolving line of credit. Excludes interest of the greater of 4.5% or 1.25% plus the prime rate (5.75% at December 31, 2017).Wyndham Insurance Company (SAC) Limited (WICL) Segregated Account AX
WICL Segregated Account AX was established by WICL, with Trupanion, Inc. as the shareholder, to enter into a reinsurance agreement with Omega General Insurance Company. All of the assets and liabilities of WICL Segregated Account AX are legally segregated from other assets and liabilities within WICL, and all shares of the segregated account are owned by Trupanion, Inc. In February 2023, our parent entity received a dividend of $7.3 million from WICL Segregated Account AX as allowed under our agreements with WICL. As required by the Office of the Superintendent of Financial Institutions regulations related to our reinsurance agreement with Omega General Insurance Company, we are required to maintain a Canadian Trust account with the greater of CAD $2.0 million or 120% of unearned Canadian premium plus 20% of outstanding Canadian claims, including all incurred but not reported claims. As of December 31, 2023, the account held CAD $15.7 million.
Though we are not directly regulated by the Bermuda Monetary Authority (BMA), WICL's regulation and compliance impacts us as it could have an adverse impact on the ability of WICL Segregated Account AX to pay dividends. WICL is regulated by the BMA under the Insurance Act of 1978 (Insurance Act) and the Segregated Accounts Company Act of 2000. The Insurance Act imposes on Bermuda insurance companies, solvency and liquidity standards, certain restrictions on the declaration and payment of dividends and distributions, certain restrictions on the reduction of statutory capital, and auditing and reporting requirements, and grants the BMA powers to supervise and, in certain circumstances, to investigate and intervene in the affairs of insurance companies. Under the Insurance Act, WICL, as a class 3 insurer, is required to maintain available statutory capital and surplus at a level equal to or in excess of a prescribed minimum established by reference to net written premiums and loss reserves.
57



Under the Bermuda Companies Act 1981, as amended, a Bermuda company may not declare or pay a dividend or make a distribution out of contributed surplus if there are reasonable grounds for believing that: (a) the company is, or would after the payment be, unable to pay its liabilities as they become due; or (b) the realizable value of the company’s assets would thereby be less than its liabilities. The Segregated Accounts Company Act of 2000 further requires that dividends out of a segregated account can only be paid to the extent that the cell remains solvent and the value of its assets remain greater than the aggregate of its liabilities and its issued share capital and share premium accounts.
(2) Consists of contractual obligations from non-cancellable office space under operating lease.
(3) Consists of contractual obligations from property and equipment purchased under capital lease.
(4) Consists of contractual obligations from non-cancellable vendor service agreements.


Critical Accounting Policies and Significant Estimates
Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, as well as the reported revenue and expenses during the reporting periods.
Critical accounting policies and estimates are those that we consider the most important to the portrayal of our financial condition and results of operations because they require our most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Generally, we base our estimates on historical experience and on various other factors that we believe to be reasonable under the circumstances. Actual results may differ from these estimates.
Reserve for Veterinary Invoices
The reserveWe use the chain-ladder method and other actuarial methods to estimate reserves for veterinary invoices for our subscription business and for the majority of our other business segment. Paid loss development factors are estimated based on historical paid loss triangles. The reserve represents our estimate of the future amount we will pay for veterinary invoices that are dated as of, or prior to, our balance sheet date. The reserve also includes our estimate of related internal processing costs. To determine the accrual, we make assumptions based on our historical experience, including the number of veterinary invoices we expect to receive, the average cost of those veterinary invoices, the length of time between the date of the veterinary invoice and the date we receive it, the member's chosen deductible, and our expected cost to process and administer the payments. As of each balance sheet date, we reevaluate our reserve and may adjust the estimate for new information.
For the year ended December 31, 2017, we paid $7.8 million for veterinary invoices dated on or before December 31, 2016, including related processing costs. Our reserve estimate for these expenses was $8.5 million as of December 31, 2016. As of December 31, 2017, we reevaluated the remaining2023, our reserve for those periods prior to December 31, 2016 and recorded an adjustment to our income statement to reduce it by $0.1 million. As of December 31, 2017, our reserveveterinary invoices was $11.1$63.2 million, consisting of $10.4$61.0 million for the amount we expect to pay in the future for veterinary invoices dated between January 1, 20172023 and December 31, 2017,2023, inclusive of related processing costs, as well as the adjustedand a reserve of $0.7$2.2 million for periodsinvoices dated prior to 2017.January 1, 2023. We believe the reserve amount as of December 31, 2023 is adequate, and we do not believe that there are any reasonably likely changes in the facts or circumstances underlying key assumptions that would result in the reserve balance being insufficient in an amount that would have a material impact on our reported results, financial position or liquidity. The ultimate liability, however, may be in excess of or less than the amount we have reserved.
Similarly, forFor the yearsyear ended December 31, 2016 and 2015,2023, we adjusted ourpaid $44.7 million for veterinary invoices dated on or before December 31, 2022, including related processing costs. Our reserve estimate for prior periods, increasing it by $0.8these expenses was $43.7 million and less than $0.1as of December 31, 2022. As of December 31, 2023, we had unfavorable development on veterinary invoice reserves of $3.3 million respectively. These adjustments were recorded in our income statement for each respective year.the year ended December 31, 2022.
Income Taxes
We determine our deferred tax assets and liabilities based on the differences between the financial reporting and tax basis of assets and liabilities. The deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that the deferred tax asset will not be recovered. We apply judgment in the determination of the consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Although we believe our assumptions, judgments and estimates are reasonable, changes in tax laws or our interpretation of tax laws and the resolution of any tax audits could significantly impact the amounts provided for income taxes in our consolidated financial statements.
On December 22, 2017, the U.S. government enacted the Tax Act, making broad and complex changes to the Code. As a result, we have made significant judgments and estimates in accordance with our understanding of the Tax Act and available guidance as of our date of filing. We may identify newly relevant information or adjust our interpretation of the requirements as additional guidance on the Tax Act becomes available. If an adjustment is required, it may materially change our income tax benefit or expense in the period in which the adjustment is made.



Stock-Based Compensation
Compensation expense related to stock-based transactions, including employee and non-employee stock option awards, restricted stock awards, and restricted stock units, is measured and recognized in the financial statements based on fair value. The fair value of stock options is estimated on the measurement date using the Black-Scholes option-pricing model that requires management to apply judgment and make estimates, including:


Expected volatility —We estimate the expected volatility based on the historical volatility of a representative group of publicly traded companies with similar characteristics to us, and our own historical volatility;
58


Expected term for awards granted to employees —We have based our expected term for awards issued to employees on the simplified method, as permitted by the SEC Staff Accounting Bulletin No. 110, Share-Based Payment, as we have insufficient historical information regarding our stock options to provide a basis for an estimate;

Risk-free interest rate—The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected term of the options; and
Expected dividend yield—We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero.
Stock-based compensation expense for stock options, restricted stock awards, and restricted stock units is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. We recognize forfeitures when they occur.



Item 7A. Quantitative and Qualitative Disclosures About Market Risks
We are exposed toMarket risk is the risk of loss arising from adverse changes in market risksrates and prices, such as interest rates (inclusive of credit spreads) and other relevant market rate or price changes. Market risk is directly influenced by the volatility and liquidity in the ordinary coursemarkets in which the related underlying assets are traded. The following is a discussion of business,our primary market risk exposures and how those exposures are managed as of December 31, 2023. Our market risk sensitive instruments are primarily related to interest rate sensitivities and foreign currency exchange risk.

entered into for purposes other than trading.
Interest Rate Risk
WeThe primary market risks to our investment portfolio are exposed to interest rate risk as a result of our debt and our investment activities. Our revolving line of credit risk associated with Pacific Western Bank (PWB) and Western Alliance Bank (WAB) bears interest at the rate of the greater of 4.5% or 1.25% plus the prime rate. As of December 31, 2017, our aggregate outstanding indebtedness was $9.5 million.investments in fixed maturity securities. The primary objective of our investment activities is to maintain principal and the majority of our investments are short-term in nature. For additional information regarding our investments, refer to Note 6, Investments, included in Item 8 of this report.
Additionally, we are exposed to interest rate risk as a result of our debt and our investment activities. Our Credit Facility bears interest at a floating base rate plus an applicable margin. As of December 31, 2023, our aggregate outstanding indebtedness was $128.9 million. A 10% change100 basis points of hypothetical interest rate increase would increase our annual interest expense by $1.3 million. Our fixed maturities portfolio is also exposed to interest rate risk. Changes in market interest rates wouldhave a direct impact on the market valuation of these securities. Certain securities are held in an unrealized loss position, but we do not intend to sell and believe we will not be expectedrequired to sell any of these securities held in an unrealized loss position before their anticipated recovery. We manage interest rate risk by investing in securities with relatively short durations. A 100 basis points of hypothetical interest rate increase would not have a material impacteffect on the fair value of our consolidated financial condition or results of operations.investments.
Foreign Currency Exchange Risk
We generate approximately 20%15% of our revenue in Canada. As our operations in Canada or the United States grow on an absolute basis and/or relative to one another, our results of operations and cash flows will be subject to fluctuations due to changes in foreign currency exchange rates. A 10% change in the Canadian currency exchange rate could have a material impact on our consolidated financial condition or results of operations. A hypothetical change of this magnitude would have increased or decreased our total revenues by approximately $4.7$16.8 million, total expenses by approximately $3.4$16.2 million, and have a net impact of $1.3$0.6 million of income or loss for the year ended December 31, 2017.2023. To date, we have not entered into any material foreign currency hedging contracts although we may do so in the future. Other foreign currency risk in European currencies is currently immaterial.




59



Item 8. Financial Statements and Supplementary Data


Trupanion, Inc.
Index to Consolidated Financial Statements
Page




































60



Report of Independent Registered Public Accounting Firm


To the Stockholders and the Board of Directors of Trupanion, Inc.


Opinion on the Financial Statements


We have audited the accompanying consolidated balance sheets of Trupanion, Inc. (the Company) as of December 31, 20172023 and 2016,2022, the related consolidated statements of operations, comprehensive loss, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2017,2023, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 20172023 and 2016,2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017,2023, in conformity with U.S. generally accepted accounting principles.


We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 26, 2024 expressed an adverse opinion thereon.

Basis for Opinion


These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB)PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.


We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.


Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosures to which it relates.

61



Reserve for Veterinary Invoices
Description of the Matter
The Company’s reserve for veterinary invoices totaled $63.2 million as of December 31, 2023. As discussed in Note 1 and Note 10 to the financial statements, the Company’s reserve for veterinary invoices is based on an actuarial analysis of the Company’s historical experience where the Company makes assumptions to estimate the amount the Company will pay for veterinary invoices that haven't been processed or received but that are dated as of, or prior to, its balance sheet date. The estimate of veterinary invoice reserves is subject to a number of variables, including historical trends involving payment patterns and amounts.

Auditing the Company’s reserve for veterinary invoices is complex and required the involvement of our actuarial specialists due to the sensitivity of the estimated reserve to management's assumptions. Estimating the ultimate cost to settle the veterinary invoice reserve is subjective due to the possibility that the actual veterinary invoice payments may not be comparable to historical trends experienced by the Company.
How We Addressed the Matter in Our AuditTo evaluate the reserve for veterinary invoices, our audit procedures included, among others, testing the completeness and accuracy of the historical veterinary paid invoice data used in management's actuarial projections. We involved our actuarial specialists to assist in our evaluation of management’s methodologies and assumptions used in the calculation of the reserve and compared the Company’s recorded reserve to a range of reasonable estimates developed independently by our actuarial specialists.



/s/ Ernst & Young LLP


We have served as the Company’s auditor since 2012.


Seattle, Washington
February 13, 201826, 2024






















62

Trupanion, Inc.
Consolidated Statements of Operations
(in thousands, except per share data)
 Year Ended December 31,
 2017 2016 2015
Revenue$242,667
 $188,230
 $146,963
Cost of revenue:  
 
Veterinary invoice expense170,122
 133,534
 103,324
Other cost of revenue29,495
 21,408
 18,410
Gross profit43,050
 33,288
 25,229
Operating expenses:     
Technology and development9,768
 9,534
 11,215
General and administrative16,820
 15,205
 15,558
Sales and marketing19,104
 15,247
 15,231
Total operating expenses45,692
 39,986
 42,004
Operating loss(2,642) (6,698) (16,775)
Interest expense533
 218
 325
Other (income) expense, net(1,244) (58) (9)
Loss before income taxes(1,931)
(6,858)
(17,091)
Income tax (benefit) expense(428) 38
 114
Net loss$(1,503) $(6,896)
$(17,205)
      
Net loss per share:     
Basic and diluted$(0.05) $(0.24) $(0.62)
Weighted average common shares outstanding:     
Basic and diluted29,588,324
 28,527,602
 27,638,443






Trupanion, Inc.
Consolidated Statements of Operations
(in thousands, except share data)
Year Ended December 31,
202320222021
Revenue$1,108,605 $905,179 $698,991 
Cost of revenue:
Veterinary invoice expense(1)
831,055 649,737 486,062 
Other cost of revenue(1)
146,534 133,257 108,583 
Total cost of revenue977,589 782,994 594,645 
Operating expenses:
Technology and development(1)
21,403 25,133 16,866 
General and administrative(1)
60,207 39,379 31,893 
New pet acquisition expense(1)
77,372 89,500 78,647 
Depreciation and amortization12,474 10,921 11,965 
Total operating expenses171,456 164,933 139,371 
Gain (loss) from investment in joint venture(219)(253)(171)
Operating loss(40,659)(43,001)(35,196)
Interest expense12,077 4,267 10 
Other expense (income), net(7,701)(3,072)14 
Loss before income taxes(45,035)(44,196)(35,220)
Income tax expense (benefit)(342)476 310 
Net loss$(44,693)$(44,672)$(35,530)
Net loss per share:
Basic and diluted$(1.08)$(1.10)$(0.89)
Weighted average shares of common stock outstanding:
Basic and diluted41,436,882 40,765,355 40,137,505 

(1)Includes stock-based compensation expense as follows:
Veterinary invoice expense$3,667 $4,145 $4,538 
Other cost of revenue1,612 2,339 2,610 
Technology and development2,846 4,742 3,056 
General and administrative17,717 12,831 8,862 
New pet acquisition expense7,319 9,336 9,160 
63

Trupanion, Inc.
Consolidated Statements of Comprehensive Loss
(in thousands)
 Year Ended December 31,
 2017 2016 2015
Net loss$(1,503) $(6,896) $(17,205)
Other comprehensive income (loss):     
Foreign currency translation adjustments277
 79
 (517)
Net unrealized gain on available-for-sale debt securities8
 46
 4
Other comprehensive income (loss), net of taxes285
 125
 (513)
Comprehensive loss$(1,218) $(6,771) $(17,718)






Trupanion, Inc.
Consolidated Statements of Comprehensive Loss
(in thousands)
Year Ended December 31,
202320222021
Net loss$(44,693)$(44,672)$(35,530)
Other comprehensive income (loss):
Foreign currency translation adjustments2,712 (4,412)(496)
Net unrealized gain (loss) on available-for-sale debt securities3,992 (4,966)502 
Other comprehensive income (loss), net of taxes6,704 (9,378)
Comprehensive income (loss)$(37,989)$(54,050)$(35,524)

64

Trupanion, Inc.
Consolidated Balance Sheets
(in thousands, except per share data)
 December 31,
 2017 2016
Assets   
Current assets:   
Cash and cash equivalents$25,706
 $23,637
Short-term investments37,590
 29,570
Accounts and other receivables20,367
 10,118
Prepaid expenses and other assets2,895
 2,062
Total current assets86,558
 65,387
Restricted cash600
 600
Long-term investments, at fair value3,237
 2,579
Equity method investment
 271
Property and equipment, net7,868
 8,464
Intangible assets, net4,972
 4,910
Other long term assets2,624
 134
Total assets$105,859
 $82,345
Liabilities and stockholders’ equity   
Current liabilities:   
Accounts payable$2,716
 $2,006
Accrued liabilities and other current liabilities7,660
 5,416
Reserve for veterinary invoices12,756
 9,521
Deferred revenue22,734
 13,463
Total current liabilities45,866
 30,406
Long-term debt9,324
 4,767
Deferred tax liabilities1,002
 1,623
Other liabilities1,233
 834
Total liabilities57,425
 37,630
Stockholders’ equity:
 
Common stock: $0.00001 par value per share, 100,000,000 shares authorized at December 31, 2017 and December 31, 2016, 30,778,796 and 30,121,496 shares issued and outstanding at December 31, 2017; 30,156,247 and 29,498,947 shares issued and outstanding at December 31, 2016
 
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized at December 31, 2017 and December 31, 2016, and 0 shares issued and outstanding at December 31, 2017 and December 31, 2016
 
Additional paid-in capital134,511
 129,574
Accumulated other comprehensive loss(92) (377)
Accumulated deficit(82,784) (81,281)
Treasury stock, at cost: 657,300 shares at December 31, 2017 and December 31, 2016(3,201) (3,201)
Total stockholders’ equity48,434
 44,715
Total liabilities and stockholders’ equity$105,859
 $82,345




Trupanion, Inc.
Consolidated Balance Sheets
(in thousands, except share data)
 December 31,
20232022
Assets
Current assets:
Cash and cash equivalents$147,501 $65,605 
Short-term investments129,667 156,804 
Accounts and other receivables, net of allowance for credit loss of $1,085 at December 31, 2023 and $540 at December 31, 2022267,899 232,439 
Prepaid expenses and other assets17,022 14,248 
Total current assets562,089 469,096 
Restricted cash22,963 19,032 
Long-term investments12,866 7,841 
Property, equipment, and internal-use software, net103,650 90,701 
Intangible assets, net18,745 24,031 
Other long-term assets18,922 18,943 
Goodwill43,713 41,983 
Total assets$782,948 $671,627 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$10,505 $9,471 
Accrued liabilities and other current liabilities34,052 32,616 
Reserve for veterinary invoices63,238 43,734 
Deferred revenue235,329 202,692 
Long-term debt - current portion1,350 1,103 
Total current liabilities344,474 289,616 
Long-term debt127,580 68,354 
Deferred tax liabilities2,685 3,392 
Other liabilities4,487 4,968 
Total liabilities479,226 366,330 
Stockholders’ equity:
Common stock: $0.00001 par value per share, 100,000,000 shares authorized; 42,887,052 and 41,858,866 shares issued and outstanding at December 31, 2023 and 42,041,344 and 41,013,158 shares issued and outstanding at December 31, 2022— — 
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized; no shares issued and outstanding— — 
Additional paid-in capital536,108 499,694 
Accumulated other comprehensive income (loss)403 (6,301)
Accumulated deficit(216,255)(171,562)
Treasury stock, at cost: 1,028,186 shares at December 31, 2023 and 2022(16,534)(16,534)
Total stockholders’ equity303,722 305,297 
Total liabilities and stockholders’ equity$782,948 $671,627 



65

Trupanion, Inc.
Consolidated Statements of Stockholders Equity
(in thousands, except share amounts)
 Common StockAdditional Paid-in CapitalAccumulated DeficitAccumulated Other Comprehensive LossTreasury StockTotal Stockholders' Equity
 SharesAmount
Balance at December 31, 201427,830,941

119,045
(57,180)11
(2,601)59,275
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings565,248

692



692
Stock compensation expense

3,107



3,107
Other comprehensive loss



(513)
(513)
Net loss


(17,205)

(17,205)
Balance at December 31, 201528,396,189

122,844
(74,385)(502)(2,601)45,356
Exercise of warrants59,999

600



600
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings1,079,080

3,083



3,083
Stock compensation expense

3,047



3,047
Purchase of treasury stock(36,321)



(600)(600)
Other comprehensive income



125

125
Net loss


(6,896)

(6,896)
Balance at December 31, 201629,498,947

129,574
(81,281)(377)(3,201)44,715
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings622,549

1,375



1,375
Stock compensation expense

3,562



3,562
Other comprehensive income



285

285
Net loss


(1,503)

(1,503)
Balance at December 31, 201730,121,496
$
$134,511
$(82,784)$(92)$(3,201)$48,434



Trupanion, Inc.
 Consolidated Statements of Stockholders Equity
(in thousands, except share amounts)
 Common StockAdditional Paid-in CapitalAccumulated DeficitAccumulated Other Comprehensive Income (Loss)Treasury StockTotal Stockholders' Equity
 SharesAmount
Balance at January 1, 202139,450,807 $— $439,007 $(91,360)$3,071 $(10,779)$339,939 
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings1,024,378 — (1,117)— — — (1,117)
Stock-based compensation expense— — 28,902 — — — 28,902 
Other comprehensive income (loss)— — — — — 
Net loss— — — (35,530)— — (35,530)
Balance at December 31, 202140,475,185 — 466,792 (126,890)3,077 (10,779)332,200 
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings632,994 — (2,124)— — — (2,124)
Stock-based compensation expense— — 35,026 — — — 35,026 
Repurchases of common stock(95,021)— — — — (5,755)(5,755)
Other comprehensive income (loss)— — — — (9,378)— (9,378)
Net loss— — — (44,672)— — (44,672)
Balance at December 31, 202241,013,158 — 499,694 (171,562)(6,301)(16,534)305,297 
Issuance of common stock in connection with the Company's equity award programs, net of tax withholdings845,708 — 1,118 — — — 1,118 
Stock-based compensation expense— — 35,296 — — — 35,296 
Other comprehensive income (loss)— — — — 6,704 — 6,704 
Net loss— — — (44,693)— — (44,693)
Balance at December 31, 202341,858,866 $— $536,108 $(216,255)$403 $(16,534)$303,722 





66

Trupanion, Inc.
Consolidated Statements of Cash Flows
(in thousands)
 Year Ended December 31,
 2017 2016 2015
Operating activities     
Net loss$(1,503) $(6,896) $(17,205)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:     
Depreciation and amortization4,232
 3,846
 2,542
Stock-based compensation expense3,419
 2,946
 3,002
Gain on sale of equity method investment(1,036) 
 
Other, net(383) 104
 (68)
Changes in operating assets and liabilities:

 
 
Accounts and other receivables(10,219) (1,830) (328)
Prepaid expenses and other assets(179) 48
 (905)
Accounts payable, accrued liabilities, and other liabilities3,019
 1,164
 (483)
Reserve for veterinary invoices3,149
 3,226
 1,241
Deferred revenue9,167
 2,398
 1,779
Net cash provided by (used in) operating activities9,666
 5,006
 (10,425)
Investing activities     
Purchases of investment securities(31,920) (31,616) (24,800)
Maturities of investment securities23,372
 27,247
 20,180
Proceeds from sale of equity method investment1,402
 
 
Purchases of property and equipment(3,131) (1,941) (4,894)
Other investments(2,779) (198) (409)
Net cash used in investing activities(13,056) (6,508) (9,923)
Financing activities

 
  
Proceeds from exercise of stock options2,545
 3,745
 1,335
Taxes paid related to net share settlement of equity awards(1,170) (662) (643)
Proceeds from debt financing, net of financing fees4,400
 4,988
 (14,900)
Other financing(694) (399) 
Net cash provided by (used in) financing activities5,081
 7,672
 (14,208)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net378
 111
 (586)
Net change in cash, cash equivalents, and restricted cash2,069
 6,281
 (35,142)
Cash, cash equivalents, and restricted cash at beginning of period24,237
 17,956
 53,098
Cash, cash equivalents, and restricted cash at end of period$26,306
 $24,237
 $17,956
Supplemental disclosures

 
  
Income taxes paid177
 19
 139
Interest paid333
 153
 155
Noncash investing and financing activities:
 
  
Purchases of property and equipment included in accounts payable and accrued liabilities390
 104
 98
Property and equipment acquired under capital lease689
 559
 
Cashless exercise of common stock warrants
 600
 




Trupanion, Inc.
Consolidated Statements of Cash Flows
(in thousands)
Year Ended December 31,
202320222021
Operating activities
Net loss$(44,693)$(44,672)$(35,530)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation and amortization12,474 10,921 11,965 
Stock-based compensation expense33,161 33,393 28,226 
Other, net1,347 1,051 (1,927)
Changes in operating assets and liabilities:
Accounts and other receivables(35,440)(66,982)(66,170)
Prepaid expenses and other assets(1,907)(5,227)(3,055)
Accounts payable, accrued liabilities, and other liabilities1,644 3,136 8,796 
Reserve for veterinary invoices19,485 4,227 10,768 
Deferred revenue32,567 56,153 54,385 
Net cash provided by (used in) operating activities18,638 (8,000)7,458 
Investing activities
Purchases of investment securities(165,936)(273,006)(95,672)
Maturities and sales of investment securities190,270 239,210 57,869 
Cash paid in business acquisition, net of cash acquired— (15,034)— 
Purchases of property, equipment, and internal-use software(18,280)(17,088)(12,355)
Other1,585 (1,598)(1,755)
Net cash provided by (used in) investing activities7,639 (67,516)(51,913)
Financing activities
Proceeds from debt financing, net of financing fees60,102 69,138 — 
Repayment of debt financing(1,717)(571)— 
Repurchases of common stock— (5,755)— 
Proceeds from exercise of stock options2,655 2,290 3,607 
Shares withheld to satisfy tax withholding(1,536)(4,359)(4,732)
Other(378)— — 
Net cash provided by (used in) financing activities59,126 60,743 (1,125)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net424 (1,459)252 
Net change in cash, cash equivalents, and restricted cash85,827 (16,232)(45,328)
Cash, cash equivalents, and restricted cash at beginning of period84,637 100,869 146,197 
Cash, cash equivalents, and restricted cash at end of period$170,464 $84,637 $100,869 
Supplemental disclosures
Income taxes paid (refund)$611 $2,498 $282 
Interest paid12,100 3,353 16 
Noncash investing and financing activities:
Purchases of property, equipment, and internal-use software included in accounts payable and accrued liabilities887 1,324 729 
67



Trupanion, Inc.
Notes to Consolidated Financial Statements
1. Nature of Operations and Summary of Significant Accounting Policies
Description of Business
Trupanion, Inc. (collectively with its wholly-owned subsidiaries, the Company)"Company") provides medical insurance for cats and dogs throughoutin the United States, Canada, Continental Europe, and Puerto Rico.Australia. The Company believes itsCompany's data-driven, vertically-integrated approach makes its subscriptionenables the Company to provide pet owners with products that the Company believes are the highest value medical insurance, priced specifically for pet owners, with pricing specific to each pet’s unique characteristics. The Company strives to operate the business similar to other subscription-based businesses, with a focus on maximizing the lifetime value of each pet while sustaining a favorable ratio of lifetime value relative to pet acquisition cost, based on the Company's desired return on investment.
Basis of Presentation
The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported amountsin the consolidated financial statements and related disclosures.accompanying notes. Actual results could differ from such estimates.
Reclassifications
Certain prior year amounts have been reclassified within the Company’s consolidated financial statements from their original presentation to conform to the current period presentation.
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At times, cash on deposit may be in excess of the applicable federal deposit insurance corporation limits.
The Company considers any cash account not held in trust for a third party that is contractually restricted to withdrawal or use to be restricted cash. The Company is partyrequired to a financing agreement requiring amaintain certain restricted cash balance.balances to comply with insurance company regulations. As of December 31, 2017,2023, the Company was in compliance with all requirements.
Accounts and Other Receivables
ReceivablesAccounts and other receivables are comprised of trade receivables and other miscellaneous receivables. Accountsreceivables and other receivables are carried at their estimated collectible amounts. Trade receivables are primarily related to the Company’s other business segment where the Company generates revenue from underwriting policies through unaffiliated general agents. These policies are typically annual policies, with monthly payment terms through the end of the twelve-month period. The Company had $249.8 million and $220.8 million accounts receivable associated with underwriting these policies as of December 31, 2023 and 2022, respectively. During the year ended December 31, 2023, the Company incurred a non-recurring $3.8 million settlement of accounts receivable due to uncollected premiums in connection with the transition of underwriting a third-party business to other insurers.
Deferred Acquisition Costs
The Company incurs certain costs, including premium taxes, fees and enrollment-based bonuses, and referral fees that directly relate to the successful acquisition of new or renewal customer contracts. These costs are deferred and are included in prepaid expenses and other assets on the consolidated balance sheet and amortized over the related policy term to the applicable financial statement line item, either sales and marketingnew pet acquisition expense or other cost of revenue. Deferred acquisition costs for the years endedas of December 31, 2017, 20162023 and 20152022 were $1.0 million, $0.7$7.4 million and $0.6$6.0 million, respectively. Amortized deferred acquisition costs classified within sales and marketingnew pet acquisition expense amounted to $1.7$6.0 million, $1.4$4.9 million, and $1.5$4.7 million and amortized deferred acquisition costs classified within other cost of revenue amounted to $13.2$45.6 million, $10.7$33.9 million, and $8.6$30.5 million, for the years ended December 31, 2017, 20162023, 2022, and 2015,2021, respectively.
Investments
The Company invests in investment grade fixed incomematurity securities of varying maturities. Long-term investmentsAvailable-for-sale securities are classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Short-term investmentsincome (loss). Held-to-maturity securities are classified as held-to-maturity and reported at amortized cost. Premiums or discounts on fixed incomematurity securities are amortized or accreted over the life of the security and included in interest income. There have been nowere $0.3 million in realized gains and $0.9 million in realized losses on sales of fixed income securities.maturity securities during the year ended December 31, 2023, and no realized gains or losses on sales of fixed maturity securities during the years ended December 31, 2022 and 2021.

68




TheEach reporting period, the Company evaluates whether declines in the fair value of its investments below bookcarrying value are other-than-temporary.the result of expected credit losses. This evaluation includes the Company's ability and intent to hold the securitythese investments until recovery of carrying value occurs, including an expected recovery occurs, the severity and durationevaluation of the unrealized loss, as well as all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts, when developing estimatesforecasts. Expected credit losses are recorded as an allowance through other expense (income), net on the Company's consolidated statements of cash flows expected to be collected.operations.
Fair Value of Financial Instruments
The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. The fair value hierarchy prioritizes valuation inputs based on the observable nature of those inputs. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value of the investments and is not a measure of the investment credit quality. The hierarchy defines three levels of valuation inputs:
Level 1 - Quoted prices in active markets for identical assets or liabilities
Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly
Level 3 - Unobservable inputs that reflect the Company's own assumptions about the assumptions market participants would use in pricing the asset or liability
The Company's financial instruments, in addition to those presented in Note 6,8, Fair Value, include cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities. The carrying amounts of accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short-term nature of these instruments.
Property, Equipment, and EquipmentInternal-Use Software
Property, equipment, and equipmentinternal-use software primarily consists of internally-developedbuilding, land and land improvements, office equipment, internal-use software related to the Company’s website, and internal support systems,systems. Internal-use software is capitalized during the application development stage of the project. Property and equipment is recorded at cost and depreciated using the straight-line method over the estimated useful life of the respective asset, estimated to be between threeasset:
LandNot depreciable
Land improvements10years
Building39years
Software3to5years
Office equipment3to5years
Goodwill and five years, once the asset is placed into service.
Intangible Assets
Indefinite-livedGoodwill and indefinite-lived intangible assets are not amortized. The Company reviews these assets for impairment at least annually or if indicators of potential impairment exist. Acquired finite-lived intangibles are amortized on a straight-line basis over the estimated useful lives of the assets. The Company has recognized no impairment loss on goodwill and indefinite-lived intangible assets for the years ended December 31, 2023, 2022, and 2021.
Asset Impairment
Long-lived assets, including property, equipment, internal-use software, and equipment,finite-lived intangible assets, are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Should an impairment exist, the impairment loss would be measured as the amount the asset's carrying value exceeds its fair value. The Company has recognized no impairment loss on long-lived assets, including property, equipment, internal-use software, and finite-lived intangible assets for the years ended December 31, 2017, 2016,2023, 2022, and 2015.2021.
69



Reserve for Veterinary Invoices
Reserve for veterinary invoices is an estimate of the future amount the Company will pay for veterinary invoices that are dated as of, or prior to, its balance sheet date. The reserve also includes the Company's estimate of related internal processing costs. To determine the accrual, the Company makes assumptions based on its historical experience, including the number of veterinary invoices it expects to receive, the average cost of those veterinary invoices, the length of time between the date of the veterinary invoice and the date the Company receives it, the member's chosen deductible, and the Company's expected cost to process and administer the payments. As of each balance sheet date, the Company reevaluates its reserve and adjusts the estimate for new information.
Deferred Revenue
Deferred revenue is primarily related to the Company’s other business segment where the Company generates revenue from underwriting policies through unaffiliated general agents. These policies are typically annual policies for which revenue is recognized pro-rata over the twelve-month policy period. Deferred revenue also consists of subscription fees received or billed in advance of the subscription services within the Company's subscription business, and the unexpired term of premiums related to the Company's unaffiliated general agents within the other business segment.business.
Revenue Recognition
The Company generates revenue primarily from subscription fees and through underwriting policies for unaffiliated general agents. For the year ended December 31, 2023, premiums from policies sourced by general agents accounted for 34% of our total revenue, and one general agent sourced members whose premiums accounted for over 10% of our total revenue. Revenue is recognized pro-rata over the terms of the customer contracts.


Veterinary Invoice Expense
Veterinary invoice expense includes the Company’s costs to review and pay veterinary invoices, administer the payments, and provide member services, and other operating expenses directly or indirectly related to this process. The Company also accrues for veterinary invoices that have been incurred but not yet received. Thisreceived or paid and the estimated cost of processing these invoices. Veterinary invoice expense also includes amounts paid by unaffiliated general agents on our behalf, and an estimate of amounts incurred and not yet paid for the other business segment.
Other Cost of Revenue
Other cost of revenue for the subscription business segment includes direct and indirect member service expenses, Territory Partner renewal fees, credit card transaction fees and premium tax expenses. Other cost of revenue for the other business segment includes the commissions the Company pays to unaffiliated general agents and costs to administer the programs in the other business segment and premium taxes on the sales in this segment.
Technology and Development
Technology and development expenses primarily consist primarily of personnel costs and related expenses for the Company’sCompany's technology staff, which includes information technology development and infrastructure support and third-party servicesservices. It also includes expenses associated with development of new products and depreciation of hardware and capitalized software.offerings.
General and Administrative
General and administrative expenses consist primarily of personnel costs and related expenses for the Company’s finance, actuarial, human resources, legal, regulatory, and general management functions, as well as facilities and professional services.
Sales and MarketingNew Pet Acquisition Expense
Sales and marketing expenses consistNew pet acquisition expense primarily consists of costs, including employee compensation, to educate veterinarians and consumers about the benefits of Trupanion, to generate leads and to convert leads tointo enrolled pets, as well as print, online and promotional advertising costs, and employee compensation and related costs.
Other Expense (Income) Expense,, Net
Other income, of $1.2net, was $7.7 million, for the year ended December 31, 2017 included the gain of $1.0$3.1 million, from the sale of the Company's equity method investment in June 2017. Interestand nil, including interest income of $0.2$9.0 million, $0.1$3.0 million, and $0.1$0.3 million was recorded in other incomeoffset by credit losses of $1.7 million, nil, and nil for the years ended December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively.
70



Advertising
Advertising costs are expensed as incurred, with the exception of television advertisements, which are expensed the first time each advertisement is aired. Advertising costs amounted to $4.9$16.9 million, $4.0$25.5 million and $5.3$23.6 million, in the years ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively.
Stock-Based Compensation
Compensation expense related to stock-based transactions, including employee and non-employee stock option awards, and restricted stock awards, and restricted stock units, is measured and recognized in the financial statements based on fair value. The fair value of restricted stock awards and restricted stock units is the common stock price as of the measurement date. The fair value of stock options is estimated on the measurement date using the Black-Scholes option-pricing model that requires management to apply judgment and make estimates, including:


Expected volatility —The Company estimates the expected volatility based on the historical volatility of a representative group of publicly traded companies with similar characteristics to the Company, and its own historical volatility;
Expected term for awards granted to employees —The Company has based its expected term for awards issued to employees on the simplified method, as permitted by the SEC Staff Accounting Bulletin No. 110,Topic 14, Share-Based Payment, as the Company has insufficient historical information regarding its stock options to provide a basis for an estimate;
Payment;
Risk-free interest rate—The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected term of the options; and
Expected dividend yield—The Company has never declared or paid any cash dividends and does not presently plan to pay cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero.


Stock-based compensation expense for stock options, restricted stock awards, and restricted stock units is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company recognizes forfeitures when they occur.
Income Taxes
The Company uses the asset and liability approach for accounting and reporting income taxes. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities, and their respective tax bases, operating loss, and tax credit carryforwards.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a tax rate change is recognized in the period that includes the enactment date. Valuation allowances are provided for when it is considered more likely than not that deferred tax assets will not be realized.
The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than a 50% likelihood of being realized. Penalties and interest are classified as a component of income taxes.
Foreign Currency Translation
The Company’s consolidated financial statements are reported in U.S. dollars. Assets and liabilities denominated in foreign currencies were translated to U.S. dollars, the reporting currency, at the exchange rates in effect on the balance sheet date. Revenue and expenses denominated in foreign currencies were translated to U.S. dollars using a weighted-averageweighted average rate for the relevant reporting period. Cumulative translation adjustments of $0.1$(0.1) million, $0.4$(2.8) million, and $0.4$1.6 million were recorded in accumulated other comprehensive loss (income) as of December 31, 2017, 2016,2023, 2022, and 2015,2021, respectively.


Reclassifications
Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings, total assets, total liabilities, or total shareholders' equity.

71



Insurance Operations

Effective January 1, 2015, the Company formed a segregated account in Bermuda as part of Wyndham Insurance Company
(SAC) Limited (WICL), and entered into a revised fronting and reinsurance arrangement with Omega General Insurance
Company (Omega) to include its newly formed segregated account. The Company maintains all risk with the business written
in Canada and consolidates the entity in its financial statements. Contractual requirements restrict dividends from this entity
until after 2016, at which time dividends will beDividends are allowed subject to the Segregated Accounts Company Act of 2000, which
allows for dividends only to the extent that the entity remains solvent and the value of its assets remain greater than the
aggregate of its liabilities and its issued share capital and share premium accounts.


For the Company’s Canadian business, all plans are written by Omega General Insurance Company (Omega) and the risk is
assumed by the Company through a fronting and reinsurance agreement. Premiums are recognized and earned pro rata over the
terms of the related customer contracts. Revenue recognized from the agreement in 2017, 20162023, 2022, and 20152021 was $47.1$167.6 million,
$36.5 $135.9 million and $30.9$112.0 million, respectively, and deferred revenue relating to this arrangement at December 31, 2017, 20162023 and 20152022 was $1.8 million, $1.3$9.5 million and $0.9$6.4 million, respectively. Reinsurance revenue was 19%15%, 19%15%, and 21%16% of total revenue in 2017, 20162023, 2022, and 2015,2021, respectively. Cash designated for the purpose of paying claims related to this reinsurance agreement was $2.8 million, $2.1$11.2 million and $2.0$7.2 million at December 31, 2017, 20162023 and 20152022, respectively. In addition, as required by the Office of the Superintendent of Financial institutionsInstitutions regulations related to the Company’s reinsurance agreement with Omega, the Company is required to fund a Canadian Trust account with the greater of CAD $2.0 million or 115%120% of unearned Canadian premium plus 15%20% of outstanding Canadian claims, including all incurred but not reported claims. As of December 31, 2017,2023, the account balance was $2.2CAD $15.7 million and the Company was in compliance with all requirements.


The Company has not transferred any risk to third-party reinsurers.
Concentrations of Credit Risk
Financial instruments, which potentially subject the Company to concentration of credit risk, consist primarily of cash and cash equivalents, investments, and investments.debt. The Company manages its risk by investing cash equivalents and investment securities in money market instruments and securities of the U.S. government, U.S. government agencies and high-credit-quality issuers of debt securities.


Recent Accounting Pronouncements Adopted during Period
In November 2015,2023, the Financial Accounting Standards Board (FASB)("FASB") issued an Accounting Standards Update (ASU) amending the accounting for income taxes and requiring all deferred tax assets and liabilities be classified as non-current in the consolidated balance sheets. The Company adopted this ASU as of January 1, 2017 and has retrospectively applied the provisions of this standard.
In March 2016, the FASB issued an ASU amending the accounting for employee share-based payments, including income tax recognition and classification. The Company adopted this ASU as of January 1, 2017. As a result, the Company has elected to use actual forfeitures in the estimate of stock-based compensation expense. Additionally, the guidance("ASU") 2023-07 related to improving segment disclosures. This ASU enhances disclosures about significant segment expenses, allows for multiple measures of a segment's profit or loss, and requires additional disclosures about the accounting for excess tax benefits and deficiencies resulted in an initial adjustment as of January 1, 2017 to the Company's net operating loss deferred tax asset to eliminate the Company's existing windfall pool amounting to $4.3 million, which was offset by an adjustment to the Company's valuation allowance. Finally, tax withholding of shares will be allowed up to the employee's maximum individual tax rate in the relevant jurisdiction without resulting in liability classification of the award, subject to the Company's internal policies for making this election.
Recent Accounting Pronouncements
In February 2016, the FASB issued an ASU amending the lease presentation guidance.Chief Operating Decision Maker. The ASU requires organizations that lease assets to recognize the rights and obligations created by those leases on the consolidated balance sheets. This ASU is effective for fiscal yearsannual periods beginning after December 15, 20182023, including interim periods within that reporting period, with early adoption permitted. TheAs of year-end, the Company has determined this guidance will require recognition of a lease liability and corresponding asset on the consolidated balance sheets equal to the present value of minimum lease payments. The carrying amount of the asset is derived from the amount of the lease liability at the end of each reporting period. The Company plans to adopt this guidance as of January 1, 2019, and is in the process ofstill evaluating the impact on its consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09 which improves and expands upon the income tax disclosures, primarily related to the rate reconciliation and income taxes paid information. The ASU is effective for annual periods beginning after December 15, 2024, including interim periods within that reporting period, with early adoption permitted. As of year-end, the Company is still evaluating the impact on its consolidated financial statements.

2. Net Loss per Share
Basic net loss per share is computed using the weighted-averageweighted average number of shares of common stock outstanding during the period. Diluted net loss per share is calculated using the weighted-averageweighted average number of shares of common stock plus, when dilutive, potential shares of common sharesstock outstanding using the treasury-stock method. Potential shares of common sharesstock outstanding include stock options, unvested restricted stock awards and restricted stock units, and warrants.units.
The following potentially dilutive equity securities were not included in the diluted earnings per share of common sharestock calculation because they would have had an antidilutive effect:
 As of December 31,
 202320222021
Stock options408,970 629,650 807,205 
Restricted stock awards and restricted stock units714,382 1,112,552 1,087,627 
72

 As of December 31,
 2017 2016 2015
Stock options4,006,399
 4,123,023
 4,871,949
Restricted stock awards and restricted stock units256,842
 352,996
 472,384
Warrants810,000
 810,000
 869,999


3. Business Combinations
PetExpert
On November 16, 2022, the Company acquired 100% of voting equity interest in Royal Blue s.r.o., the parent company of PetExpert, a veterinary-centric, managing general agent for pet insurance with operations in the Czech Republic, Slovakia, and Belgium for approximately $12.3 million in net cash. The acquisition provides the Company with a foothold in Europe, allowing for expansion within different countries within the region. Additionally, the acquired technology from PetExpert focuses on the pet space and, along with the acquired personnel, is intended to enable the Company to improve its back-end software to help facilitate growth opportunities. The Company incurred $0.2 million of acquisition-related costs that were recorded in general and administrative expenses.
The acquisition is recorded using the purchase method of accounting in accordance with Accounting Standards Codification (ASC) 805, Business Combinations, which requires that the assets acquired and liabilities assumed to be recorded at their respective fair values at the acquisition date. The excess of the purchase price over the estimated fair values of the net tangible and intangible assets acquired is recorded as goodwill. The application of the purchase method of accounting resulted in the recognition of intangible assets, the estimated fair values of which involved a discounted cash flow model and certain assumptions and estimates, including but not limited to, revenue growth rates and margins, attrition rates, and discount rates. These estimates are inherently uncertain and unanticipated events and circumstances may occur which could affect the accuracy or validity of estimates used in purchase accounting. The purchase price allocation recorded in a business combination may change during the measurement period, which is a period not to exceed one year from the date of acquisition, as additional information about conditions existing at the acquisition date becomes available.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):
November 16,
2022
Current assets, net of cash acquired$295 
Property and equipment and other long-term assets27 
Amortizable intangible assets5,121 
Goodwill9,541 
Current liabilities and short-term loan(1,677)
Deferred tax liability and other liabilities(1,056)
Total consideration transferred, net of cash acquired$12,251 

The Company acquired intangible assets which included developed technologies and customer relationships with an estimated useful life of 5.0 years. The goodwill recognized is attributable primarily to going concern value such as assembled workforce, future technology development, future customers, and expected synergies from incorporating the operations into the Company’s portfolio. It has been assigned to the subscription business segment. None of the goodwill associated with this acquisition is expected to be deductible for income tax purposes.
As of the acquisition date, the Company assumed a credit agreement entered into by PetExpert in 2021 that provides for a revolving line of credit. This line of credit was due and paid in full in May 2023.
Smart Paws
On August 31, 2022, the Company completed an acquisition of 100% of the equity of Smart Paws GmbH (Smart Paws), a managing general agent for pet insurance with operations in Germany and Switzerland, for approximately $2.8 million in net cash. The acquisition of Smart Paws provides the Company with a foothold in Europe, allowing for expansion within different countries within the region. The Company incurred $0.1 million of acquisition related costs that were included in general and administrative expenses during the year ended December 31, 2022.
The Company acquired a definite-lived intangible asset valued at $1.1 million with an estimated useful life of 5.0 years. Goodwill of $2.6 million was recognized as a result of the acquisition and attributable primarily to going concern value such as assembled workforce, future customers, and expected synergies from incorporating the operations into the Company’s portfolio. None of the goodwill associated with this acquisition is expected to be deductible for income tax purposes.
The results of PetExpert and Smart Paws operations have been included in the consolidated financial statements since the acquisition date, but were immaterial to the Company's consolidated financial statements.

73



4. Property, Equipment, and Equipment,Internal-Use Software, Net
Property, equipment, and equipment,internal-use software, net consisted of the following (in thousands):
December 31,
December 31, 20232022
2017 2016
Land and improvements
Building and improvements
Software$17,221
 $14,340
Computer equipment and other3,022
 2,470
Property and equipment, at cost20,243
 16,810
Office equipment and other
Construction in progress
Property, equipment and internal-use software, at cost
Less: Accumulated depreciation(12,375) (8,346)
Property and equipment, net$7,868
 $8,464
Depreciation expense related to property, equipment, and equipment, inclusive of assets purchased on capital lease,internal-use software was $4.2$6.7 million, $3.8$6.1 million and $2.5$7.1 million for the years ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively.



4.5. Goodwill and Intangible Assets
Goodwill arises from business acquisitions in which the purchase price exceeds the fair value of tangible and intangible assets acquired less assumed liabilities.
The following is a summary of goodwill by reportable segment for the years ended December 31, 2023 and 2022 (in thousands):
Subscription BusinessOther BusinessTotal
Balance as of January 1, 2022$32,709 $— $32,709 
Acquisitions12,159 — 12,159 
Effects of foreign currency(2,885)— (2,885)
Balance as of December 31, 202241,983 — 41,983 
Effects of foreign currency1,730 — 1,730 
Balance as of December 31, 2023$43,713 $— $43,713 
74



The following table presents the detail of intangible assets other than goodwill for the periods presented (in thousands):
Gross Carrying ValueAccumulated AmortizationNet Carrying ValueWeighted Average Useful Life Remaining as of December 31, 2023
December 31, 2023:
Licenses$4,773 $— $4,773 N/A
Leases848 (848)— 
Trade name1,294 (412)882 6.8
Developed technologies17,278 (9,023)8,255 2.6
Customer relationships8,379 (4,855)3,524 2.1
Patents, trademarks, and other2,459 (1,148)1,311 5.0
Total Intangibles$35,031 $(16,286)$18,745 2.8
December 31, 2022:
Licenses$4,773 $— $4,773 
Leases2,959 (2,866)93 
Trade name1,228 (266)962 
Developed technologies16,770 (5,164)11,606 
Customer relationships7,980 (3,001)4,979 
Patents, trademarks, and other2,768 (1,150)1,618 
Total Intangibles$36,478 $(12,447)$24,031 
The Company acquired an insurance company in 2007, which originally included licenses in 23 states. These licenses were valued at $4.8 million. The Company is currently licensed in all 50 states, the District of Columbia and Puerto Rico. MostInsurance licenses are renewed annually upon payment of various fees assessed by the issuing state. Renewal costs are expensed as incurred. This isInsurance licenses are considered an indefinite-lived intangible asset given the planned renewal of the certificates of authority and applicable licenses for the foreseeable future. No impairments have been recorded on this asset as
Amortization expense associated with intangible assets was $5.7 million, $4.8 million, and $4.9 million for the years ended December 31, 2023, 2022, and 2021, respectively.
As of December 31, 2017.2023, expected amortization expense relating to purchased intangible assets for each of the next five years and thereafter is as follows (in thousands):
Year ending December 31:
2024$5,345 
20254,556 
20261,482 
20271,311 
2028164 
Thereafter443 
Total$13,301 
5. Investment Securities
6. Investments
Available-for sale securities are classified as short-term versus long-term investments based on whether they represent the investment of funds available for current operations. All available-for-sale securities are considered short-term in nature, with the exception of certain long-term investments that are being held for statutory requirements. Held-to-maturity securities are classified as short-term versus long-term investments based on the effective maturity dates. The amortized cost, gross unrealized holding gains and losses, and estimates of fair value of available-for-salelong-term and short-term investments by major security type and class of security were as follows as of December 31, 20172023 and 20162022 (in thousands):
75



Amortized
Cost
Amortized
Cost
Gross
Unrealized
Holding
Gains
Gross
Unrealized
Holding
Losses
Fair
Value
As of December 31, 2023
Long-term investments:
Long-term investments:
Long-term investments:
Available-for-sale investments
Available-for-sale investments
Available-for-sale investments
Foreign deposits
Foreign deposits
Foreign deposits
$
Held-to-maturity investments
U.S. treasury securities
U.S. treasury securities
U.S. treasury securities
$
Short-term investments:
Available-for-sale investments
Available-for-sale investments
Available-for-sale investments
U.S. treasury securities
U.S. treasury securities
U.S. treasury securities
Mortgage-backed securities and collateralized mortgage obligations
Other asset-backed securities
Corporate bonds
Corporate bonds
Corporate bonds
$
Held-to-maturity investments
U.S. Treasury securities
U.S. Treasury securities
U.S. Treasury securities
Certificates of deposit
$
$
$
Amortized
Cost
 Gross
Unrealized
Holding
Gains
 Gross
Unrealized
Holding
Losses
 Fair
Value
As of December 31, 2017       
Available-for-sale:       
Amortized
Cost
Gross
Unrealized
Holding
Gains
Gross
Unrealized
Holding
Losses
Fair
Value
As of December 31, 2022
Long-term investments:
Long-term investments:
Long-term investments:
Available-for-sale investments
Available-for-sale investments
Available-for-sale investments
Foreign deposits$2,237
 $
 $
 $2,237
Foreign deposits
Foreign deposits
$
$
$
Held-to-maturity investments
U.S. treasury securities
U.S. treasury securities
U.S. treasury securities
$
Short-term investments:
Available-for-sale investments
Available-for-sale investments
Available-for-sale investments
U.S. treasury securities
U.S. treasury securities
U.S. treasury securities
Mortgage-backed securities and collateralized mortgage obligations
Other asset-backed securities
Municipal bond1,000
 
 
 1,000
$3,237
 $
 $
 $3,237
Short-term investments:       
Corporate bonds
$
Held-to-maturity investments
U.S. Treasury securities
U.S. Treasury securities
U.S. Treasury securities$5,783
 $
 $(4) $5,779
Certificates of deposit690
 1
 
 691
U.S. government funds31,117
 
 
 31,117
$37,590
 $1

$(4)
$37,587
       
Amortized
Cost
 Gross
Unrealized
Holding
Gains
 Gross
Unrealized
Holding
Losses
 Fair
Value
As of December 31, 2016       
Available-for-sale:       
Foreign deposits$1,587
 $
 $
 $1,587
Municipal bond1,000
 
 (8) 992
$2,587
 $

$(8)
$2,579
Short-term investments:       
U.S. Treasury securities$5,791
 $
 $
 $5,791
Certificates of deposit707
 
 
 707
U.S. government funds23,072
 
 
 23,072
$29,570
 $

$

$29,570
$
76



Maturities of debt securitiesinvestments classified as available-for-sale and held-to-maturity were as follows (in thousands):
 December 31, 2023
 Amortized
Cost
Fair
Value
Available-for-sale:
Due under one year$2,420 $2,408 
Due after one year through five years90,278 90,761 
$92,698 $93,169 
Available-for-sale collateralized:
Mortgage-backed securities and collateralized mortgage obligations$10,460 $10,454 
Other asset-backed securities12,422 12,436 
$22,882 $22,890 
Held-to-maturity:
Due under one year$25,477 $25,483 
Due after one year through five years997 1,005 
$26,474 $26,488 
 December 31, 2017
 Amortized
Cost
 Fair
Value
Available-for-sale:
 
Due after one year through five years2,237
 2,237
Due after five years through ten years1,000
 1,000
 $3,237
 $3,237
The Company evaluateddoes not expect any credit losses from its securities for other-than-temporary impairmentheld-to-maturity investments, considering the composition of the investment portfolio and considers the decline in market valuecredit loss history of these investments. For available-for-sale investments, the Company determined that there were unrealized losses of $0.3 million and $0.8 million for the securitiesyears ended December 31, 2023 and 2022, respectively. As of December 31, 2023, $18.9 million in available-for-sale investments have been in a loss position for more than twelve months, with total unrealized losses of $0.2 million. As of December 31, 2023, $25.9 million available-for-sale investments have been in a loss position for less than twelve months, with total unrealized losses of $0.1 million. As of December 31, 2022, no available-for-sale investments had been in a loss position for more than twelve months. As of December 31, 2022, $76.3 million available-for-sale investments had been in a loss position for less than twelve months, with total unrealized losses of $0.8 million. These losses relate to be primarily attributable to current economicinterest rate changes. The Company does not expect any credit losses from its available-for-sale investments, considering the composition of the investment portfolio and market conditions.the credit rating of these investments. For debtthose securities, the Company determined it is not likely to, and does not intend to, sell norprior to a potential recovery.
Proceeds from the sales of fixed maturities classified as available-for-sale were $114.7 million and $43.0 million during the years ended December 31, 2023 and 2022, respectively.

7. Other Investments
Preferred Stock Investment
The Company has invested $7.0 million in the preferred stock of a variable interest entity, Baystride, Inc., a U.S.-based privately held corporation operating in the pet food industry. The Company does not have power over the activities that most significantly impact the economic performance of the entity and is, therefore, not the primary beneficiary. The Company has the option to purchase all of the outstanding common stock issued by the entity in August 2027 at an amount approximating its expected fair value. The preferred stock investment in the entity is redeemable, and therefore, is accounted for as an available-for-sale debt security, and measured at fair value at each balance sheet date — see Note 8.
Additionally, the Company has extended a $7.0 million revolving line of credit to the variable interest entity to fund its inventory purchases, which will increase annually by $2.0 million until the note’s maturity in 2027. Borrowing amounts are subject to limitations based on Baystride’s forecasted revenues and inventory balances. The Company's investment and amounts loaned under the line of credit are recorded in other long-term assets on its consolidated balance sheet. The outstanding loan balance under the line of credit, including accrued interest, was $4.0 million and $6.3 million as of December 31, 2023 and 2022, respectively. The Company has also entered into a series of agreements to provide ancillary services to, and receive reimbursement from, the variable interest entity at cost. The Company provided $0.4 million and $0.8 million of these services for the years ended December 31, 2023 and 2022, respectively.
77



Allowance for Credit Loss
The Company regularly evaluates its investments for expected credit losses. The Company considers past events, current conditions, and reasonable and supportable forecasts in estimating an allowance for credit losses. Additionally, the Company considers the ultimate collection of cash flows from its investments and whether the Company has the intent to sell, or if it is more likely than not that the Company willwould be required to sell the securitiessecurity prior to the recovery of its amortized cost. Such evaluations are revised as conditions change and new information becomes available. Based on these considerations, the amortized cost basis which may beCompany has established an allowance for credit losses related to its investment in the preferred stock of a variable interest entity. The following table presents a rollforward of the allowance for credit losses for this investment.
 Balance as of January 1, 2022$— 
(Addition to) allowance for credit losses— 
 Balance as of December 31, 2022— 
(Addition to) allowance for credit losses(1,674)
 Balance as of December 31, 2023$(1,674)
Investment in Joint Venture
In September 2018, the Company acquired a non-controlling equity interest in a joint venture in Australia, whereby it has committed to licensing certain intellectual property and contributing up to $2.2 million AUD upon the achievement of specific operational milestones over a period of at maturity.

least four years from the agreement execution date. As of December 31, 2023, the Company has contributed $1.3 million AUD. This equity investment is accounted for using the equity method and is classified in other long-term assets on the Company's consolidated balance sheet. The Company's share of income and losses from this equity method investment is included in gain (loss) from investment in joint venture on its consolidated statement of operations. Also included in this line item are income and expenses associated with administrative services provided to the joint venture.


6.
78



8. Fair Value
InvestmentsFair Value Disclosures
The following table summarizes, by major security type, the Company's assets that are measured at fair value on a recurring basis, and placement within the fair value hierarchy (in thousands):
As of December 31, 2023
Fair ValueLevel 1Level 2Level 3
Assets
Money market funds
Money market funds
Money market funds
Fixed maturities:
Mortgage-backed securities and collateralized mortgage obligations
Mortgage-backed securities and collateralized mortgage obligations
Mortgage-backed securities and collateralized mortgage obligations
Other asset-backed securities
Corporate bonds
Foreign deposits
U.S. Treasury securities
U.S. Treasury securities
U.S. Treasury securities
Preferred stock investment
Total
As of December 31, 2017As of December 31, 2022
Fair Value Level 1 Level 2 Fair ValueLevel 1Level 2Level 3
Assets     
Restricted cash$600
 $600
 $
Money market funds
Money market funds
Money market funds
Fixed maturities:
Mortgage-backed securities and collateralized mortgage obligations
Mortgage-backed securities and collateralized mortgage obligations
Mortgage-backed securities and collateralized mortgage obligations
Other asset-backed securities
Corporate bonds
Foreign deposits2,237
 2,237
 
Municipal bond1,000
 
 1,000
Money market funds5,167
 5,167
 
U.S. Treasury securities
Preferred stock investment
Total$9,004
 $8,004
 $1,000
     
As of December 31, 2016
Fair Value Level 1 Level 2
Assets     
Restricted cash$600
 $600
 $
Foreign deposits1,587
 1,587
 
Municipal bond992
 
 992
Money market funds7,033
 7,033
 
Total$10,212
 $9,220
 $992
The Company measures the fair value of restricted cash,money market funds and foreign deposits, and money market fundsclassified as Level 1, based on quoted prices in active markets for identical assets. The Company's fixed maturity investments classified as either Level 1 or Level 2 in the above tables are priced exclusively by external sources, including pricing vendors, dealers/market makers, and exchange-quoted prices. The fair value of the municipal bondCompany's fixed maturity investments classified as Level 2 is based on either recent trades in inactive markets or quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. Held-to-maturity investments are carried at amortized cost and the fair value and changes in unrealized gains (losses) are disclosed in Note 6, Investments. The fair value of these investments is determined in the same manner as available-for-sale securities and are considered either a Level 1 or Level 2 measurement.
The Company's preferred stock investment (see Note 7) is accounted for as an available-for-sale debt security, and measured at fair value at each balance sheet date. The estimated fair value of the preferred stock investment is a Level 3 measurement, and is based on certain unobservable inputs such as the value of the underlying enterprise, volatility, time to liquidity, and market interest rates. An increase or decrease in any of these unobservable inputs would result in a change in the fair value measurement. The estimated fair value was $5.3 million and $4.1 million as of December 31, 2023 and 2022, respectively, and is recorded in other long-term assets on the Company's consolidated balance sheet.
The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. There were no transfers between levels for the years ended December 31, 2023 and 2022.
79



The following table presents the change in fair value of the Company’s investment carried at fair value and classified as Level 3 as of December 31, 2023 (in thousands):
Preferred Stock Investment
Balance as of January 1, 2021$7,949 
Unrealized gain included in other comprehensive income (loss)493 
Balance as of December 31, 2021$8,442 
Unrealized loss included in other comprehensive income (loss)(4,327)
Balance as of December 31, 2022$4,115 
Reversal of cumulative unrealized loss included in other comprehensive income (loss)2,885 
Credit loss included in earnings(1,674)
Balance as of December 31, 2023$5,326 

Fair Value Disclosures - Other Assets and Liabilities
As of December 31, 2017, theThe Company's other long-term assets balance also included a $2.5notes receivable of $6.8 million note receivable,and $9.3 million as of December 31, 2023 and 2022, respectively, recorded at itstheir estimated collectible amount. The Company estimates that the carrying value of the notenotes receivable approximates the fair value. The estimated fair value represents a Level 3 measurement within the fair value hierarchy, and is based on market interest rates and the assessed creditworthiness of the third party.
The Company estimates the fair value of long-term debt based upon rates currently available to the Company for debt with similar terms and remaining maturities. This is a Level 3 measurement. Based upon the terms of the debt, the carrying amount of long-term debt approximated fair value at December 31, 2017.2023.

7.
9. Commitments and Contingencies

The following summarizes the Company's contractual commitments as of December 31, 2017 (in thousands):
 Year Ending December 31,  
 2018 2019 2020 2021 2022 Thereafter Total
Long-term debt obligations(1)
$
 $9,500
 $
 $
 $
 $
 $9,500
Operating lease obligations(2)
1,876
 2,035
 2,116
 2,197
 2,258
 8,719
 19,201
Capital leases(3)
519
 
 
 
 
 
 519
Other obligations(4)
927
 562
 119
 17
 
 
 1,625
Total$3,322
 $12,097
 $2,235
 $2,214
 $2,258
 $8,719
 $30,845
(1) Consists of a revolving line of credit. Excludes interest of the greater of 4.5% or 1.25% plus the prime rate (5.75% as of December 31, 2017).
(2) Consists of contractual obligations from non-cancellable office space under operating lease.
(3) Consists of contractual obligations from property and equipment purchased under capital lease.
(4) Consists of contractual obligations from non-cancellable vendor service agreements.




During the third quarter of 2015, the Company entered into a lease agreement for a building located in Seattle, Washington. The initial 10-year term of the lease commenced in the third quarter of 2016. Minimum rent payments under operating leases are recognized on a straight-line basis over the term of the lease. Rental expense for operating leases was $1.8 million, $1.2 million and $1.0 million for the years ended December 31, 2017, 2016 and 2015, respectively.
Legal Proceedings
From time to time the Company is or may become subject to litigation matters and claimsvarious legal proceedings arising fromin the ordinary course of business, including but not limited to, claims of alleged infringement of trademarks, copyrights, andproceedings against members, other intellectual property rights; employment claims; coverage disputes with policyholders; disputes regarding general contracts; andentities or regulatory or governmental investigations or disputes. The Company records an estimated liability relating to such mattersbodies. Estimated liabilities are recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The outcomes of legal proceedingsAt this time, the Company does not believe any such matters to be material individually or in the aggregate. These views are inherently unpredictable, subject to significant uncertainties, and could be material to the Company's operating results for a particular period. The Company reviews its estimates at least quarterly and makes adjustments to reflectchange following the outcome of negotiations, estimated settlements, legal rulings, advicefuture events or the results of legal counsel and other information and events pertaining to a particular matter.future developments.

8.
10. Reserve for Veterinary Invoices

The reserve for veterinary invoices is an estimate of the future amount the Company will pay for veterinary invoices that haven't been processed or received but that are dated as of, or prior to, its balance sheet date. The reserve also includes the Company's estimate of related internal processing costs. The reserve estimate involves actuarial projections, and is based on management's assessment of facts and circumstances currently known, and assumptions about anticipated patterns, including expected future trendspatterns. The Company uses generally accepted actuarial methodologies, such as paid loss development methods, in estimating the numberamount of veterinary invoices the Company will receive and the average cost of thosereserve for veterinary invoices. The reserve is made for each of the Company's segments, subscription and other business, and areis continually refined as the Company receives and pays veterinary invoices. Changes in management's assumptions and estimates may have a relatively large impact to the reserve and associated expense.
Reserve for veterinary invoices
Summarized below are the changes in the total liability for the Company's subscription business segment (in thousands):
80



 Year Ended December 31, Year Ended December 31,
Subscription 2017 2016 2015Subscription202320222021
Reserve at beginning of year $8,538
 $5,384
 $4,278
Veterinary invoices during the period related to:      
Current year 155,623
 123,823
 95,390
Current year
Current year
Prior years (69) 813
 30
Total veterinary invoice expense 155,554
 124,636
 95,420
Amounts paid during the period related to:      
Current year
Current year
Current year 144,802
 115,314
 89,768
Prior years 7,777
 5,832
 4,239
Total paid 152,579
 121,146
 94,007
Non-cash expenses 454
 336
 307
Reserve at end of period $11,059
 $8,538
 $5,384
The Company's reserveCompany had unfavorable development on veterinary invoice reserves for the subscription business segment increased $2.6of $2.8 million from $8.5 million atfor the year ended December 31, 2016 to $11.12023, favorable development on veterinary invoice reserves of $2.8 million atfor the year ended December 31, 2017. This change was comprised of $155.6 million in expense recorded during the period less $152.6 million in payments of veterinary invoices. This $155.6 million in2022, and favorable development on veterinary invoice expense incurred includes a reductionreserves of $0.1$1.4 million tofor the reserves relating to prior years,year ended December 31, 2021, all of which iswere the result of ongoing analysis of recent payment trends. The Company's adjustments to increase prior year reserves were $0.8 million and less than $0.1 million as a result of analysis of payment trends in the years ended December 31, 2016 and 2015, respectively.



Summarized below are the changes in total liability for the Company's other business segment (in thousands):
 Year Ended December 31, Year Ended December 31,
Other Business 2017 2016 2015Other Business202320222021
Reserve at beginning of year $983
 $890
 $829
Veterinary invoices during the period related to:      
Current year 14,739
 9,027
 7,983
Current year
Current year
Prior years (171) (129) (79)
Total veterinary invoice expense 14,568
 8,898
 7,904
Amounts paid during the period related to:      
Current year
Current year
Current year 13,053
 8,048
 7,095
Prior years 801
 757
 748
Total paid 13,854
 8,805
 7,843
Non-cash expenses 
 
 
Reserve at end of period $1,697
 $983
 $890


The Company’s reserveCompany had unfavorable development on veterinary invoice reserves for the other business segment increased $0.7of $0.5 million from $1.0 million atfor the year ended December 31, 2016 to $1.72023, unfavorable development on veterinary invoice reserves of $1.1 million atfor the year ended December 31, 2017. This change was comprised of $14.6 million in expense recorded during the period less $13.9 million in payments of veterinary invoices. This $14.6 million in2022, and favorable development on veterinary invoice expense incurred includes a reductionreserves of $0.2 million tofor the reserves relating to prior years,year ended December 31, 2021, all of which iswere the result of ongoing analysis of recent payment trends. The Company's adjustments to decrease prior
Reserve for veterinary invoices, by year reserves were $0.1 million as a result of analysis of payment trends in each of the years ended December 31, 2016 and 2015.occurrence
Veterinary invoice expenses


In the following tables, the cumulative number of veterinary invoices represents the total number received as of December 31, 2017,2023, by year the veterinary invoice relates to, referred to as the year of occurrence. If a pet is injured or becomes ill, multiple trips to the veterinarian may result in several invoices. Each of these veterinary invoices is included in the cumulative number, regardless of whether the veterinary invoice was paid. Information for years 20142020 through 20162022 is provided as required supplementary information. Amounts in these tables are presented on a constant currency basis to remove the impact of changes in the foreign currency exchange rate on development. The cumulative expenses as of the end of each year are revalued using the currency exchange rate as of December 31, 2017.2023.


81



The following table summarizes the development of veterinary invoice expense, on a constant currency basis, for the Company's subscription business segment by year of occurrence (in thousands, except for cumulative number of veterinary invoices data):
  Cumulative veterinary invoice expenses Reserve Cumulative number of veterinary invoices
    
  As of December 31, As of December 31,
Subscription 2014 2015 2016 2017 2017 2017
Year of Occurrence (unaudited) (unaudited) (unaudited)      
2014 $72,100
 $72,039
 $72,204
 $72,222
 $27
 379,078
2015   $95,661
 $96,217
 $96,276
 $130
 475,626
2016     $125,127
 $124,910
 $535
 587,007
2017       $156,580
 $10,367
 656,490
        $449,988
 $11,059
  
Cumulative veterinary invoice expensesReserveCumulative number of veterinary invoices
As of December 31,As of December 31,
Subscription202020212022202320232023
Year of Occurrence(unaudited)(unaudited)(unaudited)
2020$279,236 $278,325 $277,839 $278,342 $— 1,205,693 
2021$354,083 $351,797 $352,320 $— 1,482,674 
2022$438,148 $439,448 $1,342 1,775,110 
2023$542,362 $30,206 1,981,465 
$1,612,472 $31,548 




The following table summarizes the development of veterinary invoice expense, on a constant currency basis, for the Company's other business segment by year of occurrence (in thousands, except for cumulative number of veterinary invoices data):
Cumulative veterinary invoice expensesReserveCumulative number of veterinary invoices
As of December 31,As of December 31,
Other Business202020212022202320232023
Year of Occurrence(unaudited)(unaudited)(unaudited)
2020$72,289 $72,026 $72,255 $72,352 $— 536,416 
2021$129,814 $130,650 $130,577 $— 906,658 
2022$211,724 $212,163 $945 1,289,524 
2023$287,365 $30,745 1,414,664 
$702,457 $31,690 
  Cumulative veterinary invoice expenses Reserve Cumulative number of veterinary invoices
    
  As of December 31, As of December 31,
Other Business
 2014 2015 2016 2017 2017 2017
Year of Occurrence (unaudited) (unaudited) (unaudited)      
2014 $5,966
 $5,889
 $5,888
 $5,895
 $
 34,587
2015   $7,974
 $7,846
 $7,850
 $
 46,900
2016     $9,028
 $8,844
 $11
 59,243
2017       $14,741
 $1,686
 95,182
        $37,330
 $1,697
  


Cumulative paid veterinary invoice expense


In the following tables, amounts are by the year the veterinary invoice relates to, referred to as the year of occurrence. Amounts in these tables are presented on a constant currency basis to remove the impact of changes in the foreign currency exchange rate. The cumulative amounts paid as of the end of each year are revalued using the currency exchange rate as of December 31, 2017.2023. Information for years 20142020 through 20162022 is provided as required supplementary information.


The following table summarizes the amounts paid for veterinary invoices, inclusive of related internal processing costs and reported on a constant currency basis, for the subscription segment (in thousands):
Year Ended December 31,
Subscription2020202120222023
Year of Occurrence(unaudited)(unaudited)(unaudited)
2020$261,780 $276,589 $277,839 $278,342 
2021$334,187 $350,925 $352,320 
2022$417,419 $438,106 
2023$512,156 
$1,580,924 
Total amounts unpaid and recorded as a liability$31,548 
82



  Year Ended December 31,
Subscription 2014 2015 2016 2017
Year of Occurrence (unaudited) (unaudited) (unaudited)  
2014 $67,886
 $71,969
 $72,132
 $72,196
2015   $90,261
 $95,928
 $96,145
2016     $116,879
 $124,375
2017       $146,213

       $438,929
Total amounts unpaid and recorded as a liability  $11,059



The following table summarizes the amounts paid for veterinary invoices, inclusive of related internal processing costs and reported on a constant currency basis, for the other business segment (in thousands):
Year Ended December 31,
Other Business2020202120222023
Year of Occurrence(unaudited)(unaudited)(unaudited)
2020$63,362 $72,013 $72,255 $72,352 
2021$112,562 $130,157 $130,577 
2022$190,026 $211,218 
2023$256,620 
$670,767 
Total amounts unpaid and recorded as a liability$31,690 

  Year Ended December 31,
Other Business 2014 2015 2016 2017
Year of Occurrence (unaudited) (unaudited) (unaudited)  
2014 $5,137
 $5,887
 $5,887
 $5,895
2015   $7,086
 $7,842
 $7,850
2016     $8,049
 $8,833
2017       $13,055
        $35,633
Total amounts unpaid and recorded as a liability  $1,697


9.11. Debt
On March 25, 2022, the Company entered into a credit agreement with Piper Sandler Finance, LLC, acting as the administrative agent, that provides the Company with $150.0 million in credit (the Credit Facility) consisting of:
(a) an initial term loan in an aggregate principal amount of $60.0 million (Initial Term Loan), which was funded at closing;
(b) commitments for delayed draw term loans in an aggregate principal amount not in excess of $75.0 million (Delayed Draw Term Loans, and together with the Initial Term Loan, the Term Loans), which may be drawn from time to time until September 25, 2023. On December 29, 2022, February 17, 2023, and September 21, 2023, the Company borrowed Delayed Draw Term loans of $15.0 million, $35.0 million, and $25.0 million, respectively; and
(c) commitments for revolving loans in an aggregate principal amount at any time outstanding not in excess of $15.0 million (Revolving Loans), which may be drawn at any time prior to March 25, 2027.
The Company hasCredit Facility bears interest at a revolving line of credit of up to $30.0 million, secured by any and all interests in the Company's assets that are not otherwise restricted. Interest on the revolving line of credit is payable monthly at the greater of 4.5% or 1.25%floating base rate plus the primean applicable margin. The stated interest rate (5.75% at December 31, 2017). The borrowing agreement includes other ancillary services and letters of credit of up to $4.5 million as of December 31, 2017.2023 was approximately 10.5% for the original $60.0 million term loan and for the aggregate $75.0 million term loans. The facility also requiresCompany incurred total debt issuance cost of approximately $5.9 million, which is reported in the consolidated balance sheet as a depositdirect reduction from the carrying amount of restricted cashthe Credit Facility, and is amortized as interest expense over the term of $0.6 million. five years.
The agreement was amended during the current year to extend the maturity date to December 2019. The credit agreement requiresCredit Facility is secured by substantially all assets of the Company to comply with variousand its subsidiaries. Proceeds from the Credit Facility may be used for permitted acquisitions and investments, working capital and other general corporate purposes. The Credit Agreement contains financial and non-financial covenants.other covenants. As of December 31, 2017,2023, the Company was in compliance with all covenants.financial and other covenants.
BorrowingsTo the extent not previously paid, the Initial Term Loan is due and payable on March 25, 2027, the Delayed Draw Term Loans are due and payable on the revolving lineearlier of credit were limited to the lesserfive-year anniversary of $30.0 milliontheir initial funding or March 25, 2028, and the total amountRevolving Loans are due and payable on March 25, 2027. The Company must repay 0.25% of cashany then-outstanding Term Loans, together with accrued and securities held by the Company's insurance subsidiaries (American Pet Insurance Company and Wyndham Insurance Company (SAC) Limited Segregated Account AX)unpaid interest, on a quarterly basis.
Future principal payments on outstanding borrowings as of December 31, 2017 and 2016. As of December 31, 2017, available borrowing capacity on the line of credit was $18.7 million, with an outstanding balance of $1.8 million for ancillary services and letters of credit, and borrowings under the facility of $9.5 million, recorded net of financing fees of $0.2 million.2023 are as follows (in thousands):
Year Ending December 31,December 31, 2023
2024$1,350 
20251,350 
20261,350 
202772,113 
202857,125 
Thereafter— 
Total$133,288 
10.
83



12. Stock-Based Compensation
Stock-based compensation expense includes stock options restricted stock awards, and restricted stock units granted to employees and non-employeesother service providers and has been reported in the Company’s consolidated statements of operations depending on the function performed by the employee or non-employee.other service provider. Stock-based compensation expense recognized in each category of the consolidated statementstatements of operations for the years ended December 31, 2017, 20162023, 2022 and 20152021 was as follows (in thousands):
Year Ended December 31, Year Ended December 31,
2017 2016 2015 202320222021
Veterinary invoice expense$355
 $234
 $219
Other cost of revenue239
 41
 44
Technology and development216
 246
 404
General and administrative1,887
 1,893
 1,889
Sales and marketing722
 532
 446
New pet acquisition expense
Total expensed stock-based compensation
Capitalized stock-based compensation
Total stock-based compensation$3,419
 $2,946
 $3,002
As of December 31, 2017, for all employees,2023, the Company had 991,754714,382 unvested stock options and 256,842 restricted stock awards and restricted stock units that are expected to vest. Total stock-basedunits. Stock-based compensation expense of $5.7 million related to unvested stock options and $0.9$44.6 million related to unvested restricted stock awards and restricted stock units isare expected to be recognized over a weighted-averageweighted average period of approximately 2.7 years2.4 years.
In March 2023, two executives terminated employment with the Company and 1.3 years, respectively.one executive signed a separation agreement effective June 1, 2023. In conjunction with these departures, the Company accelerated the vesting of certain RSUs as of the termination date and extended the purchase date of certain vested options from 90 to 365 days. These award modifications resulted in the recognition of $4.8 million share-based compensation expense during the year ended December 31, 2023.
Stock Options
The grant date fair value of stock option awards are estimated on the date of grant using the Black-Scholes option-pricing model. Valuation assumptions forThe Company did not grant any new stock options during the years ended December 31, 2017, 20162023, 2022, and 2015 are presented in the following table:2021.

84


  Year Ended December 31,
  2017 2016 2015
Valuation assumptions:      
Expected term (in years) 6.25 5.04-6.25 3.0-6.25
Expected volatility 37.1%-39.8% 37.6%-42.1% 37.2%–49.4%
Risk-free interest rate 1.8%-2.2% 1.1%-2.0% 1.1%–2.0%
Expected dividend yield —% —% —%



The following table presents information regarding stock options granted, exercised and forfeited for the periods presented:
Number
of
Options
 
Weighted Average
Exercise
Price per Share
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 20145,112,556
 $3.19
 $21,116
Number
of
Options
Number
of
Options
Weighted Average
Exercise
Price per Share
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of January 1, 2021
Granted698,764
 7.84
 
Exercised(632,829) 2.12
 3,703
Forfeited(306,542) 7.65
 
Outstanding as of December 31, 20154,871,949
 3.71
 29,644
Outstanding as of December 31, 2021
Granted666,664
 13.37
 
Exercised(1,119,367) 3.35
 11,980
Forfeited(296,223) 8.14
 
Outstanding as of December 31, 20164,123,023
 5.06
 43,185
Outstanding as of December 31, 2022
Granted657,339
 17.74
 
Exercised(670,823) 3.80
 10,392
Forfeited(103,140) 12.25
 
Outstanding as of December 31, 20174,006,399
 7.16
 88,578
Outstanding as of December 31, 2023
     
Exercisable at December 31, 20172,998,099
 $4.50
 $74,278
Exercisable at December 31, 2023
Exercisable at December 31, 2023
Exercisable at December 31, 2023
As of December 31, 2017,2023, stock options outstanding and stock options exercisable had a weighted average remaining contractual life of 5.4 years and 4.3 years, respectively.2.5 years.


The weighted-average grant date fair value of stock options granted and the fair value of options vested were as follows for the years endingended December 31, 2017, 2016,2023, 2022, and 2015:2021. The Company didn't grant any stock options in these three years.
Fair Value of Options Vested
(in thousands)
Year:
2021$313 
2022$— 
2023$— 

85


  Weighted Average Grant Date Fair Value per Share 
Fair Value
of Options
Vested (in thousands)
Year:    
2015 $3.46
 $3,276
2016 $5.64
 $4,645
2017 $7.25
 $6,313




Restricted Stock Awards and Restricted Stock Units
The below table summarizesA summary of the Company’s restricted stock award and restricted stock unit activity for the years endingended December 31, 2017, 20162023, 2022 and 2015:2021 is as follows:
Number of 
Shares
Weighted Average
Grant Date Fair Value per
Share
Unvested shares as of January 1, 2021782,755 $34.81 
Granted787,730 101.32 
Vested(426,725)40.10 
Forfeited(56,133)72.93 
Unvested shares as of December 31, 20211,087,627 78.94 
Granted623,401 84.11 
Vested(516,077)72.81 
Forfeited(82,399)81.91 
Unvested shares as of December 31, 20221,112,552 84.46 
Granted366,870 26.77 
Vested(669,413)72.52 
Forfeited(95,627)79.60 
Unvested shares as of December 31, 2023714,382 $66.64 

13. Stockholders Equity
  
Number of 
Shares
 
Weighted Average
Grant Date Fair Value per
Share
Unvested shares as of December 31, 2014 584,385
 $4.77
Granted 2,385
 7.26
Vested (119,262) 4.80
Forfeited 
 
Unvested shares as of December 31, 2015 467,508
 4.77
Granted 
 
Vested (116,877) 4.77
Forfeited 
 
Unvested shares as of December 31, 2016 350,631
 4.77
Granted 23,659
 30.19
Vested (116,877) 4.77
Forfeited (571) 30.19
Unvested shares as of December 31, 2017 256,842
 $4.77
11. Stockholders EquityCommon Stock and Preferred Stock
As of December 31, 2017,2023, the Company had 100,000,000 shares of common stock authorized and 30,121,49641,858,866 shares of common stock outstanding. Holders of common stock are entitled to one vote on each matter properly submitted to the stockholders of the Company except those related to matters concerning possible outstanding preferred stock. At December 31, 2017,2023, the Company had 10,000,000 shares of undesignated shares of preferred stock authorized for future issuance and did not have any outstanding shares of preferred stock. The holders of common stock are also entitled to receive dividends as and when declared by the board of directors of the Company (the Board), whenever funds are legally available. These rights are subordinate to the dividend rights of holders of allany senior classes of stock outstanding at the time. The Company is unabledoes not intend to declare or pay any cash dividends in the foreseeable future.
Share Repurchase Program
In April 2021, the Board approved a share repurchase program, pursuant to stockholders as of December 31, 2017 due to restrictions in its credit agreements.
Warrants
At December 31, 2017which the Company may, between May 2021 and 2016, warrants to purchase 810,000May 2026, repurchase outstanding shares of the Company's common stock at $10.00 per share remained outstanding.stock. The warrants expire in 2018 and 2019.

Company repurchased no shares during the year ended December 31, 2023. The Company repurchased 95,021 shares under this program during the year ended December 31, 2022.


12.
86



14. Accumulated Comprehensive Income (Loss)
A summary of the components of accumulated other comprehensive income (loss) is as follows (in thousands):
Foreign Currency TranslationNet Unrealized Gain (Loss) on Available-for-Sale SecuritiesTotal
Balance as of January 1, 2021$2,120 $951 $3,071 
Other comprehensive income (loss)(496)502 
Balance as of December 31, 2021$1,624 $1,453 $3,077 
Other comprehensive income (loss)(4,412)(4,966)(9,378)
Balance as of December 31, 2022$(2,788)$(3,513)$(6,301)
Other comprehensive income (loss)2,712 3,992 6,704 
Balance as of December 31, 2023$(76)$479 $403 

87


15. Segments
The Company has two aggregated reporting segments: subscription business and other business. The subscription business segment includes monthly subscriptionsconsists of products that have been created to meet the needs of their distribution channels and have similar target margin profiles. This segment generates revenue primarily from subscription fees related to the Company’s medical insurance which is marketed directly to consumers, while theCompany's direct-to-consumer products. The other business segment includes allgenerates revenue primarily by underwriting policies on behalf of third parties. The Company does not undertake marketing efforts for these policies and has a business-to-business relationship with these third-parties. The other business segment also includes other products and insurance software solutions that is not directly marketed to consumers.have a different margin profile from the Company’s subscription business segment.
The chief operating decision maker uses two measuresreviews revenue and operating income (loss) to evaluate segment performance:performance. Revenue, veterinary invoice expense, other cost of revenue, and gross profit. Additionally, othernew pet acquisition expenses are generally directly attributed to each segment. Other operating expenses, such as salestechnology and marketing expenses,development expense, general and administrative expense, and depreciation and amortization, are generally allocated toproportionately based on revenue in each segment and evaluated when material.segment. Interest and other expenses and income taxes are not allocated to the segments, nor included in the measure of segment profit or loss. The Company does not analyze discrete segment balance sheet information related to long-term assets.
Revenue and gross profitOperating income (loss) of the Company’s segments were as follows (in thousands):
Year Ended December 31,
202320222021
Subscription business:
Revenue$712,906 $596,610 $494,862 
Veterinary invoice expense543,196 436,880 356,448 
Other cost of revenue70,490 60,804 51,216 
Technology and development13,765 16,555 11,942 
General and administrative36,256 25,964 22,579 
New pet acquisition expense77,172 88,959 78,148 
Depreciation and amortization8,021 7,205 8,494 
Subscription business operating loss(35,994)(39,757)(33,965)
Other business:
Revenue395,699 308,569 204,129 
Veterinary invoice expense287,859 212,857 129,614 
Other cost of revenue76,044 72,453 57,367 
Technology and development7,638 8,578 4,924 
General and administrative23,951 13,415 9,314 
New pet acquisition expense200 541 499 
Depreciation and amortization4,453 3,716 3,471 
Other business operating loss(4,446)(2,991)(1,060)
Gain (loss) from investment in joint venture(219)(253)(171)
Total operating loss(40,659)(43,001)(35,196)
Interest expense12,077 4,267 10 
Other expense (income), net(7,701)(3,072)14 
Loss before income taxes$(45,035)$(44,196)$(35,220)






88

 Year Ended December 31,
 2017 2016 2015
Revenue:     
Subscription business$218,354
 $173,356
 $133,406
Other business24,313
 14,874
 13,557
 242,667
 188,230
 146,963
Veterinary invoice expense:     
Subscription business155,554
 124,636
 95,420
Other business14,568
 8,898
 7,904
 170,122
 133,534
 103,324
Other cost of revenue:     
Subscription business21,329
 16,685
 14,008
Other business8,166
 4,723
 4,402
 29,495
 21,408
 18,410
Gross profit:     
Subscription business41,471
 32,035
 23,978
Other business1,579
 1,253
 1,251
 43,050
 33,288
 25,229
      
Technology and development9,768
 9,534
 11,215
General and administrative16,820
 15,205
 15,558
Sales and marketing:     
Subscription business18,886
 15,029
 15,151
Other business218
 218
 80
 19,104
 15,247
 15,231
Operating loss$(2,642) $(6,698) $(16,775)


The following table presents the Company’s revenue by geographic region of the member (in thousands):
Year Ended December 31, Year Ended December 31,
2017 2016 2015 202320222021
United States$195,297
 $151,361
 $116,585
Canada47,370
 36,869
 30,378
Canada and other
Total revenue$242,667
 $188,230
 $146,963
Substantially all of the Company’s long-lived assets were located in the United States as of December 31, 20172023 and 2016.

2022.

89
13.


16. Dividend Restrictions and Statutory Surplus
The Company’s business operations are conducted through subsidiaries, one of which is an insurance company domiciled in New York, American Pet Insurance Company (APIC), and one of which is a segregated cell business, Wyndham Segregated Account AX, located in Bermuda. In 2022, the Company incorporated a new wholly-owned insurance subsidiary, GPIC Insurance Company (GPIC), domiciled in Canada. In 2021, the Company established two new wholly-owned insurance subsidiaries in the United States, ZPIC Insurance Company (ZPIC) and QPIC Insurance Company (QPIC), domiciled in Missouri and Nebraska, respectively. In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, insurance companies are subject to further regulations that, among other things, may require such companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their parent corporations.
New York law restrictsApplicable regulations generally restrict the ability of the Company's insurance subsidiary in New Yorkentities to pay dividends to its holding company parent. These restrictions are based in part on the prior year’s statutory income and surplus. In general,the United States, dividends up to specified levels are generally considered ordinary and may be paid without prior approval, and dividendsapproval. Dividends, in larger amounts, orknown as extraordinary dividends, are subject to approval by the New York State Department of Financial Services, the subsidiary's primaryinsurer's domiciliary state regulator. An extraordinary dividend or distribution is generally defined as a dividend or distribution that, in the aggregate in any 12-month period, exceeds the lesser of (i) 10% of surplus as of the preceding December 31 or (ii) the insurer’s adjusted net investment income for suchthe 12-month period immediately preceding the declaration or distribution of the current dividend increased by the excess, if any, of net investment income over dividends declared or distributed during the period commencing thirty-six months prior to the declaration or distribution of the current dividend and ending twelve months prior thereto, and not including realized capital gains. Under regulatory requirements at December 31, 2017, the amountAPIC paid dividends of dividends that may be paid by the Company’s insurance subsidiary in New York$7.6 million to the Company without prior approval by regulatory authorities was $0.2 million. Thisduring the year ended December 31, 2023. None of the Company's U.S. insurance subsidiary did not paysubsidiaries paid dividends to the Company during the years ended December 31, 2017, 2016,2022 and 2015.2021.
The Company's insurance subsidiary in Bermuda is regulated by the Bermuda Monetary Authority. Under the Bermuda Companies Act of 1981, as amended, a Bermuda company may not declare or pay a dividend or make a distribution out of contributed surplus if there are reasonable grounds for believing that: (a) the company is, or would be after the payment, unable to pay its liabilities as they become due; or (b) the realizable value of the company’s assets would thereby be less than its liabilities. The Segregated Accounts Company Act of 2000 further requires that dividends out of a segregated account can only be paid to the extent that the cell remains solvent. The value of its assets must remain greater than the aggregate of its liabilities, issued share capital, and share premium accounts. Per our contractual agreements with Wyndham Insurance Company (SAC) Limited, the allowable dividend is equivalent to the positive undistributed profit attributable to the shares. This insurance subsidiary paid the Company a dividend of $2.7$7.3 million, during the year ended December 31, 2017. No dividends were paid$6.9 million, and $5.6 million during the years ended December 31, 20162023, 2022 and 2015.2021, respectfully.
The statutory net income for 2017, 20162023, 2022 and 20152021 and statutory capital and surplus at December 31, 2017, 20162023, 2022 and 2015,2021, for the Company’s insurance subsidiary in New YorkAPIC were as follows (in thousands):
 As of December 31, As of December 31,
 2017 2016 2015 202320222021
Statutory net income $7,507
 $4,081
 $1,386
Statutory capital and surplus 37,190
 30,451
 26,068
As of December 31, 2017, the Company’s insurance subsidiary in New York2023, APIC maintained $37.2$199.6 million of statutory capital and surplus which was above the required amount of $22.2$137.6 million of statutory capital and surplus to avoid additional regulatory oversight.
During the year ended December 31, 2023, the Company funded $3.8 million, $0.2 million, and CAD $8.5 million of statutory capital to APIC, ZPIC and GPIC, respectively. During the year ended December 31, 2022, the Company funded $8.0 million and $7.8 million of statutory capital to ZPIC and QPIC, respectively. ZPIC, QPIC and GPIC will each be required to maintain a level of surplus as determined by their respective domiciliary regulators. As of December 31, 2017 and 2016,2023, neither ZPIC, QPIC nor GPIC has begun underwriting any insurance policies.
As of December 31, 2023, the Company had $6.6$14.6 million on deposit with various states in which it writesis licensed to write policies.

14. Related Parties
90
The Company is sometimes party to arrangements with the father and brother of the Company’s Chief Executive Officer, who both serve as independent contractors to develop veterinary relationships. The terms of the independent contractor agreements are consistent with the terms of other similar independent contractors that do business with the Company. Total amounts paid to the related parties were less than $0.5 million for each year ended December 31, 2017, 2016, and 2015.


15.17. Income Taxes
Loss before income taxes was as follows for the years ended December 31, 2017, 20162023, 2022 and 20152021 (in thousands):
 Year Ended December 31, Year Ended December 31,
 2017 2016 2015 202320222021
United States $(1,965) $(6,906) $(17,222)
Foreign 34
 48
 131
 $(1,931) $(6,858) $(17,091)
$
The components of income tax expense (benefit) expense were as follows (in thousands):
 Year Ended December 31,
 202320222021
Current:
U.S. federal & state$(8)$82 $58 
Foreign464 814 2,066 
456 896 2,124 
Deferred:
U.S. federal & state11 (15)
Foreign(805)(431)(1,799)
(798)(420)(1,814)
Income tax expense (benefit)$(342)$476 $310 
  Year Ended December 31,
  2017 2016 2015
Current:      
U.S. federal & state $183
 $25
 $31
Foreign 15
 13
 84
  198
 38
 115
Deferred:      
U.S. federal & state (620) 
 
Foreign (6) 
 (1)
  (626) 
 (1)
Income tax (benefit) expense $(428) $38
 $114


On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes to the Internal Revenue Code, including, but not limited to, a corporate tax rate decrease to 21% effective January 1, 2018. The Company has calculated its best estimate of the impact of the Tax Act for the year ended December 31, 2017, based on its understanding of the Tax Act and guidance available as of the date of filing, and recorded an income tax benefit of $0.6 million.

On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of US GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. In accordance with SAB 118, the Company has determined that the $0.6 million income tax benefit recorded in connection with the remeasurement of its deferred tax liabilities was a provisional amount and a reasonable estimate as of December 31, 2017. Any necessary subsequent adjustments will be recorded in 2018.

A reconciliation of income tax expense at the statutory federal income tax rate and income taxes as reflected in the financial statements is presented below:
 Year Ended December 31,    
 202320222021
Federal income taxes at statutory rate21.0 %21.0 %21.0 %
U.S. state income taxes7.9 3.5 7.5 
Equity compensation(9.2)2.5 30.4 
Change in valuation allowance(19.1)(26.7)(58.4)
Other, net(0.1)(1.7)(1.7)
Credits0.3 0.3 0.3 
Effective income tax rate0.8 %(1.1)%(0.9)%
91

  Year Ended December 31,    
  2017 2016 2015
Federal income taxes at statutory rate 34.0 % 34.0 % 34.0 %
U.S. state income taxes (9.5) (0.6) (0.7)
Equity compensation 189.1
 7.7
 (1.2)
Change in valuation allowance (229.6) (40.5) (34.2)
Meals and entertainment (3.0) (0.9) (0.4)
Other, net 2.0
 (0.3) 1.8
Change in federal tax rate 32.1
 
 
Credits 7.1
 
 
Effective income tax rate 22.2 % (0.6)% (0.7)%



The principal components of the Company’s deferred tax assets and liabilities were as follows (in thousands):
 As of December 31,         
 20232022
Deferred tax assets:
Deferred revenue$10,017 $8,610 
Accruals and reserves2,190 1,860 
Net operating loss carryforwards71,231 63,772 
Depreciation and amortization2,310 1,421 
Equity compensation1,875 3,179 
Credits1,147 997 
Other1,995 1,661 
Total deferred tax assets90,765 81,500 
Deferred tax liabilities:
Deferred costs(1,549)(1,322)
Intangible assets(3,103)(3,603)
Other(3,471)(2,398)
Total deferred tax liabilities(8,123)(7,323)
Total deferred taxes82,642 74,177 
Less deferred tax asset valuation allowance(85,245)(77,507)
Net deferred tax liability$(2,603)$(3,330)
  Year Ended December 31,         
  2017 2016
Deferred tax assets:    
Unearned premium reserves $966
 $918
Accruals and reserves 606
 782
Net operating loss carryforwards 18,211
 22,632
Depreciation and amortization 317
 535
Equity compensation 1,024
 1,137
Credits 208


Other 270
 101
Total deferred tax assets 21,602
 26,105
Deferred tax liabilities:    
Deferred costs (183) (226)
Intangible assets (1,002) (1,623)
Total deferred tax liabilities (1,185) (1,849)
Total deferred taxes 20,417
 24,256
Less deferred tax asset valuation allowance (21,419) (25,879)
Net deferred tax liability $(1,002) $(1,623)
At December 31, 2017,2023, the Company had U.S. federal, U.S. state, and foreign net operating loss carryforwards of $86.7$71.2 million (tax-effected) and U.S. federal income tax credits of $0.2$1.1 million. Use of the carryforwards is limited based on the future income of the Company. The federal net operating loss carryforwards currently wouldwill begin to expire in 2026. Foreign net operating loss carryforwards will begin to expire in 2024. U.S. federal income tax credits will begin to expire in 2036. Pursuant to Sections 382 and 383 of the Internal Revenue Code, annual use of the Company’s net operating loss carryforwards and credit carryforwards may be limited if the Company experiences an ownership change. As of December 31, 2017,2023, the utilization of approximately$0.5 million of net operating losses are subject to limitation as a result of prior ownership changes; however, subsequent ownership changes may further affect the limitation in future years.
A valuation allowance is required to reduce the deferred tax assets reported if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a full valuation allowance against its U.S. Federal, the majority of its U.S. State, and a portion of its foreign deferred tax assets as of December 31, 20172023, 2022, and 20162021 because the Company’s management has determined that it is more likely than not that these assets will not be fully realized.
TheFor the year ended December 31, 2023, the Company intendsrecognized a net increase of $7.7 million in valuation allowance against its net deferred tax assets associated with U.S. federal and certain foreign and U.S. state jurisdictions, primarily attributable to reinvest all foreign earnings indefinitely outside of the U.S.current year activity.
The Company is open to examination by the U.S. federal tax jurisdiction for the years ended December 31, 20142020 through 2017. The Company2023, and is also open to examination for 20072006 and forward with respect to net operating loss carryforwards generated and carried forward from those years in the United States. The Company is opensubject to taxation in various states and countries, and may be subject to audit or examination by the Canada Revenue Agencyrelevant authorities in respect to those particular jurisdictions primarily for 2018 and thereafter.
For the yearsyear ended December 31, 2013 through 2017 for2023, the Company intends to invest substantially all corporateof its foreign subsidiary earnings, as well as its capital in its foreign subsidiaries, indefinitely outside of the U.S. in those jurisdictions in which it would incur significant, additional costs upon repatriation of such amounts. A deferred tax matters,liability related to taxes due upon repatriation to the U.S. has not been recorded.
The Company is booking Global Intangible Low-Taxed Income ("GILTI") on a current basis and open for the years ended December 31, 2009 through 2017 for transactions with non-arm’s length non-Canadian residents.is not booking deferred taxes related to GILTI.
92


The Company accounts for uncertain tax positions based on a two-step process of evaluating recognition and measurement criteria. The first step assesses whether the tax position is more likely than not to be sustained upon examination by the taxing authority, including resolution of any appeals or litigation, on the basis of the technical merits of the position. If the tax position meets the more-likely-than-not criteria, the portion of the tax benefit greater than 50% likely to be realized upon settlement with the relevant taxtaxing authority is recognized in the financial statements. No significant changes in uncertain tax positions are expected in the next twelve months.


A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):
  
Year Ended December 31,
 202320222021
Balance, beginning of year$151 $138 $133 
Increases (decreases) to tax positions related to prior periods(72)— 
Increases to tax positions related to the current year
Balance, end of year$80 $151 $138 
  
 Year Ended December 31,
  2017 2016 2015
Balance, beginning of year $120
 $80
 $65
Increases to tax positions related to prior periods 91
 
 
Increases to tax positions related to the current year 116
 40
 15
Balance, end of year $327
 $120
 $80


18. Employee Benefits
The Company has a 401(k) plan for its U.S. employees. The plan allows employees to contribute a percentage of their pretax earnings annually, subject to limitations imposed by the Internal Revenue Service. The plan also allows the Company to make a matching contribution, subject to certain limitations. To date,As of December 31, 2023, the Company has made no matching contributions to the 401(k) plan.

17. Quarterly Financial Information (Unaudited)

19. Related Parties
In August 2018, the Company invested $0.3 million in a limited liability entity in exchange for a 17.5% ownership interest. The following table contains quarterly financial datainvestee is considered to be a related party, as the Company has the ability to exercise significant influence over the investee. In February 2020, the Company entered into a service agreement with the investee, under which the Company incurred $2.2 million and $3.5 million of expenses for consulting services provided by the investee related to pet acquisition during the years ended December 31, 20172023 and 2016 (in thousands, except per share data). The unaudited quarterly information has been prepared2022, respectively, recorded as new pet acquisition expense on a basis consistent with the auditedCompany's consolidated financial statements and includes all adjustments that the Company considers necessary for a fair presentationstatement of the information shown. The operating results for any fiscal quarter are not necessarily indicative of the operating results for a full fiscal year or any future period and there can be no assurances that any trend reflected in such results will continue in the future.operations.

93
 Three Months Ended
 
Dec. 31, 2017(1)
 Sept. 30, 2017 
Jun. 30, 2017(2)
 Mar. 31, 2017 Dec. 31, 2016 Sept. 30, 2016 Jun. 30, 2016 Mar. 31, 2016
Total revenues$66,545
 $63,118
 $58,275
 $54,729
 $51,340
 $48,359
 $45,832
 $42,699
Gross profit11,737
 11,807
 10,351
 9,155
 9,218
 8,500
 8,266
 7,304
Net (loss) income(838) 406
 411
 (1,482) (1,723) (1,637) (964) (2,572)
Net (loss) income per share:
Basic and diluted(0.03)
0.01

0.01

(0.05)
(0.06)
(0.06)
(0.03)
(0.09)
Weighted-average common shares outstanding:
Basic29,847,574
 30,037,282
 29,510,907
 29,254,681
 29,020,559
 28,732,417
 28,348,348
 27,999,248
Diluted29,847,574
 33,113,981
 32,734,624
 29,254,681
 29,020,559
 28,732,417
 28,348,348
 27,999,248


(1) The Company recorded a tax benefit as of December 31, 2017, as a result of the Tax Act. See "Note 15" for additional information regarding this tax benefit.
(2) The Company sold an equity method investment during the second quarter of 2017. See "Note 1" for additional information regarding the sale.


Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e)13a-15(e) and 15d- 15(e)15d-15(e) under the Exchange Act), as of the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, our Chief Executive OfficerCEO and Chief Financial OfficerCFO have concluded that as of such date, ourDecember 31, 2023, the disclosure controls and procedures were effective.not effective due to material weaknesses in internal control over financial reporting, described below.

Notwithstanding the identified material weaknesses described below, management does not believe that these material weaknesses had an adverse effect on our reported operating results or financial condition and management has determined that the financial statements and other information included in this report and other periodic filings present fairly in all material respects our financial condition, results of operations, and cash flows at and for the periods presented in accordance with U.S. GAAP.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined under Rule 13a-15(f) and 15d-15(f) under the Exchange Act. Management has assessed the effectiveness of itsOur internal control over financial reporting as of December 31, 2017 based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). As a result of this assessment, management concluded that, as of December 31, 2017, its internal control over financial reporting was effective in providingis designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.GAAP and includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and the dispositions of our assets; (2) provide reasonable assurance that our transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2023, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). As a result of this assessment, management concluded that, as of December 31, 2023, its internal control over financial reporting was not effective because management identified material weaknesses in internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

We noted a material weakness related to the design of information technology general controls (ITGCs) in the areas of user access and program change-management over certain information technology (IT) systems related to revenue, veterinary invoice expense, accounts receivable, reserve for veterinary invoices and deferred revenue in our subscription business segment. We believe that these control deficiencies were a result of: (1) risk-assessment processes that were inadequate to identify and assess the scope of IT systems that could impact internal controls over financial reporting; and (2) IT control processes lacking sufficient documentation around the affected systems. Process level controls (business and automated) that are dependent on the affected IT environments were also deemed ineffective.

We also noted a material weakness related to the processing of transactions performed by an unaffiliated general agent related to revenue, veterinary invoice expense, accounts receivable, reserve for veterinary invoices and deferred revenue accounts within our other business segment. The Company had not sufficiently evaluated the design of processes and controls over such transactions, including ITGCs and process level controls.

These material weaknesses did not result in any material misstatements to the financial statements in this Form 10-K, and we have not identified any changes required to our previously issued financial statements.

We have completed substantive procedures for the year ended December 31, 2023. Based on these procedures, management believes that our consolidated financial statements included in this Form 10-K have been prepared in accordance with U.S. GAAP. Our CEO and CFO have certified that, based on their knowledge, the financial statements, and other financial information included in this Form 10-K, fairly present in all material respects our financial condition, results of operations and cash flows as of, and for, the periods presented in this Form 10-K. Ernst & Young LLP has issued an unqualified opinion on our financial statements, which is included in Item 8 of this Form 10-K.

In addition, Ernst & Young LLP has issued a report on our internal control over financial reporting as of December 31, 2023, and its report appears below.
94



Planned Material Weakness Remediation Activities
Management has been, and intends to continue, implementing measures designed to remediate the control deficiencies contributing to the material weaknesses described above. The remediation actions for the material weakness related to the design of ITGCs in the areas of user access and program change-management over certain information technology include: (1) enhancing our IT compliance oversight function and expanding our team members with experience designing and implementing ITGCs; (2) developing a training program addressing ITGCs and policies, including educating control owners about the principles and requirements of each control, with a focus on those related to user access and change-management over IT systems; (3) developing and maintaining documentation underlying ITGCs to promote knowledge transfer upon IT personnel and function changes; (4) developing enhanced risk assessment procedures and controls related to changes in IT systems; (5) implementing an IT management review and testing plan to monitor ITGCs; and (6) enhanced quarterly reporting on the remediation measures to the Audit Committee of our board of directors. With respect to the material weakness related to the processing of transactions performed by an unaffiliated general agent, we are developing our remediation plan.
A material weakness will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. Until management has concluded that we have remediated the material weaknesses, we intend to continue completing additional substantive procedures sufficient for management to believe that our consolidated financial statements have been prepared in accordance with U.S. GAAP.
Changes in Internal Control
There wereExcept for changes relating to the material weaknesses identified above, there have been no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d)13a-15(f) or 15d-15(d)15d-15(f) of the Exchange Act during the quarter ended December 31, 2017period covered by this Annual Report on Form 10-K that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
95


Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Trupanion, Inc.

Opinion on Internal Control Over Financial Reporting

We have audited Trupanion, Inc.’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, because of the effect of the material weaknesses described below on the achievement of the objectives of the control criteria, Trupanion, Inc. (the Company) has not maintained effective internal control over financial reporting as of December 31, 2023, based on the COSO criteria.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management's assessment. Management has identified a material weakness related to the design of information technology general controls (ITGCs) in the areas of user access and program change-management over certain information technology (IT) systems and related process controls related to revenue, veterinary invoice expense, accounts receivable, reserve for veterinary invoices and deferred revenue in the subscription business segment. Management has also identified a material weakness related to inadequate design of ITGC and process level controls over the processing of transactions performed by an unaffiliated general agent related to revenue, veterinary invoice expense, accounts receivable, reserve for veterinary invoices and deferred revenue accounts within the other business segment.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive loss, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes and financial statement schedule listed in the Index at Item 15(a)(2). These material weaknesses were considered in determining the nature, timing and extent of audit tests applied in our audit of the 2023 consolidated financial statements, and this report does not affect our report dated February 26, 2024, which expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the
96


company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP
Seattle, Washington
February 26, 2024


Item 9B. Other Information
None.

Rule 10b5-1 Plan

During the three months ended December 31, 2023, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted or terminated, including by modification, a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
97


PART III
Item 10. Directors, Executive Officers and Corporate Governance
Information required by this item is incorporated herein by reference to our Proxy Statement with respect to our 20182024 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the end of the fiscal year covered by this Annual Report.
Item 11. Executive Compensation
Information required by this item is incorporated herein by reference to our Proxy Statement with respect to our 20182024 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the end of the fiscal year covered by this Annual Report.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Information required by this item is incorporated herein by reference to our Proxy Statement with respect to our 20182024 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the end of the fiscal year covered by this Annual Report.
Item 13. Certain Relationships and Related Transactions and Director Independence
Information required by this item is incorporated herein by reference to our Proxy Statement with respect to our 20182024 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the end of the fiscal year covered by this Annual Report.
Item 14. Principal Accountant Fees and Services
Information required by this item is incorporated herein by reference to our Proxy Statement with respect to our 20182024 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report.

98



PART IV
Item 15. Exhibits, Financial Statement Schedules
(a)(1) Financial Statements
We have filed the financial statements listed in the Index to Financial Statements as a part of this Annual Report on Form 10-K.
(a)(2) Financial Statement Schedules
Schedule I Condensed Financial Information of Registrant
No other financial statement schedules have been provided because the information called for is not required or is shown either in the financial statements or notes thereto.
(a)(3) Exhibits
The listfollowing exhibits are filed as part of exhibits included in the Exhibit Index to this Annual Report on Form 10-K isor are incorporated herein by reference.
ExhibitIncorporated by ReferenceFiled/Furnished
NumberExhibit DescriptionFormFile No.ExhibitExhibit Filing DateHerewith
8-K001-365373.16/12/2023
8-K001-365373.26/12/2023
X
S-1333-1968144.16/16/2014
S-1333-19681410.16/16/2014
S-1333-19681410.26/16/2014
S-1333-19681410.36/16/2014
S-1333-19681410.46/16/2014
10-K001-36537
10.132/24/2015
10-K001-3653710.142/24/2015
10-K001-36537
10.152/24/2015
10-K001-3653710.232/14/2020
X
X
10-Q001-3653710.18/4/2023
99


8-K001-3653710.14/4/2023
8-K001-3653710.24/4/2023
10-Q001-3653710.28/4/2023
8-K001-3653710.19/6/2023
8-K001-3653710.210/29/2020
8-K001-3653710.310/29/2020
10-Q001-3653710.14/29/2022
X
X
X
X
X
X
X
X
101.INSXBRL Instance Document - the instance does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X
101.SCHInline XBRL Taxonomy Extension Schema With Embedded LinkBase Documents.X
104Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)X
+Indicates a management contract or compensatory plan or arrangement.
Registrant has omitted portions of the referenced exhibit pursuant to a request for confidential treatment under Rule 24b-2 promulgated under the Exchange Act. The omitted portions of this exhibit have been filed separately with the SEC.
*This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

100


Item 16. Form 10-K Summary
None.

101



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Seattle, state of Washington, on this 13th26th day of February, 2018.
2024.
TRUPANION, INC.
By:TRUPANION, INC.
By:/s/ Darryl Rawlings
Darryl Rawlings
Chief Executive Officer and PresidentChairperson of the Board
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Darryl Rawlings, Tricia PloufFawwad Qureshi and Asher Bearman,Chris Kearns, and each of them, as his or her true and lawful attorneys-in-fact, proxies and agents, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact, proxies and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, proxies and agents, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



102


Date: February 13, 201826, 2024/s/ Darryl Rawlings
Darryl Rawlings
Chief Executive Officer and PresidentChairperson of the Board
(Principal Executive Officer)
Date: February 26, 2024/s/ Fawwad Qureshi
Date: February 13, 2018/s/ Tricia Plouf
Tricia Plouf
Fawwad Qureshi
Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: February 26, 2024/s/ Max Broden
Max Broden
Director
Date: February 13, 201826, 2024/s/ Jacqueline Davidson
Jacqueline Davidson
Director
Date: February 26, 2024/s/ Paulette Dodson
Paulette Dodson
Director
Date: February 26, 2024/s/ Richard Enthoven
Richard Enthoven
Director
Date: February 26, 2024/s/ Dan Levitan
Dan Levitan
Director
Date: February 26, 2024/s/ Murray Low
Murray Low
Chairman of the Board of Directors

Director
Date: February 26, 2024/s/ Betsy McLaughlin
Betsy McLaughlin
Director
Date: February 13, 201826, 2024/s/ Chad Cohen
Chad Cohen
Director
Date: February 13, 2018/s/ Michael Doak
Michael Doak
Director
Date: February 13, 2018/s/ Robin Ferracone
Robin Ferracone
Director
Date: February 13, 2018/s/ Dan Levitan
Dan Levitan
Director
Date: February 13, 2018/s/ H. Hays Lindsley
H. Hays Lindsley
Director
Date: February 13, 2018/s/ Glenn Novotny
Glenn Novotny
Director
Date: February 13, 2018/s/ Howard Rubin
Howard Rubin

Director


EXHIBIT INDEX
The following exhibits are filed as part of this Annual Report on Form 10-K or are incorporated herein by reference. Where an exhibit is incorporated by reference, the number in parentheses indicates the document to which cross-reference is made. See the end of this exhibit index for a listing of cross-reference documents.
103
Exhibit   Incorporated by Reference Filed/Furnished
Number Exhibit Description Form File No. Exhibit Exhibit Filing Date Herewith
             
  10-Q 001-36537 3.1 8/28/2014  
             
  8-K 001-36537 3.1 6/3/2016  
             
  10-Q 001-36537 3.2 8/28/2014  
             
  S-1 333-196814 4.1 6/16/2014  
             
  S-1 333-196814 4.4 6/16/2014  
             
  8-K 001-36537 99.1 2/8/2018  
             
  S-1 333-196814 10.1 6/16/2014  
             
  S-1 333-196814 10.2 6/16/2014  
             
  S-1 333-196814 10.3 6/16/2014  
             
  S-1 333-196814 10.4 6/16/2014  
             
  S-1 333-196814 10.6 6/16/2014  
             
  S-1 333-196814 10.8 6/16/2014  
             
  10-Q 001-36537 10.2 5/5/2016  
             
  10-K 001-36537 10.13 2/15/2017  
             
  10-K 001-36537 10.14 2/15/2017  
             
  8-K 001-36537 10.1 2/8/2018  
             
  10-K 001-36537 10.15 2/15/2017  
             
  10-Q 001-36537 10.1 5/2/2017  
             




Date: February 26, 2024/s/ Zay Satchu
10-Q001-36537
10.111/2/2017
10-Q001-36537
10.211/2/2017
10-K001-36537
10.132/24/2015
10-K001-3653710.142/24/2015
10-K
001-36537

10.152/24/2015
10-K
001-36537

10.162/24/2017��
10-K
001-36537

10.172/24/2017
X
X
X
X
X
X
X
X
101.INSXBRL Instance Document.X
101.SCHXBRL Taxonomy Extension Schema Document.X
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.X
Zay Satchu
Director


104
101.LABXBRL Taxonomy Extension Label Linkbase Document.X
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.X



+Indicates a management contract or compensatory plan or arrangement.
Registrant has omitted portions of the referenced exhibit pursuant to a request for confidential treatment under Rule 24b-2 promulgated under the Exchange Act. The omitted portions of this exhibit have been filed separately with the SEC.
*This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.



Schedule I - Condensed Financial Information of Registrant

Trupanion, Inc.
Condensed Statements of Operations and Comprehensive Loss
(Parent Company Only, in thousands)
 Year Ended December 31,
 202320222021
Expenses:
Veterinary invoice expense$253 $4,144 $4,538 
Other cost of revenue240 2,340 2,610 
Technology and development1,507 4,930 3,130 
General and administrative5,345 16,346 11,714 
New pet acquisition expense806 9,351 9,177 
Depreciation and amortization494 289 473 
Total expenses8,645 37,400 31,642 
Loss from investment in joint venture(237)(192)(33)
Operating loss(8,882)(37,592)(31,675)
Interest expense11,998 4,255 (2)
Other income, net(14,442)(8,047)(5,755)
Loss before equity in undistributed earnings of subsidiaries(6,438)(33,800)(25,918)
Income tax benefit15,766 14,544 12,272 
Equity (loss) in undistributed earnings of subsidiaries(54,021)(25,416)(21,884)
Net loss$(44,693)$(44,672)$(35,530)
Other comprehensive income (loss), net of taxes:
Other comprehensive income (loss) of subsidiaries6,704 (9,378)
Other comprehensive income (loss)6,704 (9,378)
Comprehensive loss$(37,989)$(54,050)$(35,524)

105


Trupanion, Inc.
Condensed Statements of Comprehensive Loss
(Parent Company Only, in thousands)
  Year Ended December 31,
  2017 2016 2015
Expenses:  
Veterinary invoice expense $354
 $269
 $226
Other cost of revenue 239
 41
 44
Technology and development 528
 531
 628
General and administrative 4,204
 3,627
 3,852
Sales and marketing 889
 871
 621
Total expenses 6,214
 5,339
 5,371
Operating loss (6,214) (5,339) (5,371)
Interest expense 529
 218
 325
Other (income) expense, net (4,101) 23
 (2)
Loss before equity in undistributed earnings of subsidiaries (2,642) (5,580) (5,694)
Income tax benefit (expense) 5,302
 
 
Equity in undistributed earnings of subsidiaries (4,163) (1,316) (11,511)
Net loss $(1,503) $(6,896) $(17,205)
Other comprehensive income (loss), net of taxes:      
Other comprehensive income (loss) of subsidiaries 285
 125
 (513)
Other comprehensive income (loss) 285
 125
 (513)
Comprehensive loss $(1,218) $(6,771) $(17,718)
Trupanion, Inc.
Condensed Balance Sheets
(Parent Company Only)
(In thousands, except share data)
 December 31,
 20232022
Assets
Current assets:
Cash and cash equivalents$10,994 $16,052 
Accounts and other receivables5,739 
Prepaid expenses and other assets804 697 
Total current assets11,799 22,488 
Restricted cash22,963 19,032 
Property and equipment, net3,981 2,398 
Intangible assets, net5,808 5,710 
Other long-term assets12,540 13,960 
Advances to and investments in subsidiaries377,031 312,559 
Total assets$434,122 $376,147 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable, accrued liabilities, and other current liabilities$336 $484 
Long-term debt - current portion1,350 750 
Total current liabilities1,686 1,234 
Long-term debt127,580 68,354 
Deferred tax liabilities1,106 1,100 
Other liabilities28 162 
Total liabilities130,400 70,850 
Stockholders’ equity:
Common stock: $0.00001 par value per share, 100,000,000 shares authorized; 42,887,052 and 41,858,866 shares issued and outstanding at December 31, 2023; 42,041,344 and 41,013,158 shares issued and outstanding at December 31, 2022— — 
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized; no shares issued and outstanding— — 
Additional paid-in capital536,108 499,694 
Accumulated other comprehensive income (loss)403 (6,301)
Accumulated deficit(216,255)(171,562)
Treasury stock, at cost: 1,028,186 shares at December 31, 2023 and 2022(16,534)(16,534)
Total stockholders’ equity303,722 305,297 
Total liabilities and stockholders’ equity$434,122 $376,147 


































106


Trupanion, Inc.
Condensed Balance Sheets
(Parent Company Only)
(In thousands, except per share data)
  December 31,
  2017 2016
Assets  
Current assets:    
Cash and cash equivalents $1,105
 $3,401
Accounts and other receivables 2,261
 1,492
Prepaid expenses and other assets 295
 106
Total current assets 3,661
 4,999
Restricted cash 600
 600
Equity method investment 
 271
Property and equipment, net 661
 1,070
Intangible assets, net 4,795
 4,773
Other long term assets 2,488
 
Advances to and investments in subsidiaries 47,209
 40,086
Total assets $59,414
 $51,799
Liabilities and stockholders’ equity    
Current liabilities:    
Accounts payable, accrued liabilities, and other liabilities $654
 $492
Total current liabilities 654
 492
Long-term debt 9,324
 4,767
Deferred tax liabilities 1,002
 1,622
Other liabilities 
 203
Total liabilities 10,980
 7,084
Stockholders’ equity:    
Common stock: $0.00001 par value per share, 100,000,000 shares authorized at December 31, 2017 and December 31, 2016, 30,778,796 and 30,121,496 shares issued and outstanding at December 31, 2017; 30,156,247 and 29,498,947 shares issued and outstanding at December 31, 2016 
 
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized at December 31, 2017 and December 31, 2016, and 0 shares issued and outstanding at December 31, 2017 and December 31, 2016 
 
Additional paid-in capital 134,511
 129,574
Accumulated other comprehensive loss (92) (377)
Accumulated deficit (82,784) (81,281)
Treasury stock, at cost: 657,300 shares at December 31, 2017 and December 31, 2016 (3,201) (3,201)
Total stockholders’ equity 48,434
 44,715
Total liabilities and stockholders’ equity $59,414
 $51,799
Trupanion, Inc.
Condensed Statements of Cash Flows
(Parent Company Only, in thousands)
 Year Ended December 31,
 202320222021
Operating activities
Net loss$(44,693)$(44,672)$(35,530)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Loss attributable to investments in subsidiaries39,184 19,331 17,501 
Dividends from subsidiaries14,837 6,942 5,567 
Depreciation and amortization494 289 473 
Stock-based compensation expense4,575 33,393 28,226 
Other, net4,200 533 (161)
Changes in operating assets and liabilities6,194 (166)(1,219)
Net cash provided by operating activities24,791 15,650 14,857 
Investing activities
Cash paid in business acquisition, net of cash acquired— (15,034)— 
Purchases of property and equipment(172)(516)(280)
Advances to and investments in subsidiaries(87,198)(71,671)(71,721)
Other investments1,586 (1,598)(1,755)
Net cash used in investing activities(85,784)(88,819)(73,756)
Financing activities
Proceeds from debt financing, net of financing fees59,972 69,138 — 
Repayments of debt financing(1,225)(487)— 
Repurchase of common stock— (5,755)— 
Proceeds from exercise of stock options2,655 2,290 3,607 
Taxes paid related to net share settlement of equity awards(1,536)(4,359)(4,732)
Net cash (used in) provided by financing activities59,866 60,827 (1,125)
Net change in cash, cash equivalents, and restricted cash(1,127)(12,342)(60,024)
Cash, cash equivalents, and restricted cash at beginning of period35,084 47,426 107,450 
Cash, cash equivalents, and restricted cash at end of period$33,957 $35,084 $47,426 





Trupanion, Inc.
Condensed Statements of Cash Flows
(Parent Company Only, in thousands)
  Year Ended December 31,
  2017 2016 2015
Operating activities  
Net loss $(1,503) $(6,896) $(17,205)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:      
Loss attributable to investments in subsidiaries 4,163
 1,316
 11,511
Depreciation and amortization 697
 251
 126
Stock-based compensation expense 3,419
 2,946
 3,002
Gain on sale of equity method investment (1,036) 
 
Other, net (380) 58
 21
Changes in operating assets and liabilities 743
 1,742
 (1,383)
Net cash provided by (used in) operating activities 6,103
 (583) (3,928)
Investing activities      
Proceeds from sale of equity method investment 1,402
 
 
Purchases of property and equipment (135) 1
 (149)
Advances to and investments in subsidiaries (12,168) (9,333) (19,900)
Other investments (2,668) 
 (300)
Net cash used in investing activities (13,570) (9,332) (20,349)
Financing activities      
Proceeds from exercise of stock options 2,545
 3,745
 1,335
Taxes paid related to net share settlement of equity awards (1,170) (662) (643)
Proceeds from (repayment of) debt financing, net of financing fees 4,400
 4,988
 (14,900)
Other financing (604) (195) 
Net cash provided by (used in) financing activities 5,170
 7,876
 (14,208)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net 
 
 (517)
Net change in cash, cash equivalents, and restricted cash (2,296) (2,039) (39,002)
Cash, cash equivalents, and restricted cash at beginning of period 4,001
 6,040
 45,042
Cash, cash equivalents, and restricted cash at end of period $1,705
 $4,001
 $6,040
Supplemental disclosures      
Interest paid 333
 153
 155
Noncash investing and financing activities:      
Property and equipment acquired under capital lease 471
 
 
Cashless exercise of common stock warrants 
 600
 




1. Organization and Presentation
The accompanying condensed financial statements present the financial position, results of operations and cash flows for Trupanion, Inc. These condensed unconsolidated financial statements should be read in conjunction with the consolidated financial statements of Trupanion, Inc. and its subsidiaries and the notes thereto (the Consolidated Financial Statements). Investments in subsidiaries are accounted for using the equity method of accounting. Certain prior year amounts have been reclassified withinTrupanion, Inc. received cash dividends from subsidiaries of $14.9 million, $6.9 million and $5.6 million for the accompanying condensed financial statements from their original presentation to conform to the current period presentation. For the yearyears ended December 31, 2017,2023, 2022 and 2021, respectively. These cash dividends were recorded within Trupanion, Inc. recorded a cash dividend received from a subsidiary of $2.7 million within's other income. This dividend isincome and were eliminated within the consolidated financial statements of Trupanion, Inc.
The Company has made an immaterial presentation error correction within the Condensed Statements of Cash Flows, reclassifying prior years' dividends from subsidiaries from investing to operating activities. Additional information about Trupanion, Inc.’s accounting policies pertaining to intangible assets, commitments and contingencies, debt financing, stock-based compensation, stockholders’ equity, and income taxes are set forth in Notes 4, 7,5, 9, 10, 1112, 13, and 15,17, respectively, to the Consolidated Financial Statements.

107



Compensation expense related to stock-based transactions, including employee and non-employee stock option awards, restricted stock awards, and restricted stock units, is measured and recognized in the financial statements based on fair value. Effective January 1, 2023, we entered into an intercompany agreement with a non-insurance subsidiary whereby stock-based compensation costs are allocated to this entity. For the year ended December 31, 2023, stock-based compensation expenses of $28.3 million were included within equity (loss) in undistributed earnings of subsidiaries within the Condensed Statements of Operations and Comprehensive Loss and in advances to and investments in subsidiaries in the Condensed Balance Sheets. There was no impact to net income as a result of this intercompany agreement.

95
108